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Abstract 
ABSTRACT 
This thesis describes the kinetics and mechanism of oxidation of some 
drugs in different media. The reactions have been followed 
spectrophotometrically. The study of oxidation of drugs is of immense importance 
both from mechanistic and synthetic point of view. It has a bearing on the 
chemical processes of life also. 
The introductory chapter reports the kinetics and mechanism of oxidation 
of Levofloxacin (LF) by KMn04 in alkaline medium at a constant ionic strength 
(0.10 mol dm'^). It is a first order reaction, but fractional order in both LF and 
alkali. Decrease in the dielectric constant of the medium results in a decrease in 
the rate of reaction. The effects of added products arid ionic strength'have also 
been investigated. The main products identified were hydroxylated LF and 
Mn(VI). A mechanism involving free radical is proposed. In a composite 
equilibrium step, LF binds to MnOi Pto form a complex that subsequently 
decomposes to the products. Investigations of the reaction at different 
temperatures allowed the determination of the activation parameters with respect 
to the slow step of the proposed mechanism. 
Second chapter deals with the effect of cationic-cetyltrimethylam.monium 
bromide, (CTAB) and anionic surfactant sodium dodecyl sulphate, (SDS) on the 
rate of oxidation of D-penicillamine by alkaline hexacyanoferrate(III) has been 
^ " " ^ ^ ^ 
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Studied by spectrophotometrically at different temperatures. The effect of CTAB 
and SDS on the rate of reaction has been studied even below the critical miceller 
concentration (CMC) of the surfactants indicating binding of the substrate with 
the surfactants. On the basis of the kinetic results, the mechanism of the reaction 
has been proposed. The kinetic data have been rationalized in terms of Manger 
and Portnoy's model for micellar inhibition and binding parameters (viz. binding 
constants, partition coefficient, free energy transfer from water to micelle, etc.) as 
well as activation parameters. 
Two simple and sensitive kinetic methods for the determination of 
Ampicillin (AMP), are described. The first method is based on kinetic 
investigation of the oxidation reaction of the drug with alkaline potassium 
permanganate at room temperature at fixed time of 25 min. The absorbance of 
the colored manganate ions is measured at 610 nm. The second method is based 
on the reaction of AMP with l-chloro-2,4-dinitrobenzene (CDNB) in the presence 
of 0.1 mol/L sodium bicarbonate. Spectrophotometric measurement was done by 
recording the absorbance at 490 nm for a fixed time of 60 min. All variables 
affecting the development of the color were investigated and the conditions were 
optimized. Plots of absorbance against concentration in both procedures were 
rectilinear over the ranges 5-30 and 50-260 /4gmL~', with mean recoveries of 
99.75 and 99.91, respectively. The proposed methods were successfully applied 
for the determination of AMP in bulk powder and in dosage form. The 
Abstract 
determination of AMP by the fixed concentration method is feasible with the 
calibration equations obtained, but the fixed time method proves to be more 
applicable. 
Chapter four includes the kinetics of oxidation of L-Glutamic acid by 
quinoliniumdichromatre in perchloric acid medium. The rate of the reaction was 
found to increase with increasing concentrations of the L-Glutamic acid, 
perchloric acid and ionic strength. The reactions are first order with respect to 
both QDC and L-Glutamic acid. Added products, had insignificant effect on the 
reaction rate. The activation parameters have been evaluated and lend further 
support to the proposed mechanism. The thermodynamic quantities were also 
determined and discussed. 
Chapter five deals with the the kinetics and mechanism of substitution of 
cyanide ion in hexacyanoferrate(II) by EDTA catalysed by mercury(II), It has 
been studied spectrophotometrically at 365 nm in potassium hydrogen phthalate 
buffer ofpH = 5.0 and ionic strength, I = O.IM, maintained by (KNO3) at 25°C. 
Effect of the pH and concentration of the EDTA, [FefCN/'eJ on the rate of 
reaction has been studied. The kinetics and mechanism of the reaction has been 
shown through dissociative mechanism. The catalytic activity of mercury(II) has 
also been studied as a function of its concentration. The maximum reaction 
product was detected at pH = 5 after which a decline in absorption occurs 
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Abstract 
followed by precipitation. It is an inexpensive method to identify and remove the 
cyanide ion in solution even at very low concentration of the order oflO'^M. 
Kinetics and mechanism of oxidation of captopril (CPL) by 
hexacyanoferrate(lll) in alkaline medium has been studied 
spectrophotometrically. The reaction showed first order kinetics in 
hexacyanoferrate(III) and alkali concentrations and, an order of less than unity in 
CPL concentration. The rate of reaction increases with increase in alkali 
concentration. Increasing ionic strength increases the rate but the dielectric 
constant of the medium has no significant. A mechanism involving the formation 
of a complex between CPL and hexacyanoferrate(III) has been proposed. The 
reaction constants involved in the mechanism are evaluated. There is a good 
agreement between the observed and calculated rate constants under different 
experimental conditions. Investigations at different temperatures allowed the 
determination of the activation parameters with respect to the slow step of the 
proposed mechanism. 
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Abstract 
ABSTRACT 
This thesis describes the kinetics and mechanism of oxidation of some 
drugs in different media. The reactions have been followed 
spectrophotometrically. The study of oxidation of drugs is of immense importance 
both from mechanistic and synthetic point of view. It has a bearing on the 
chemical processes of life also. 
The introductory chapter reports the kinetics and mechanism of oxidation 
of Levofloxacin (LF) by KMnO.^ in alkaline medium at a constant ionic strength 
(0.10 mol dm'). It is a first order reaction, but fractional order in both LF and 
alkali. Decrease in the dielectric constant of the medium results in a decrease in 
the rate of reaction. The effects of added products and ionic strength have also 
been investigated. The main products identified were hydroxylated LF and 
Mn(VI). A mechanism involving free radical is proposed. In a composite 
equilibrium step, LF binds to MnOf Pto form a complex that subsequently 
decomposes to the products. Investigations of the reaction at different 
temperatures allowed the determination of the activation parameters with respect 
to the slow step of the proposed mechanism. 
Second chapter deals with the effect of cationic-cetyltrimethylammonium 
bromide, (CTAB) and anionic surfactant sodium dodecyl sulphate, (SDS) on the 
rate of oxidation of D-penicillamine by alkaline hexacyanoferrate(III) has been 
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studied by spectrophotometrically at different temperatures. The effect of CTAB 
and SDS on the rate of reaction has been studied even below the critical mice Her 
concentration (CMC) of the surfactants indicating binding of the substrate with 
the surfactants. On the basis of the kinetic results, the mechanism of the reaction 
has been proposed. The kinetic data have been rationalized in terms of Manger 
and Portnoy's model for micellar inhibition and binding parameters (viz. binding 
constants, partition coefficient, free energy transfer from water to micelle, etc.) as 
well as activation parameters. 
Two simple and sensitive kinetic methods for the determination of 
Ampicillin (AMP), are described. The first method is based on kinetic 
investigation of the oxidation reaction of the drug with alkaline potassium 
permanganate at room temperature at fixed time of 25 min. The absorbance of 
the colored manganate ions is measured at 610 nm. The second method is based 
on the reaction of AMP with 1 -chloro-2,4-dinitrobenzene (CDNB) in the presence 
of 0.1 mol/L sodium bicarbonate. Spectrophotometric measurement was done by 
recording the absorbance at 490 nm for a fixed time of 60 min. All variables 
affecting the development of the color were investigated and the conditions were 
optimized. Plots of absorbance against concentration in both procedures were 
rectilinear over the ranges 5-30 and 50-260 ngmL~', with mean recoveries of 
99.75 and 99.91, respectively. The proposed methods were successfully applied 
for the determination of AMP in bulk powder and in dosage form. The 
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determination of AMP by the fixed concentration method is feasible with the 
calibration equations obtained, but the fixed time method proves to be more 
applicable. 
Chapter four includes the kinetics of oxidation of L-Glutamic acid by 
quinoliniumdichromatre in perchloric acid medium. The rate of the reaction was 
found to increase with increasing concentrations of the L-Glutamic acid, 
perchloric acid and ionic strength. The reactions are first order with respect to 
both QDC and L-Glutamic acid. Added products, had insignificant effect on the 
reaction rate. The activation parameters have been evaluated and lend further 
support to the proposed mechanism. The thermodynamic quantities were also 
determined and discussed. 
Chapter five deals with the the kinetics and mechanism of substitution of 
cyanide ion in hexacyanoferrate(II) by EDTA catalysed by mercury(II), It has 
been studied spectrophotometrically at 365 nm in potassium hydrogen phthalate 
buffer ofpH = 5.0 and ionic strength, I = O.IM, maintained by (KNO3) at 25"C. 
Effect of the pH and concentration of the EDTA, [Fe(CNf'J on the rate of 
reaction has been studied. The kinetics and mechanism of the reaction has been 
shown through dissociative mechanism. The catalytic activity of mercury(II) has 
also been studied as a function of its concentration. The maximum reaction 
product was detected at pH = 5 after which a decline in absorption occurs 
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Abstract 
followed by precipitation. It is an inexpensive method to identify and remove the 
cyanide ion in solution even at very low concentration of the order of 10' M. 
Kinetics and mechanism of oxidation of captopril (CPL) by 
hexacyanoferrate(ni) in alkaline medium has been studied 
spectrophotometrically. The reaction showed first order kinetics in 
hexacyanoferrate(III) and alkali concentrations and, an order of less than unity in 
CPL concentration. The rate of reaction increases with increase in alkali 
concentration. Increasing ionic strength increases the rate but the dielectric 
constant of the medium has no significant. A mechanism involving the formation 
of a complex between CPL and hexacyanoferrate(III) has been proposed. The 
reaction constants involved in the mechanism are evaluated. There is a good 
agreement between the observed and calculated rate constants under different 
experimental conditions. Investigations at different temperatures allowed the 
determination of the activation parameters with respect to the slow step of the 
proposed mechanism. 
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Kinetics and Mechanism of Oxidation of Levofloxacin by permanganate 
Kinetics and Mechanism of Oxidation of 
Levofloxacin by Permanganate in Alkaline medium 
INTRODUCTION 
Potassium permanganate is widely used as an oxidizing agent where the 
reactions are governed by the pH of the medium. Of all the oxidation states (+2 
to +7) of manganese i-7 is the most potent state in both acid and alkaline media. 
Permanganate ion finds extensive application in organic synthesis [1-2] and, in 
catalysis [3-5]. Kinetic studies are important source of mechanistic information 
of the reaction as demonstrated by the results referring to unsaturated acids 
both in aqueous [6] and non-aqueous media [7]. The mechanism of oxidation 
depends on the nature of the substrate and pH of the system [8]. In strongly 
alkaline medium, the stable reduction product [9-11] of Mn04" is Mn04"". 
although MnOa appears only after the complete consumption of MnCf. No 
mechanistic information is available to distinguish between a direct one-
electron reduction of Mn(VIl) to Mn(Vl) and a mechanism, in which a 
hypomanganate ion is formed in a two-electron reduction followed by its rapid 
oxidation [12-13]. 
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Levofloxacin, (-)-(S)-9-fluoro-23-dihydro-3-methyl-10- (4-methyl- 1-
piperazinyl) -7-oxo-7H pyrido[l,2,3-cle]-l,4-benzoxazine-6-carboxylic acid 
hemihydrate (Fig.l) is one of the commonly used fluoroquinolone 
antimicrobials, being active S-isomer, was isolated from the racemic ofloxacin. 
Levofloxacin possesses a broad spectrum of activity against Gram-positive and 
Gram-negative bacteria [14]. It is also active against Chlamydia pneumoniae 
and Mycoplasma pneumoniae [15]. Because of its effective antibacterial 
activity and low frequency of adverse effect on oral administration, 
levofloxacin is widely used in the treatment of infectious diseases, such as 
community-acquired pneumonia and acute exacerbation of chronic bronchitis 
[16]. The antibacterial action of the quinolones is not linearly proportional to 
their concentration and optimum concentration must be maintained to prevent 
the replication of surviving bacteria [17]. The intrinsic fluorescence of 
fluoroquinolones is used for their determination in biological samples after 
their preliminary extraction with organic solvents [18]. A method was proposed 
for determining these antibiotics in biological fluids using a mixed-ligand 
complex formed by terbium and triphenyl phosphine oxide [19]. The 
interaction of fluoroquinolones with metal ions has attracted considerable 
interest not only for the development of analytical techniques but also to 
provide information about the mechanism of action of the pharmaceutical 
preparation [20]. Since the metal ions cause fluorescence quenching of the drug 
P«g^ 2 ^ 0 ^ 
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spectrofluorimetric method for quantitative determination of tlie quinolone type 
drugs has been developed [21]. Although titrimetric [22] spectrophotometeric 
[23], electrochemical [24], electrophoretic [25] and chromatographic [26] 
techniques are already in use they are time consuming. The accumulation of 
fluoroquinolone antibiotics in aquatic environments even in low 
concentrations, may cause threat to the ecosystem and human health by 
inducing multiplication of drug resistant bacteria as a result of long-term 
exposure. Chemical oxidation of pollutants in drinking and waste water by 
permanganate ion has been widely used. The present study is an attempt to 
explore the mechanistic pathway of oxidation of levofloxacin by permanganate 
ion in alkaline medium. 
EXPERIMENTAL 
Analytical reagent grade chemicals were used. Double distilled water 
was used throughout the work. The solution of Levofloxacin (Sigma-Aldrich, 
India) was prepared in distilled water. The potassium permanganate (Ranbaxy 
Fine Chem. Ltd, India) solution was prepared and standardized against oxalic 
acid[27]. Potassium permanganate solution was prepared as described by 
Carrington and Symons [28]. KOH and KNO3 (Merck Ltd., Mumbai, India) 
were employed to maintain the alkalinity and ionic strength, respectively. The 
absorption spectra were obtained with Elico-SL-169 double beam UV-vis 
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spectrophotometer. All potentiometric measurements were carried out with 
Elico-LI-120 pH meter.IR spectra of the product was scanned with Nicolet 
5700-FT-IR spectrometer (Thermo, U.S.A.). 
Kinetic measurements and procedure 
The oxidation of Levofloxacin by permanganate ion was followed 
under pseudo- first order conditions where its concentration was greater than 
that of manganese (VII), unless otherwise stated. The reaction was initiated by 
mixing previously thermostated solutions of Mn04' and Levofloxacin which 
also contained required quantities of KOH and KNO3 to maintain alkalinity and 
ionic strength, respectively. The course of the reaction was followed by 
monitoring the change in absorbance of Mn04' at its absorption maximum of 
526 nm. It was already verified that there was no interference from other 
reagents in the range of absorption under consideration. Application of Beer's 
Law was verified, giving e ^ 2083 ±50 dm^ mof' cm'' [9]. The first order rate 
constant Kobs was evaluated from a plot of log [permanganate] versus time. It 
was linear up to 75% of the reaction (Fig.2). Fresh solutions were used while 
conducting the experiments. Regression analysis of experimental data to obtain 
the regression coefficient, r and the standard deviation S of points from the 
regression line was done using a Microsoft Excel-2007. 
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RESULTS AND DISCUSSION 
The order of the reaction was determined form a plot of log^ oft^  versus 
log (concentration) of drug and, OH' separately keeping other factors constant. 
Keeping the concentration of LF (1.0 x lO"-' mol dm'-'), alkali ( 2.0 ^ 10'^  mol 
dm'^  ) and ionic strength constant (0.10 mol dm""') the permanganate 
concentration was varied in the range of 4.0 x 10'^  to 6.0 x 10"'* mol dm'''. All 
kinetic runs exhibited identical characteristics. The linearity of plots of log 
(absorbance) versus time, for different concentrations of permanganate 
indicates order in Mn(VII) concentration as uniform (Fig.2). It was also 
confirmed by the constant values of pseudo first order rate constants, kobs» for 
different Mn(VII) concentrations (Table 2). The LF concentration was varied 
(4.0x10''' to 6.0 X lO"'' mol dm'"') keeping permanganate concentration and ionic 
strength constant. The k^ bs increased with increaseing concentration of LF (Fig. 
4). At low concentration of LF, the reaction was first order and, at high 
concentrafion, the reaction was independent of its concentration. Keeping all 
other factors constant the alkali concentration was varied (1.0x10'"' to 1.0x10"^  
mol dm"^ ). The rate constant increases with increasing concentration (Fig. 5), of 
alkali indicating a fractional-order dependence of the rate on alkali 
concentration. 
Stoichiometry and product analysis 
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Different set of reaction mixtures containing LF and an excess of 
MnO"*" with constant OH" and KNO3 concentration were kept in closed vessels 
under nitrogen atmosphere. After 2 hours, the Mn(VII) concentration was 
assayed by measuring the absorbance at 526 nm. The results indicated a 1:2 
stoichiometry, as given in Scheme 1. 
A 
// 
\ 
0 0 
N Y N / 
OH 
/ N J 0 ^ 
/ 
Scheme I. 
0 0 
OH 
t2 
A, OH 
NJ OV\ 
H H J O 
The main reaction product, Mn(VI) and 9-fluoro-2,3-dihydro-3-methyl-
5-hydroxy-10-(4-methy 1-1 -piperazinyl)-7-oxo-7Hpyrido[ 1,2,3-cle]-1,4 
benzoxazine-6 carboxylic acid was isolated and identified by TLC and FT-IR 
spectrum. The v(C=0) of free LF at 1,722 cm"' was shifted to 1,626 cm"' when 
complexed with metal ions (Fig.6) suggesting coordination through the 
carboxylate group. 
This is known that when there is a difference of over 200 cm-1 between 
symmetric and antisymmetric (CO) streaching frequency of the carboxylate 
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group it is boded as a bidentate group while a difference of 100-200 cm"' in the 
same region it refers to a the bonding of carboxylate group in a monodentate 
fashion[29-30]. 
In a our case, we have observed a difference of 144cm"' (Table 1) 
between the antisymmetric and symmetric v(C=0) it is therefore ascertained 
that it is acting as monodentate group. The relative positions of the asymmetric 
and symmetric stretching vibrations are given in (Table 1) gives a separation 
>100 cm"', suggesting monodentate bonding for the carboxylate group. 
Effect of ionic strength, dielectric constant and temperature 
The effect of ionic strength was studied by varying the potassium nitrate 
concentration between 0.01 to 0.10 mol dm""' keeping all other parameters 
constant. The effect of the dielectric constant (D) was studied by varying the t-
butanol-water content (v/v) keeping all other conditions constant. The rate of 
reaction increases with increasing t-butanol volume. The plot of log kobs versus 
1/D was linear with positive slope (Fig.7). The kinetics was also studied at four 
different temperatures with varying concentrations of LF and alkali, keeping 
other conditions constant. The rate constant was found to increase with increase 
in temperature. The rate of the slow step was obtained from the slopes and 
intercepts of 1/kobs versus 1/[LF] and 1/kobs versus 1/[0H"] plots at four 
different temperatures (20-37°C). The activation energy corresponding to these 
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rate constants was evaluated from the Arrhenius plot of log k versus 1/T from 
which other activation parameters were obtained (Table 3). 
Test for free radicals 
In order to test for the interference by the free radicals, the acrylonitrile 
was added to the reaction mixture and then left for 24 hours under nitrogen 
atmosphere. Subsequent of methanol resulted in the precipitation of a polymer, 
suggesting the involvement of free radicals in the reaction. The blank 
experiment of reacting permanganate and LF alone with acrylonitrile did not 
induce polymerization under the same conditions. Initially added acrylonitrile 
decreased the rate of reaction [31] 
The reduction product of Mn(VII), i.e., Mn(VI) is stable at pH 12, and 
no further reduction is observed [10]. However, on prolonged standing, the 
green Mn(VI) is reduced to Mn(IV) under our experimental conditions. 
Permanganate ion in alkaline medium exhibits various oxidation states, such as 
Mn(VII), Mn(V) and Mn(VI). During the course of the reaction, colour 
changes from violet Mn(VII) to dark green Mn(VI) through blue Mn(IV). Fig. 
3 clearly shows five peaks in the spectrum of which three peaks are prominent. 
The concentration of MnO''" decreases at 526 nm as a result of the Mn(VII), 
while increases formation of Mn(VI) at 610 and 460 nm. As the reaction 
proceeds, a yellow turbidity slowly develops and, after keeping for a long time 
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the solution decolourises and forms a brown precipitate. This suggests that the 
initial products might have undergone further oxidation resulting in a lower 
oxidation state of manganese. It appears that the alkali combines with 
permanganate to give [Mn04.0H]^' [32-33]. In the second step, [Mn04.0H]^' 
combines with LF to form an intermediate complex. The variable order with 
respect to LF most probably results from the complex formation between 
oxidant and LF prior to the slow step. A plot of 1/kobs versus 1/[LF] (Fig.4) 
shows an intercept which is in confirmity with the complex formation. Further 
evidence was obtained from the UV-vis spectra of reaction mixtures. Two 
isosbestic points were observed for this reaction (Fig. 3), indicating an 
attainment of equilibrium before the slow step [34-35]. In our proposed 
mechanism, one electron is transferred from LF to Mn(VII), The cleavage of 
this complex (C) is regarded as the slowest step, leading to the formation of an 
LF radical intermediate and Mn(VI). The radical intermediate further reacts 
with another Mn(VII) species, [Mn04.0H]^', to give the, Mn(VI) and alcohol 
(Scheme 2). The effect of the ionic strength and dielectric constant on the rate 
is consistent with the involvement of a neutral molecule in the reaction. 
The proposed structure of the complex (C) is given below. 
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From Scheme 2, the rate law (Eq. 7) can be derived as follows: 
R a t e = ' - ^ ? ^ ' = kKiK2[Mn04-],[LFHOH-], (1) 
The total [Mn04"] can be written as 
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Rate ='-^^Jn24'] = kKiK2[Mn04-]f[LFMOH-]f 
[Mn04-]t = [Mn04-]f + [Mn04.0Hf'+ [Complex] 
= [Mn04-]f + [Mn04-][0H-] +KiK2[Mn04-][LF][OH-] 
= [Mn04-]f (1+ Ki[OH-] + KiK2[LF][0H-]) 
[Mn04-]t 2) 
[Mn04 ]f ^^ Ki[OH-] + KiK2[LF][0H-] 
where "t" and "f' stand for total and free concentration of [OH ]. Similarly, 
total [OH "] can be calculated as 
[OHIt = [OH-]f + [Mn04.0Hf-+ [Complex] 
[OH-]t (3) 
[0H-], =-
1+Ki[Mn04-] + KiK2[LF][Mn04-] 
In view of the low concentrations of Mn04' and LF, the terms Ar/[Mn04'] and 
KiK2\^XiO^\ [LF] in Eq.3 can be neglected 
Thus, 
[OH-]f = [OH-Jt (4) 
Similarly, 
[LF]f = [LF]t (5) 
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Substituting Eq. 2, 4, and 5 in Eq. 1 we get 
kKiK2[Mn04-][LF][OH-] 
Rsts — 
1+Ki[0H-] + KiK2[LF][0H-] 
(6) 
Or 
Rate ,^^^, kKiK2[LF][0H-] ^^ 
[Mn04"] 1+Ki(0H1 + KiK2[LF][0H-l 
Equation 7 confirms all the observed orders with respect to different 
species, which can be verified by rearranging then to equation 8. 
kobs kKiK2[LF][0H-] kKzILF] k '^ ^ 
The other conditions being constant, plots of 1/kobs versus 1/[LF] and 1/kobs 
versus 1/[0H'] are linear (Figs. 4 and 5). The slopes and intercepts of such 
plots yield Kl, K2 and k (Table 3). The rate constants were calculated from 
these values and, there is a reasonable agreement between the calculated and 
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the experimental [36] values (Table 2). The thermodynamic quantities for the 
first and second equilibrium steps of Scheme 2 can be evaluated. The [LF] and 
[OH "] (Table 1) were varied at four different temperatures. Van't Hoff s plots 
of \ogKi versus 1/T and \0gK2 versus 1/T gave the values of enthalpy, AH*, 
entropy, AS* and free energy of reaction, AG, calculated for the first and second 
equilibrium steps (Table 3). A comparison of the latter (from K2) with those 
obtained for the slow step of the reaction shows that they mainly refer to the 
rate-limiting step, supporting the fact that the reaction before the rate 
determining step is fairly fast and involves low activation energy [37-38]. The 
moderate values of AH* and AS* were both favorable for electron transfer 
process. The AS* value is within the expected range for radical reactions and 
has been ascribed to the nature of electron pairing and unpairing processes and, 
the loss of degrees of freedom formerly available to the reactants upon the 
formation of a rigid transition state [39]. The negative value of AS* indicates 
that complex (C) is more ordered than the reactants [40-41]. The enthalpy of 
activation and a relatively low value of the entropy and a higher rate constant 
of the slow step indicate that the oxidation most probably occurs via inner-
sphere mechanism [42-43]. A detailed mechanistic interpretation is given in 
scheme 3. 
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Mn04- + OH- - ^ [Mn040H]2-
Complex(C) 
i2- *^ 2 + [ M n 0 4 0 H ] 2 — ^ Complex (C) 
0 0 
/ . / ^ /x /H 
. +Mn042-+H2O 
Slow N'V N 
/ ' 
/ 
N.y 0 
0 0 
/ N 
0 0 
OH fast F N ^ 
. +[Mn040H] 2- OH 
/ 
+MnO/ 
Scheme 2. Mechanism for the Oxidation of Levofloxacin by Alkaline MnO/. 
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Mn04- + 0H- ^?=^ [Mn040Hl2 
O O 
+ [Mn040H] 2- ^^ 2 
N ^ 0 ^ 
(9" 
o o oJj 
^to , O 0 
Slow 
N ^ O . ^ / N ^ O^^ 
+ Mn042-+ H2O 
[Mn040H]''- + H*^ 
0 O 
2 . ^ u + - 5 ! L Mn042-+OH + [H] 
0 0 
N v ^ O ^ ^ 
Schemes. Detailed Mechanistic of Oxidation of Levofloxacin by 
Permanganate in Alkaline medium. 
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CONCLUSION 
It is noteworthy that the oxidant species [MnO"*'] required for 
completion of reaction at pH 12, gets disturbed below this pH and produces 
Mn(IV) product, which slowly develops yellow turbidity. In this reaction, the 
role of pH is crucial. The rate constant of the slowest step and other 
equilibrium constants involved in the mechanism were evaluated and, 
activation parameters with respect to the slowest step were computed. The 
proposed mechanism is consistent with the product and kinetic parameters. 
Page 
16 
Kinetics and Mechanism of Oxidation of Levofloxacin by permanganate 
Fig. I Structure of Levofloxacin 
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Fig. 2 First order plots of the oxidation of levofloxacin by permanganate in 
aqueous alkaline medium. [LF] = l^l(r\ [OH] = 2^1(r\ I = 0.10/mol 
dm-\ fMnO/Jy^IO' mol dm'^ = (A) 0.4, (B) 0.8, (C) 1.0, (D) 2.0, (E) 3.0. 
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400 450 500 550 600 
Wavelength (nm) 
650 700 
Fig.3 Spectral changes during the oxidation of levofloxacin (LF) by MnO/ 
in alkailine medium at 25 "C: fMnO/J = /x l(r\ [LF] = lxlff\ fOITJ 
= 2xl(r\l=0.10/moldm-\ 
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0.1 0.2 0.3 0.4 0.5 0.6 
l/|LF|10^(dm^nior') 
Fig.4 Plots ofl/kobs vs 1/[LF] at four different temperatures 
25 °C 
20 °C 
0.1 0.2 0.3 0.4 0.5 0.6 
l/|OH110^(dm^mor') 
Fig. 5 Plots ofl/kobs vs l/lOtT] at four different temperatures 
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Fig.6 FT-IR spectrum of oxidation product of levofloxacin 
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Fig. 7 Effect of dielectric constant on the oxidation of levofloxacin by 
alkaline MnO; at 25.0 °C. 
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Tablel. FT-IR frequencies (cm') of levofloxacin and its oxidation 
product 
Compound 
Levofloxacin 
Oxidation Product 
v(OH) 
3411 
3305 
v(C=0) 
1722 
1626 
Vasym (COO) 
1622 
1586 
V,yJCOO 
1462 
1442 
Table 2. Effects of/LFJ, [MnO''], and [OffJ on the oxidation of levofloxacin 
by permanganate at 25^C and ionic strength I = 0.10/mol dm'^. 
10*x [MnO/] 
(mol dm"^ ) 
lO^x [LF] 
(mol dm'^ ) 
Variation of [MnO/J 
0.4 
0.8 
1.0 
2.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
Variation offLFJ 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
0.4 
0.6 
0.8 
1.0 
4.0 
6.0 
Variation offOITJ 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
lO x^ [OH] 
(mol dm"^ ) 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
0.4 
0.8 
1.0 
2.0 
4.0 
6.0 
kcal X 1 0 ' 
(s-') 
4.12 
4.12 
4.12 
4.12 
4.12 
3.67 
3.76 
3.12 
4.28 
5.38 
5.41 
2.19 
2.39 
2.84 
3.32 
3.61 
4.43 
kobs X 1 0 ' 
(s-') 
4.10 
4.10 
4.10 
4.10 
4.10 
3.65 
3.74 
4.10 
4.25 
5.35 
5.40 
2.18 
2.38 
2.82 
3.30 
3.60 
4.41 
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Table 3. Activation and thermodynamic parameters for the oxidation of 
levofloxacin by alkaline permanganate with respect to the slow step 
of the reaction scheme 2 
Effect of temperature with respect to slow step oftl 
Temperature (K) 
293 
298 
303 
310 
Activation parameters 
Ea(kJmor') 
AH^(kJmor') 
A^(JK' mot') 
AG^(kJmor') 
le Scheme 1 
kxlO^(s') 
10.6 
11.8 
12.2 
13.5 
Values 
14.9 
11.9 
-143.2 
63.05 
(c) Equilibrium Constants Ki and K2 at Different Temperatures. 
Temp. (K) K, ^10-^dm^ mof^ 
293 
298 
303 
310 
5.44 
7.59 
9.62 
12.43 
(d) Thermodynamic K, values 
Parameters 
Aft(kJmor') 
AS^(JK' mor') 
ACt (kJ mol 
58.1 
123.5 
-8.7 
K2^ia^ dm^ mor' 
6.17 
6.69 
5.32 
4.34 
K2 values 
-78.6 
-89.7 
-8.35 
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Kinetics and Mechanism of D-Penicillamine 
Kinetics and Mechanism of Oxidation of 
D-penicillamine by Potassium 
HexacyanofeiTate(III) Ions in Aqueous Solution in 
the Presence of Sodium Dodecyl Sulphate and 
Cetyltrimethylammonium Bromide 
INTRODUCTION 
D penicillamine (D-PENSH) and 3-mercapto-D-valine are degradation 
product of P-lactam antibiotics. D-PENSH is used in the treatment of Wilson's 
disease to sequester copper from the brain [1]. It has also been used for the 
treatment of cystiuria, heavy metal poisoning and rheumatoid arthritis [2]. 
Several methods have been reported for its analysis including colorimetry [3-
11], fluorimetry [12]. chromatography [13-21], flow injection analysis [22-
24], electrophoresis [25-27], potentiometry [28-29], voltammetry [30-33] and 
NMR spectrometry [34-35]. 
Rates of enzymatic, organic and inorganic reactions have been 
investigated in the presence of micelles formed by a variety of surfactants after 
undergoing both thermal and photochemical reactions [36]. Most kinetic 
studies of micellar effects upon electron-transfer reactions have been made 
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utilizing charged micelles as reaction medium, where both hydrophobic and 
electrostatic interactions have been found [37]. The rate of bimolecular 
reaction between organic substrates and inorganic ions are affected by the 
medium of chemical reaction and properties of the micellar surface. They are 
also dependent on how strongly organic substrates and reactive ions bind to 
micellar surfaces [38]. Hexacyanoferrate(III) is a one electron oxidant with a 
redox potential of + 0.36V [41], which has been used extensively to study the 
oxidation of many organic substrates [39-43]. 
In this work the oxidation of D-PENSH by hexacyanoferrate(III) in 
aqueous solution has been studied in detail in presence of cationic surfactants, 
cetyltrimethylammonium bromide (CTAB ) and anionic surfactant, sodium 
dodecyl sulphate (SDS). The effect of CTAB and SDS on the rate of reaction 
has been observed even below the critical miceller concentration (CMC) of the 
surfactants indicating binding of the substrate with the surfactants. On the basis 
of the kinetic results, the mechanism of the reaction has been proposed. The 
kinetic data have been rationalized in terms of Manger and Portnoy's [44] 
model for micellar inhibition, binding parameters (viz. binding constants, 
partition coefficient, free energy transfer from water to micelle, etc.) and 
activation parameters. 
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EXPERIMENTAL 
Materials 
Stock solution of potassium hexacyanoferrate(III) (BDH), D-PENSH 
and the surfactants, SDS, and CTAB (Merck Ltd, Mumbai, India) were 
prepared just before the experiment to avoid ageing. Hexacyanoferrate(II) 
solution was prepared by dissolving a known amount of K4[Fe(CN)6] in water. 
NaOH and NaC104 (Merck Ltd, Mumbai, India) were used to maintain 
alkalinity and ionic strength respectively. 
Procedure 
Appropriate quantities of solutions of hexacyanoferrate(III), NaOH and 
surfactant were transferred in a 50 cm^ glass vessel. The reaction was initiated 
by adding a suitable amount of D-penicillamine and placed separately on a 
water bath maintained at adesired temperature. The rate of reaction was 
measured by monitoring the absorbance by hexacynoferrate(III) as a function 
of time at 420 nm. Molar absorption coefficient of hexacynoferrate(III) was 
found to bel060±50 dm^mof'cm''. 
Critical Micelle Concentration 
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CMC of the surfactant (CTAB and SDS) solution was determined from the 
curve of specific conductivity versus surfactant concentration and, the break 
point of nearly two straight lines was taken as an indication of micelle 
formation [45^6] (Table 4). 
Stoichiometry of the Reaction 
The reaction mixtures containing an excess of [Fe(CN)6 "^] over [D-
PENSH] were kept separately in presence and absence of alkali and in presence 
of each surfactant at 25°C for 24 h. The amount of unreacted [Fe(CN)6 '^] in 
reaction mixture was determined spectrophotometrically. The reaction may be 
represented by the following scheme 1. 
2 D - P E l S r S H + 2 F e ( C N ) 6 ^ - + 2 O H " 
D - P E N S — S N E P - D + 2 F e C C N ) ^ ^ - f - H 2 O 
Scheme 1 
Evaluation of rate constant 
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The reaction was studied at different concentrations of the reactants. The 
log (absorbance) versus time plots (Fig. 1) were linear upto 80% of the reaction 
which suggests a first-order dependence of the rate in hexacyanoferrate(III). 
Thus, the pseudo first-order rate constant k^ in hexacyanoferrate(III) was 
evaluated from the slopes of these plots. The results were reproducible within 
±5% in repeat kinetic runs. 
RESULTS AND DISCUSSION 
In the absence of the surfactants the reactions showed a first order 
dependence of the rate with respect to each alkali, oxidant and substrate 
concentration. The observed rate constant k^ in the presence of surfactant at 
different initials concentration of [hexacyanoferrate(lll)] were almost identical 
(Table 1). The plot of ^^  versus [substrate] was found to be linear (Fig. 2) in the 
absence of the surfactant, while in the presence of surfactant the rate constant 
deviates from linearity at higher concentrations of the substrate, suggesting that 
in the presence of surfactant the order of reaction in substrate decreases at 
higher [substrate]. The plot of 1/^ ,^  versus 1/[substrate] in the presence of the 
surfactant (Fig. 3) was also found to be linear with a positive intercept, which 
further confirmed the suggested Michaelis-Menten type kinetic behavior. 
The effect of alkali on the rate of oxidation at fixed ionic strength were 
identical both in the absence and presence of surfactants. The plot of k^ versus 
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[OH ] (Fig. 4) was linear with positive slope, suggesting a first-order 
dependence of rate with respect to [0H~]. 
It is noteworthy that even the addition of hexacyanoferrate(II) (0.002 
mol dm~^  ) and sodium perchlorate ( 0.04 mol dm" )^ had negligible effect on 
rate of oxidation of D-PENSH in the presence of surfactants. 
The effect of each surfactant on the rate of reaction has been studied 
over a wide concentration range of surfactant at four temperatures. The rate 
constant of surfactant shows that k^ decreases on increasing surfactant 
concentration (Figs. 5 and 6) and attains constancy at higher concentration. The 
retarding effect of CTAB and SDS has been observed below CMC of surfactant 
(9.4x10"'' mol dm"^  in case of CTAB and 7.8 x 10""^  mol dm"^  in case of SDS). 
The activation parameters (£a, A// and AV ) have been evaluated in the 
presence and absence of the surfactant using Arrhenius and Eyring equations 
(Table 2). The large values of £a and A// in the presence of surfactants are 
consistent with the accepted view that the slow reaction (in the presence of 
surfactant) would require a higher £a or A//*. The entropy of activation is less 
negative in presence and absence of the surfactant. A negative value of AS* 
indicates that the activated complex in the transition state has a more ordered 
structure than the reactants in the ground state [47]. A positive change in 
entropy of activation in the presence of the surfactant, (less negative AS") 
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suggests that the reactants become relatively more rigid, which is not 
surprising, in view of the binding of the reactants to the surfactant. Change in 
the free energy (AG° =55.5±1.0 kJ/mol) suggests the same mechanism of 
reaction both in the absence and presence of surfactants. 
On the basis of kinetic results, the mechanism of reaction in the absence 
of surfactant may be proposed (Scheme 2). 
D-PENSH + OH — ^ D-PENS'+ H2O 
D-PENS' + Fe(CN)6^- , ^ ' D-PEN^+ Fe(CN)6^- Slow 
D-PENS + D-PENS' - ^ D-PENS-SNEP-D Fast 
D-PENS + Surfactant ^ Product W 
Scheme 2 
The formation of D-PENS~ in alkaline medium and the existence of its 
free radical in the presence of one or two electron abstracting oxidant is 
reported [47]. 
According to Scheme 2, the rate of disappearance of [Fe(CN)6''" ] may be 
shown as, 
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- ^Fe(CN)6^- ] ^ i:^[D-PENS][Fe(CN)6^-] (1) 
dt 
And 
[D-PETvJS] = A : / [ D - P E T N J S H ] [ O H ] ( 2 ) 
Ki also includes water molecule. On substituting the value of [D-PENS~] in Eq. 
(1), the rate law becomes, 
- ( l [ F e ( C N ) 6 ^ = i:,[D-PENSH][OH][Fe(CNV-l (3) 
dt 
The rate law (3) is in agreement with the first-order dependence of rate with 
respect to hexacyanoferrate(III), [OH] and substrate concentration in the 
absence of the surfactants. A positive salt effect in the absence of surfactant is 
also in favour of the rate determining step involving interaction between 
similarly charged species. In the presence of the surfactants, an inhibition effect 
on the rate of reaction and kinetic results suggests the binding of substrate with 
the surfactants (Scheme 2). 
The total concentration of D-PENSH is given as 
[D-PENSH]T =[D-PENSHj+[D-PENSl + [Xl (4) 
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where [D-PENS] = /^[D-PENSH][OH-l, and 
[X] *[D-PENS][Surfactant] =i:/^ [^D-PENSH][OH-][Surfactant] 
On substituting the value of [D-PENS~] and [X] in Eq. (4), the value of [D-
PENSH] in terms of [D-PENSH]T may be obtained as. 
p-BSBl = £ 5 5 * (51 
l+pH-]!l+fc[Surfactaiit]} 
Therefore, the rate law (3) in terms of [D-PENSH], may be written as, 
_d[Fe(CN)e'-] . ^/[D-PENSH]T [OHI [ F e P ) / ' ] (^ j 
~ d t l+A:,[OH-]{l+&[Surfactant]} 
The rate law (6) is in agreement with the observed experimental results in the 
presence of surfactants, i.e. first-order dependence of the rate with respect to 
hexacyanoferrate(III) and D-PENSH concentration; fractional order 
dependence of the rate with respect to [OH"^ ] and retarding effect of surfactants 
on the rate of reaction. To evaluate the binding constants between the substrate 
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and surfactants (Scheme 3), the kinetic data have been analysed in terms of 
Mangar and Portnoy's [48] model reported for micellar catalysis/inhibition. 
According to this model the substrate 'S' is distributed between the aqueous 
and micellar pseudo phase (Scheme 3.) 
Dn 
K. 
^. Product -^-
SjDn 
Scheme 3 
The observed rate constant A:^  may be given as 
Kf/ = 
k,„ + l(mKs{[D] - CMC} 
1 + Ks{[D] - CMC} 
(7) 
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where k^^, k^, k^ are rate constants in aqueous phase, micellar media and 
observed rate constant, respectively. A^s is the binding constant of substrate with 
surfactant. Dn, S, and SDn represent micellar surfactant, free substrate, and 
associated substrate, respectively. 
The above equation may be rearranged in the form 
K-h K-X K-i^MDj-CMC} 
(8) 
This equation (8) has been found to be most appropriate for continuous 
binding in different reactions. The applicability of Mangar and Portnoy's [44] 
model can be tested by the plot of l/( k,„ - k^) versus 1/{[D]-CMC}. The k„, 
and Ks may also be evaluated with the help of intercept and slope of the plot. In 
the present investigation the binding of CTAB and SDS has been observed at 
the concentrations which are below their CMC. The validity of the equation in 
this case has been tested by plotting l/( ^^ - k^) against 1/{[D]-CMC} (Figs. 7 
and 8) and showed the applicability of the Mangar and Portnoy's model in the 
system. The k^ and K^ have also been evaluated. The K^ of the substrate with 
surfactant can also be correlated to the partition coefficient, P i.e. 
[substrate]micelle / [substrate]water ratio [49-52], by the following relation. 
Page 37 
Kinetics and Mechanism of D-penicillamine 
K, = 1^1^ 
where ^ is the partial molar volume [53] of surfactant monomer. The 
standard transfer free energy [54-55] per mole A//° of a solute from water to 
micelle is also related to binding constant, K^ by the following equation. 
A//0 = -RTln(55.5)Ks 
The effect of organized structure on the rate of chemical reaction has 
been attributed to the hydrophobic and electrostatic interactions (Table 3). The 
electrostatic surface potential at the miceller surface can attract or repel the 
reaction species and hydrophobic interactions can bring about incorporation 
into micelle even if the reagent bears the same charge. Thus, the rate and the 
mechanism of chemical reactions may be affected by electrostatic or 
hydrophobic interactions. The results of the present investigation can be 
explained on the basis of both the electrostatic and hydrophobic forces. 
The observed kinetic data, retardation of the rate with an increase in 
surfactant concentration and negative values of k^ in the case of CTAB and 
SDS indicate that the reaction between negatively charged D-PENSH and 
hexacyanoferrate (III) proceeds in the aqueous phase, not in the miceller phase. 
When surfactant is present in the reaction mixture, it binds the substrate by 
hydrophobic interactions causing a decrease in the concentration of the 
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substrate in aqueous phase and, thus a retarding effect of the surfactant on the 
rate of reaction was observed. High value of A^s and P in case of CTAB clearly 
indicates that the D-PENSH is more solubilized or bind with CTAB. In case of 
CTAB, the electrostatic attraction between D-PENS" and positively charged 
surfactant in alkaline medium may favor the binding of surfactant with 
substrate in addition to hydrophobic interactions. Thus, CTAB binds the 
substrates leaving a small fraction in aqueous phase. In case of SDS, the 
electrostatic repulsion between negatively charged substrate and anionic 
surfactant opposes the binding between the surfactant and the substrate. Thus, 
the hydrophobic interaction favored the binding while electrostatic repulsions 
opposed it. Consequently, the binding between the surfactant and the substrate 
may be less (and hence a less retarding effect of the surfactant on the rate) in 
case of SDS. This is supported by the low values of K^ and P of SDS in 
comparison with CTAB. The K^ and P decrease with increasing temperature 
in both CTAB and SDS. It suggest that the binding is an exothermic process. 
The transfer of free energy change per mole from water to micelle (A//°) are 
also in accordance with the above results. 
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Fig.l Plots ofabsorbance versus times (min) at 25°C,[Fe(CN)/'] = 10.0 
^10~^ mol dnf\ [substrate] = 12.0^ 10'^ mol dnf\ fCTABJ = 5.5 x 
10" mol dm~\ fOirj= A= 2^10~^ B = 2^10'^ C = 2^10'^ D = 2x10'^ 
andE = 2^10'^ mol dm'^ respectively, l=0.8x 10'^ mol dm~^ 
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I 
O I 
(Substrate) X iO mol dm 
Fig.2 Plot ofk^ versus [D-PENSH] at 25"C. fFe(CN)/-J = 10.0 ^10~^ mol 
dm~\ [0H~] = 2^10~^ mol dm~^ respectively, 1 = 0.8^ 10~^ mol dm~^ 
1.2 n 
R = 0,9793^ 
l/|Substrate| X 10 mol dm 
Fig.3 Plots ofl/kij/ versus 1/fsubstrateJ at 25''C. /Fe(CN)/~J = 10.0 x 10'^ 
mol dm~\ [OH-] = 2.0 x 10'^ mol dm~^, fCTABJ = 5.5 x 10'^ mol 
dm-3, fSDSJ = 13.86 x 10'^ mol dm~\ respectively. I = 0.8>^ 10'^ mol 
dm~^ 
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Fig. 5 Plots ofk^ versus [surfactant/ at various temperatures. [Fe(CN)6~] 
=10.0^10'^ mol dm'\ [D-PENSH] = 12.0^10'^ mol dm~\ [0H-] = 
2.0^ 10'^ mol dm~\ 
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Fig.6 Plots ofk^ versus [surfactant] at various temperatures. fFe(CN)/ J 
=10.0x10'^ mol dm~\ [D-PENSH] = 12.0^10'^ mol dnf\ fOH-J = 
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Fig. 7 Plots ofl/(k(,j - k^) versus 1/{[D]-CMC} at different temperatures; 
llFe(CN)t] =10.0^10' mol dm~\ [D-PENSHJ = 12.0^10'^ mol dm'\ 
fOH-J = 2.0X 10~^ mol dmi 
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[Fe(CN)t] =10.0^10-^ mol dm~\ [D-PENSH] = 12.0^10-^ mol dm'^ [OfTJ 
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Table 1. Effect of [hexacyanoferrate(III)J on the rate constant at 25''C, [D-
PENSH] = 12.0x10^ mol dnf^, fCTABJ = .55^10^ mot dm^, 
fSDSJ =12.25x10-^ mol dm^ and [OH-] =2.0x10^ mol dm-^ 
IFe(CN)tl 10' (mol dm ') 
6.0 
8.0 
10.0 
12.0 
14.0 
k^^IoUmoldm ^s ') 
jCTABI 
8.7 
8.1 
8.6 
8.6 
8.6 
ISDSl 
3.2 
3.1 
3.0 
3.0 
3.0 
Table 2. Activation parameters for the oxidation of D-PENSH in absence 
and presence of surfactants 
Surfactant 
Absent 
CTAB 
SDS 
Ea(kJmor') 
71.4 
73.6 
91.5 
Mf(kJmor') 
69.5 
70.4 
88.2 
-AS** (JIT' mor') 
123.6 
116.3 
69.4 
A<f(kJmor') 
54.9 
56.3 
55.6 
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Table 3. Binding Constants (Ks) and Rate Constants in Micellar Media (lint) 
Partition Coefficients (P), Partial molar volume and Free-Energy 
Transfer from Water to Micelle f-A/i") at Different Temperatures 
2 
1 
i5i 
ICC 
25''C 
acc 
35°C 
CTAB 
kmlOf 
(mot 
dnf^ s') 
9.2 
44 
2\ 
1.3 
Ks 
JO" 
302 
255 
223 
126 
P 
1142 
857 
571 
285 
V 
26 44 
29.75 
39.06 
44.21 
-A^yU 
mar') 
101 4 
98.7 
96.0 
904 
SDS 
km 
10^ (mol 
dm~^ s') 
11.2 
7,6 
4.3 
2.6 
Ks 
10" 
2.31 
2,14 
1.57 
1 13 
P 
88 
4.4 
18 
14 
V 
26,25 
4863 
88.70 
84 96 
-/^'(kJ 
mar') 
666 
648 
62.2 
58.9 
Table 4. Critical micelle concentration value of CTAB and SDS surfactant in 
the presence of [Fe(CN)3-6 ] =10.0x10'^ mol dm~\ [D-PENSH] = 
12.0>^10~^ mol dm~^ 
Surfactant 
CTAB 
SDS 
CMC mol dm ^ 
9.4x10"' 
7.8x10"' 
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Kinetics of Ampicillin 
The determination of Ampicillin in Pharmaceutical 
Preparations by potassium permanganate and 1 -
chloro-2,4-dinitrobenzene 
INTRODUCTION 
Ampicillin, AMP (6R)-6-(a-phenyl-D-glycylamino) penicillanic acid 
(Fig 1) is a semisynthetic penicillin [1] . It is prepared from the benzylpenicillin 
or penicillin-G [2], which is prepared by a biosynthetic process using various 
strains of Penicillium notatum and Penicillium chrysogenum [3] Penicillin-G 
was the first antibiotic to be used in the chemotherapy. It is a bacterio static 
drug of choice for the treatment of infections caused by most of the Gram-
positive and Gram-negative bacteria [4-5]. AMP is acidic in nature, and it acts 
by inhibiting the protein synthesis [6] of the bacterial cell wall. The basic 
ampicillin is 6-aminopenicillanic acid, which consists of a thiazolidine ring 
linked to p-lactam ring. The side chain determines the antibacterial and 
pharmacological characteristics of this compound [7]. Several procedures 
reported for the determination of ampicillin in pure form, pharmaceutical 
formulations and biological fluids include spectrophotometric [8-11], 
polarographic [12-13], flow injection analysis [14] and HPLC [15-16]. The 
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complexes of ampicillin with different metal ions have also been studied [17-
19]. 
Kinetic-based methods of pharmaceutical analysis are not widely 
applied although they do not suffer any interference from additives which 
probably affects other methods. 
In the present work, we are reporting a spectrophotometric method for the 
determination of AMP by measuring the absorbance at 610 nm after its 
oxidation by alkaline KMn04 or, at 490 nm after addition of CDNB in the 
presence of borate buffer. All variables affecting the development of the color 
were investigated and the conditions were optimized. The determination of 
AMP by the fixed concentration method is effective with the calibration 
equations obtained, but the fixed time method proves to be more sensitive. 
EXPERIMENTAL 
Apparatus 
A Shimadzu UV-visible 1601 spectrophotometer, Elico-LI 120 pH 
meter and a water bath shaker NSW 133, India were used. 
Materials 
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Ampiciline (Sigma, India) KMn04, NaOH, HCl and CDNB, (Merck 
Ltd, Mumbai, India) were used. Pharmaceutical preparations were purchased 
from commercial sources in the local market. Double distilled, de-ionized 
water was used throughout. Stock solutions of the compounds were wrapped 
with carbon paper to protect them from light. 
Preparation of standard Solution 
The stock solution of AMP (1 xiO'^ M) was prepared in 1 xiO"^ M M HCl 
and stored at 4°C. 
Procedure A 
AMP equivalent to 5-30 |ag mL~' (solution A) was transferred into a 
series of 50 mL volumetric flasks. To each flask 1 mL of 0.5 mol L"' NaOH 
and 2 mL of 5x10"^ mol L"' KMnOa was added and made up with water, and 
left to stand for 25 min. The absorbance of the resulting solution was measured 
at 610 nm at 5-min intervals at ambient temperature (25°C) against a blank 
solution prepared simultaneously. To obtain the standard calibration curve, a 
plot of absorbance against the concentration of drug was made. 
Procedure B 
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Aliquots equivalent to 50-260 i^g mL"' AMP (solution B) were transfer 
into a series of 10-mL volumetric flask. To each flask 2 mL of 3.5 x lO"'^  mol 
L'' CDNB and 0.2 mol L"' borate buffer was mixed and made up to the mark 
with distilled water, and left to stand for 60 min. The absorbance of the reaction 
mixture was measured at 490 nm at 10-min intervals at ambient temperature 
(25 °C) against a blank solution. To obtain the standard calibration curve, a plot 
of absorbance against the concentration of AMP was made. 
Procedures for formulations 
The drug equivalent to 500 mg of AMP was transferred into a 100 ml 
volumetric flask containing about 75 ml of distilled water. It was shaken 
thoroughly for about 15-20 min, filtered through a Whatman filter paper No. 
40 and made up to the mark with distilled water. 25 ml of the filtrate was 
diluted to 100 ml and a suitable aliquot was analyzed . 
RESULTS AND DISCUSSION 
Optimization of the reactions conditions: 
Method A (oxidation with KMn04) 
The reaction between AMP and KMn04 in alkaline solution yields a 
green color as a result of the formation of manganate ion, which absorbs at 610 
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run (Fig. 2). The maximum intensity of the color is attained after 25 min, and 
remains stable for at least 1 h. The reaction was investigated under various 
\»i** ^" '^^  ^bt 
conditions of reagent concentration and alkalinity. ^»^/- '~ '^ '*^-^-N^ 
¥^/ > • 
The influence ofKMn04 on the absorbance %*^<; ^ ^ > ^ 
An increase in the rate of reaction is directly proportional to the 
concentration of KMn04. The absorbance was studied in the range 1x10''' to 
1 X 10'^  mol L ' keeping all other parameters constant. It was found that 7.5 x 
10''' mol L~' KMn04 is the optimum concentration for the absorbance of AMP 
as shown in (Fig 3). The effect of the colour development was investigated by 
adding different volumes (0.1-2.0 ml of 7.5 x lO"'' mol L~') of KMn04 to the 
drug. The maximum absorbance of the green colour was attained with 1.8 ml of 
the reagent, and then remained constant even when higher volumes were added 
(Fig. 4) and hence 2 ml of the reagent was used throughout the experiment. 
The influence of the NaOH 
The absorbance of Mn04^' was also examined as function of volume 
(0.2-2.0ml) of 0.5 mo! i ; ' NaOH at 25°C. The optimum absorbance was 
obtained with 0.9 ml NaOH, after which increase in volume of NaOH did not 
make any change in absorbance. 1 ml of 0.5mol L~' NaOH was, therefore, used 
throughout the experiment (Fig.5). 
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Method B (complexation with CDNB) 
The reaction of AMP with CDNB in slightly alkaline borate buffer 
produces an orange-yellow color with maximum absorbance at 477 nm (Fig. 
6). This bathochromic shift from 370 nm CDNB to 490 nm may be attributed 
to the formation of a charge transfer complex through n-u* interaction, where 
the electron donor is the amine moiety and the ;i-acceptor is the CDNB moiety 
of the drug [20]. The possibility of the reaction of AMP with CDNB was 
investigated under various conditions. It was found that the reaction proceeds 
in alkaline medium at room temperature. The colored adduct remains stable for 
about 1.5 hours. The extent of formation of this species depends on the 
concentration of reactants, alkalinity, temperature and pH. 
The influence of the CDNB 
The effect of CDNB concentration on the absorbance of yellow colored 
Meisenheimer complex was studied in the range 1 x 10"'^  - 4 xiO"-^  mol L~'. It 
was found that 3.5 x 10"' mol L ' CDNB is the optimum concentration for the 
absorbance of AMP (Fig.7). Therefore, the optimum concentration of 3.5 x 10'"' 
mol L"' of CDNB was chosen for further work. 
The influence ofpH 
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Maximum absorbance was obtained at pH 7.8 after which the 
absorbance of the reaction product began to decrease gradually until pH 9.5., 
The optimum pH was, therefore, kept at 7.8 (Fig. 8). Other buffers having the 
same pH such as phosphate buffer and hexamine buffer were tried and 
compared with 0.2 mol If' of borate buffer. The borate buffer was found to be 
superior to other buffers of the same pH since it gave the highest absorbance. 
Calibration Graphs 
After optimizing the reaction conditions, the fixed time was applied to 
the determination of AMP in pure form over the concentration ranges 5-30 
^g/mL and, 50-260 jig/mL for both methods. (Fig. 9,10). 
Analysis of the data gave the following regression equations: 
A = 0.1606 + 0.01054C (r= 0.9906) Method A 
A = 0.3068 + 0.001126C (r = 0.9919) Method B 
Kinetic study of the reactions 
The rate of the reaction was studied at room temperature and was found 
to be dependent on the concentration of AMP. 
The rates were followed with: 
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1. In the range 5-30 |^ g mL"', keeping KMn04 and NaOH constant at high 
concentration as described in the general procedures, applying method A; and 
2. In the range 50-260 jjg mL~', keeping other reactants, and CDNB constant at 
high concentration as described in the general procedures, applying method B. 
It is clear from the plots (Figs. 11 and 12) that the rate is proportional to 
the concentration of AMP and obeys the equation: 
Rate = K'[AMP]" (1) 
where K' is the pseudo first-order rate constant and n is the order of the 
reaction. The rate may be estimated by the variable-time method measured as 
A^/A/. where A is the absorbance and t is the time in seconds [21 J. Taking 
logarithms of rates and concentration as shown in Table 2, Eq. (1) is 
transformed into: 
log (rate) = log AA /A t = log K' + n log |AMP| (2) 
Regression of log (rate) versus log (AMP) gave the regression equations: 
log (rate) = -0.9172 -t- 0.9923 log C 
r = 0.9936 Method A 
log (rate) = -0.6790 + 0.8808 log C 
r = 0.9914 Method B 
Hence K'= 0.1215"' or 0.2095'"', applying methods A or B. respectively.and the 
reactions can be approximated to first order (n-l) with respect to AMP 
concentration 
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Evaluation of the Kinetic Methods 
Under the optimized experimental conditions the concentration of AMP 
was determined using an excess of KMn04 and NaOH with respect to AMP, 
applying method A; and an excess concentration of CDNB with respect to the 
initial concentration of AMP applying method B. However, the rate is directly 
proportional to the concentration of drug in a pseudo-first rate equation as 
follows: 
Rate = K'|drugl (3) 
where K' is the pseudo-order rate constant. Several experiments were then 
carried out to obtain the drug concentration from the rate data according to Eq. 
(3). The rate constant, fixed- concentration and fixed time methods [22-23] 
were tried and the most suitable analytical method was selected taking into 
account the applicability, the sensitivity, the correlation coefficient (r) and the 
intercept. 
Rate-constant method 
Graphs of log (absorbance) versus time over a large concentration range 
of AMP (1.4xl(r to 8.4xl(r mol L''. and 1.5x10^ to 7.5x]0"^ mol L"') were 
plotted by method A or B, respectively. The pseudo-first order rate constants 
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corresponding to different AMP concentrations were tlien calculated from the 
slopes multiplied by -2.303 (Table 3). 
Regression of (C) versus K' gave the equations: 
K' = -4.5 xlO~^  + 76.96 C(r^ 0.9831; Method A 
K' = -4.1 xlO"^  + 0.5119 C(r = 0.8739J Method B 
The value of r is indicative of poor linearity, probably because of inconsistency 
ofK'. 
Fixed-concentration method 
Rate of reaction was recorded for different concentrations of AMP 
(5.6x10"^ to 8.4x10"^ mol L"', and 4.5x10"^ to 7.5x10^ ) mol L"'. A pre-
selected value of the absorbance was fixed and the time was measured in 
seconds. The reciprocal of time (\/t) versus the initial concentration of AMP 
was plotted (Table 4). The following equations for calibration graphs were 
obtained by linear regression: 
1/t = -4.5 xlO H 76.97 C (r = 0.9831) for Method A 
1/t = -4.1x10"^ + 1.862 C (r = 0.9962) for Method B 
Fixed-time method 
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The absorbance was measured at a preselected fixed time. Calibration 
graph of absorbance versus initial concentration of AMP was established at 
fixed time of 5. 10. 15. 20 and 25 min applying method A and. 10, 20. 30. 40, 
50 and 60 min applying method B with the regression equation shown in 
Table 1. 
It is clear that the slope increases with time and the most acceptable 
values of the correlation coefficient (r) and the intercept were obtained for a 
fixed times interval for measurement (Table 5). 
Mechanism of the Reaction 
The stoichiometry of the reaction was studied adopting the limiting 
logarithmic method [24]. The ratio of the reaction between log Abs versus log 
[AMP], log [KMn04] and log [CDNB] were calculated by dividing the slope 
of KMn04 and CDNB by the slope of the drug curve. The ratio of AMP to 
KMn04 and that for AMP to CDNB was found to bel:2 and 1:1 respectively 
The proposed pathway of the reaction is given below. 
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VALIDATION OF THE PROPOSED METHOD 
Accuracy and Precision of the Proposed Methods 
Accuracy and precision was checked according to USP validation 
guidelines [25] at three concentration levels within the specified range. Six 
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replicate measurements were recorded at each concentration level. The results 
are summarized in Table 6 
Limit of detection (LOD) 
LOD was calculated from standard deviation of response and the slope 
of calibration curve. The limit of detection was expressed as : 
LOD = 3 o / S 
where o is the standard deviation of intercept, S is the slope of calibration curve 
(Table 5). In our work, reasonably good results were obtained where the 
calculated drug concentration by LOD equations were actually detected in 
these experiments. 
Limit of quantitation (LOQ) 
LOQ was calculated based on standard deviation of intercept and slope 
of calibration curve. In this method, the limit of quantification is expressed as : 
LOQ = 10o /S 
The results were (Table 5) indicate good sensitivity of the proposed method. 
The calculated LOQ values were further validated by laboratory experiments. 
In our work, good results were obtained where the calculated drug 
concentration by LOQ equations were actually quantified in these experiments. 
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Application to pharmaceutical dosage forms 
The rate constant and fixed time methods have been appHed for the 
determination of AMP in commercial pharmaceutical dosage forms. The 
concentration of investigated AMP was computed from its regression 
equations. The results of proposed methods were statistically compared with 
those of reported methods [26-28]. The mean recovery values were 99.7533 
and 99.91 respectively , which ensures that there is no interference of other 
active compounds present in the drug. The calculated and theoretical values of 
both the proposed and the reported methods had 95% confidence level. This 
indicates good precision and accuracy in the analysis of AMP in 
pharmaceutical dosage forms. 
CONCLUSION 
Different methods were established to determine AMP concentration 
kinetically. The reaction rate, rate constant and fixed time methods were 
applied. Applying the fixed time method, it is clear that the slope increased 
with time and the most acceptable values of correlation coefficients (r) and 
intercepts were obtained. The proposed method is sensitive enough to enable 
determination of trace amounts of drug. Since our method is selective it avoids 
interference of colored and turbid background of samples. 
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Fig.l Structure of AMP 
I 
700 
Fig.2 Absorption spectrum of AMP (25figmL ') after reaction with KMn04: 
(a) oxidation product, (b) manganate ion (Method A) 
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3.0 5.0 7.0 
Concentration 
9.0 11.0 
Fig.3 Effect of the concentration (1 x IffUo 1 x KT^ mol U') ofKMnOi on 
absorbance produced by its reaction with AMP (25 jugmL''; 1 ml of 0.5 
mol L ' NaOH) 
1.1 1.6 
Voluine(mi) 
2.1 
Fig.4 Effect of the volume ofKMn04 2 mol L ' on the intensity of the colour 
produced by its reaction with AMP ( 25 fdgml'; 1 ml of 0.5 mol U' 
NaOH) 
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0.6 
0.5 -
0.4 
0.3 
.3 1.5 
Fig.5 Effect of the volume ofNaOH (0.5 mol L ') on the intensity of the 
colour produced by the reaction of AMP ( 25 ftgrnt'); with KMn04 
(2 ml of 7.5 mol L'') 
0.61 -I 
0.51 
0.41 
I 0.31 
0.21 
O.Il 
0.01 
3 0 0 400 500 
Wavelength 
600 
Fig. 6 Absorption spectrum of AMP (250 figmL ') after its reaction with 
CDNB atpH 7.8 (Method B) 
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0.7 
0.6 
0.5 
0.4 ^ 
0.3 
0.2 H 
0.1 
0 
0.0001 0.0011 0.0021 0.0031 
ICDNBI 
0.0041 
Fig. 7 Effect of the concentration (1 x lO"' -4 x 10'^ mol L~') of 
CDNB on the absorbance of the reaction product of AMP (250 
jugmL') in 0.2 mol L"' borate buffer. 
i 0 
Fig.8 Effect of the pH of CDNB ( 3.5 >^ W' mol L ' ) on the 
absorbance of the product keeping AMP Constant (250 /igml'). 
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Fig,9 Spectrophotometric calibration curve for Method A 
U.b -
0.55 -
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1 0.45 -
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0.35 ' 
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• ^ ^ 
1 1 1 
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50 100 150 200 
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250 
Fig. 10 Spectrophotometric calibration curve for Method B 
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0.6 n 
10 15 
Time (in in) 
25 
Fig. 11 Absorbance vs. time plots for the reaction of AMP in alkaline 
KMn04 (Method A) showing the dependence of the reaction on AMP 
concentration. Concentration of AMP: (1) 1.4^1(r\ (2) 2.8^10~\ (3) 
4.2xl(r\ (4) 5.6^1(r\ (5) 7.0xl(r\ (6) 8.4^10~'mol L ' 
Page 70 
Kinetics of Ampicillin 
0.7 n 
0.6 -
0.5 
Q) 
o 
<5 0.4 -
O (0 
§ 0.3 
0.2 
0.1 -
0 -
( 
— C 
^ D 
^ E 
r 1 
) 10 
1 
20 
1 
30 
Time(min) 
1 
40 
I 
50 
I 
60 
Fig. 12 Absorbance vs. time plots for the reaction of AMP and CDNB 
(Method B) showing the dependence of the reaction on AMP 
concentration. Concentration of AMP: (A) 1.5^ l(f, (B) 3^l(f, (C) 
4.5^1(f, (D) 6^10^, (E) 7.5^10' molL' 
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Table 1. Calibration equations at different fixed times for AMP in the ranges 
5 -30 figmL'' and 50 -260 figmL ' applying methods A and B, respectively 
Tiine(min.) Regression Equation Correlation coefficient (r) 
Method A (oxidation with KMn04) 
5 A= -.05554 + .04126 C 
10 A= -.04602 + .04406 C 
15 A= -.02212 + .05130 C 
20 A= -.00122 + .0286 C 
25 A= -.00015+ .0311 C 
Method B (Reaction with CDNB) 
10 A= -.04041 +.03805 C 
20 A= -.02110 + .04102 C 
30 A= -.0076 + .0032 C 
40 A= -.00078 + .0032 C 
50 A= -3.05x10"^ + .03826 C 
60 A= 2.12x10"-^  + .03932 C 
0.9912 
0.9945 
0.9975 
0.9932 
0.9982 
0.9968 
0.9959 
0.9982 
0.9991 
0.9989 
0.9994 
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Table 2. Logarithms of the rates for different concentrations of AMP 
Log AA/At 
Method A (oxidation with KMn04) 
-3.942 
-3.690 
-3.491 
-3.360 
-3.281 
-3.150 
Methods (Reaction with CDNB) 
-4.066 
-3.750 
-3.552 
-3.500 
-3.452 
Log [AMP], (mol L ' ) 
-4.854 
-4.553 
-4.376 
-4.244 
-4.155 
-4.075 
-3.824 
-3.523 
-3.251 
-3.222 
-3.125 
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Tables. Values of K'calculated from slopes of log A versus t graphs 
multiplied by -2.303, for different concentrations of AMP. 
K' (s-') 
Method A (oxidation with KMn04) 
-9.4773x10"' 
-7.9414x10-'' 
-5.6421x10"' 
-4.9483x10-" 
-5.3669x10-" 
^.8899x10-" 
Method B (Reaction 
^.9344x10-" 
-4.6647x10-" 
-3.7702x10-" 
-1.5545x10-" 
-1.0255x10-" 
with CDNB) 
Log [AMP], (mol L~') 
1.4x10'-' 
2.8x10-^ 
4.2 xiO"-
5.6x10-^ 
7.0x10-' 
8.4x10"' 
1.5x10-" 
3.0x10-" 
4.5x10-" 
6.0x10-" 
7.5x10-" 
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Table 4. Values of reciprocal of time taken at fixed absorbance (0.4 and 0.3) 
for different rates of various concentrations of AMP 
l//(s-') 
Method A (oxidation with KMn04) 
l . l lx 10'^  
8.40X lO"'' 
6.70X IQ-" 
Method B (Reaction with CDNB) 
3.34X 10'^ 
3.03 X 10-^  
2.78X 10-'* 
Log [AMP), (mol L"') 
5.6x10-' 
7.0x10'-
8.4x10"^ 
4.5x lO"* 
6.0x 10"'* 
7.5x10"^ 
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Table 5. Analytical parameters for fixed time method for spectrophotometric 
determination of AMP in pure form 
Parameters 
Optical characteristics: 
Xmax, nm 
Linearity range (figmL"') 
Regression equation: 
intercept (a) 
Standard deviation of 
intercept 
(Sa) 
slope (b) 
Standard deviation of 
slope 
(Sb) 
Correlation coefficient(r) 
LOD(^gmL-') 
LOQ(^gmL-') 
Method A 
610 
5-30 
0.086321 
0.681385 
0.013807 
0.00201 
0.9977 
0.162 
0.493 
Method A 
490 
50-260 
0.099403 
0.581394 
0.002215 
0.000445 
0.9919 
0.866 
0.2625 
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JflWe 6. Evaluation of precision for determination of AMP ^i "y^ 
Amount 
Taken 
(Hg ml-l) 
Method A 
10 
20 
30 
Method B 
55 
150 
260 
Amount Found 
(Hg mI-1) 
9.96 
19.2 
30.05 
54.95 
150.02 
259.05 
% Recovery ± 
S.D. 
99.86 
99.34 
100.06 
99.97 
100.04 
99.72 
± RSD-CVo) 
0.520 
0.478 
0.368 
0.432 
0.428 
0.424 
'sAy '^^  
0.02 
0.04 
0.05 
0.02 
0.03 
0.06 
i\^^ 
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Kineitc Study of 2-aminopentanedioic acid by qumoliniumdichromatre 
Kineitcs and Mechanism of deamination and 
decarboxylation of 2-aminopentanedioic acid by 
quinoliniumdichromatre (QDC) in aqueous perchloric acid 
INTRODUCTION 
Oxidation of amino acids is of great importance both from chemical 
view point and from its bearing on the mechanism of amino acid metabolism. 
Amino acids not only act as building blocks in protein synthesis but also play a 
significant role in the metabolism. They are subjected to many reactions and 
can supply precursors for many endogenous substances like hemoglobin in 
blood. They can undergo many kinds of reactions, depending on whether a 
particular amino acid contains a polar or non-polar subtituent. 2-
Aminopentanedioic acid / L-Glutamic acid (glu-e) is one of the most abundant 
amino acids, especially high in cereal proteins and can be oxidized by different 
oxidants [1-4]. A salt of glu-e is used in the production of monosodium 
glutamate and nutritional supplements. L-glutamate itself can be used as 
medicine and promotes oxidation process. It combines with ammonia as a 
drug-free glutamine. It is mainly used for the treatment of hepatic coma and 
severe liver dysfunction, but the response is not satisfactory. Racemic 
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glutamate is used for the production of drugs. Physiologically, it plays a role in 
the metabolism of amino groups and is the precursor of neurotransmitter, 
gamma-aminobutyric acid, L-glutamic acid. Being acidic in nature it is 
important in determining 3-D conformation of proteins. 
It is well established that the reduction of chromium(VI) to 
chromium(III) with a variety of organic and inorganic reductants can occur by 
a multiplicity of mechanisms which depend on the nature of the reducing agent 
[5]. The existence of different species of chromium(Vl) in acid solutions, 
unstable oxidation states [chromium(IV) and chromium(V)] and the tendency 
of chromium(III) to form a variety of complexes, all combine to give systems 
of considerable complexity [6]. Attempts have been made to confirm the 
intermediacy of chromium(IV) and chromium(V) by use of competitive 
experiments [7-8] In acid solution, the reported reduction potential of the 
Cr(VI)/Cr(III) couple is 1.33V [9]. The reagent, quinoliniumdichromate (QDC) 
is a versatile oxidant that deserves further investigation and some kinetic 
studies of the oxidation of inorganic substrates by QDC are available [10]. A 
number of reports on the mechanism of oxidation of several substrates by 
quinolinium dichromate are available which is shown to oxidize primary and 
secondary alcohols to the corresponding aldehydes [11-12], cyclic alcohols to 
cyclic ketones [13], bicyclic alcohols [14] and benzyl alcohol [15]. The a-
hydroxyacids [16] and a-ketoacids [17] are oxidized with QDC and their 
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reactions are studied kinetically. QDC oxidizes cinnamic and crotonic acids 
smoothly in N,N-dimethylformamide in the presence of an acid to give 
aldehydes [18-27]. 
Since there are no reports on the kinetics of oxidation of 2-
aminopentanedioic acid by QDC we are reporting the kinetics of its oxidation 
by QDC in perchloric acid, in order to identify the chromium(VI) intermediate 
and to propose a suitable mechanism. The activation parameters and 
thermodynamic quantities have been determined and discussed. 
EXPERIMENTAL 
Stock solutions of L-glutamic acid (Merck, Mumbai,India). quinolinium 
dichromate (QDC) (Sigma-Aldrich) were prepared in double distilled water 
and standardized iodometrically [12]. HCIO4 and NaC104 were employed to 
maintain the required acidity and ionic strength, respectively. 
Kinetic Studies 
The reaction was initiated by mixing the previously thermostated 
solutions of Glu-e and QDC, which also contained the required amount of 
perchloric acid, sodium perchlorate and double distilled water. The reaction 
was followed spectrophotometrically at 360 nm . The spectral changes during 
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the reaction under standard conditions at room temperature are given in Fig.l. 
Application of Beer's law under the reaction conditions was verified between 
1.0x10"'' and 1.0x10'"^  mol dm""' of QDC and the extinction coefficient was 
found to be e = 1,246 ± 12 dm^mol'cm"'. The pH of the reaction mixture in the 
beginning and in the end remained constant. The kinetic runs were followed for 
more than 80% completion of the reaction and first order kinetics was 
observed. The pseudo-first order rate constants, k„bs obtained from the slope of 
the plots of log(absorbance) versus time were linear (Fig.2). The kobs were 
reproducible within ±5% and are the average of at least three independent 
kinetic runs (Table 1). 
RESULTS AND DISCUSSION 
Reaction Orders 
The order of reaction was determined from a plot of log kobs versus 
log(concentration) of QDC (2.0x10"'' to 2.0x10""* mol dm"^  ) at constant 
concentration of glu-e (2.0x10"^ mol dm"\ HCIO4 =3.0 mol dm"^ ) and ionic 
strength, I = 2.80 mol dm"\ and was found to be unity. Negligible variation in 
kobs occurs with varying concentration of QDC (Table 1). The plot of log [a/(a-
x)] versus time for different concentrations of QDC is linear and uniform 
(Fig.2). The Glu-e concentration was varied in the range of (5x10"^ to 5 x 10' 
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^ mol dm'-' ) at constant concentration of QDC. HCIO4 and ionic strength was 
found to be uniform (Table 1). 
Product Analysis 
Different sets of reaction mixtures containing glu-e, an excess of QDC 
with constant ionic strength and acidity were left to stand for 12 h in an inert 
atmosphere at 25°C. The succinic semialdehyde produced was also identified 
from FT-IR spectrum. The v(C=0) appears at 1696 cm' (Fig.3) which is the 
characteristic band of aldehyde. It does not undergo further oxidation. 
Ammonia was identified by Nessler's reagent [29]. The CO2 liberated was 
qualitatively detected [30] by passing the gas into lime water. The results 
indicated that two moles of QHCr04 (in term of Cr (VI)) consumed four mole 
of glu-e (Scheme 1.) 
4 COOHCH2CH2CHNH2COOH + 2 QHCr04 + 2 H ' 
4 COOHCH2CH2CHO + 2Cr02- + 4CO2 + 4NH3 + 4 H ' + 2Q 
Scheme.l 
Page 8 5 
Kineitc Study of 2-aminopentanedioic acid by quinoliniumdichromatre^ 
Effect of Temperature 
The rate of reaction was measured at different temperature with varying 
concentration of perchloric acid and keeping other conditions constant. The 
rate constant, k obtained from the intercept of the plots of 1/kobs versus 1/glu-e 
was found to increase with temperature .The values of rate constant of glu-e at 
293 K 298 K 303 K and 308 K, was found to be 6.50 s'', 7.36 s'', 11.32 and 
13.28 s~', respectively. The energy of activation corresponding to these 
constants was evaluated from a plot of log k versus 1/T (Table 2). 
Effect of perchloric acid Concentration 
The effect of acidity on the rate of reaction was studied by varying the 
concentration of the perchlroric acid (2.5-4.5mol dm"^ ). The kobs was found to 
be directly proportional to the concentration of the acid (Table 1). 
Effect of Ionic Strength and Dielectric Constant 
When the ionic strength was varyied the rate constant was found to be 
proportional to the ionic concentration. The plot of log koh^ versus / was linear 
with positive slope (Fig.5) (r > 0.9985. a < 0.0836). The effect of relative 
permittivity {D) on the rate constant was studied by varying the acetic acid 
content (v/v). Attempt to measure the relative permittivity was unsuccessful. 
However, they were computed from the values of pure liquids [31]. The rate 
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constant was found to increase with increase in tlie dielectric constant of the 
medium. A plot of log A:obs versus \ID was linear with negative slope (Fig.6) (r 
> 0.9614, a < 0.0791). 
The QDC reacts with two moles of HCIO4 to give H2Cr04 [32-33]. It 
H2Cr04 reacts with glu-e forming a complex, which is reduced to an 
intermediate chromium(IV) and a product of glu-e. Subsequently, another 
molecule of acid chromate reacts with one molecule of glu-e producing another 
chromium(IV) intermediate, and a product of glu-e. In a further fast step, one 
molecule of chromium(IV) reacts with one more molecule of glu-e giving 
chromium(III) and final product of succinic semialdehyde (Scheme 2). 
The results indicate the formation of a complex between glu-e and 
chromium(VI) in presence of perchloric acid. The formation of this complex 
was proved kinetically by Michaelis-Menten plot, i.e., a non-zero intercept of 
the plot of 1/kobs versus l/[glu-e] (Fig.4). The colour indicates the formation of 
Cr(VI)-species and appearance of Cr(III)-species with the isosbestic point at 
/l=530 nm. 
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QQ(^ ^ 2H^ > HXrO.+ Q(Quinoline) 
H2Cr04 + COOHCH2CH2CHNH2COOH ^ Complex 
k 
Complex • COOHCH,CH2CHO + H2Cr03 +CO2+NH3 
^'^^ ' Cr(IV) 
Fast 
H2Cr04+COOHCHoCH.CHNH,COOH • COOHCH.CH^CHO + HjCrOj 
Cr(IV) 
+ C0 . +NH, 
Fast 
H2Cr03+COOHCH2CH2CHNH2COOH • COOHCH2CH2CHO + CrOj 
Cr(IIl) 
+ CO2 +NH3 +2H' 
Scheme 2 
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Appearance of isosbestic point indicates very low concentration of the probable 
intermediates like Cr(V), Cr(IV) [34] and their gradual decay to [Cr(III)] . The 
characteristic of electronic spectrum of Cr(III)-species lies in the range 320-
600 nm. The original absorption maxima, (560 and 430 nm) was replaced by a 
single peak at 360 nm due to the formation of chromium(VI). Similar results 
have also been obtained by the oxidation of 2-propanol from chromium(VI) in 
aqueous acetic acid and, oxidation of thallium(I) by QDC in aqueous acetic 
acid-chloride media [35-36]. 
Rate = k Complex C 
Rate= - ^ I 2 £ ^ ] = kKiK2[Glu-e]f [QDC]f[H^]f2 (1) 
dt 
The total concentration of QDC is given by, 
[QDC]t= [QDC]f + [H2Cr04] + [Complex C] 
[QDCJr [QDC]f+K,[QDCHH']f^ +K,K2[Glu-e]f[QDC]f[H']f2 
= [QDC]f+ {1+K, [H']f2 +K,K2[Glu-eHH"]f2} 
Page 89 
Kineitc Study of 2-aininopentanedioic acid by quinoliniumdichromatre 
Therefore 
[QDC], 
[QDC]f = ^^ ^ 
I + T 2 K K , [Hnf '+K,K2[Glu-e ] f [Hnf ' 
where 't' and 'f stand for total and free concentration of QDC. 
[Glu-e]t = [Glu-e]f+[Complex C] 
[Glu-e]f+K,K2[Glu-e]f[QDC]f[H"]f2 
+ 1 2 
= [Glu-e]f{l+K|K2[QDC]fr]f^} 
Therefore, 
[Glu-e]f 
[Glu-e], = ^^ J 
1+ K,K2[QDC]f[}r]f2 
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In view of the low concentration of QDC used in the experiment (Eq. 3) the 
term K1K2 [QDC]f [H+ ]f^  can be neglected in comparison to unity. 
Hence, 
[Glu-e], = [Glu-e]f (4) 
and 
[H+ It^  = [H"" ]f2+ [H2Cr04] + [Complex C] 
= [H^]f'+Ki[QDC]p^lf2 +KiK2[Glu-e]f[QDC]f[H"]f2 
= [ ^ ]f2 { 1+ Ki QDC]f + K1K2 [Glu-e]f [QDC]f} 
[H" ]f2 = (5) 
1+K, [QDC]f +K,K2[Glu-e]f[QDC]f 
Similarly, 
[H"],2 = [H^],-' (6) 
Substituting Eqs. 2,4, and 6 in Eq. 1, we get Eq. 7, which explains all the 
experimentally observed orders with respect to different species of reaction. 
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d[QDC] kK,K2[Glu-e][QDC][}r]2 
Rate = - = \') 
dt 1+K|[H^]2 +K,K2[Glu-e][H^]2 
Or 
Rate kK,K2[Glu-e][H^]2 (8) 
The rate law (8) can be rearranged to Eq. 9. which is suitable for verification. 
' - ' , 1 1 
According to Eq. 8, plots of 1/kobs versus l/[glu-e] and 1/kobs versus I/[H'']^ 
should be linear (Fig. 4). The slopes and intercepts of such plots determine the 
values of Ki, K ,^ k and the thermodynamic quantities for the first and second 
equilibrium steps of Scheme 2 (Table 2). 
For example at 35 °C: 
(i)From the plot of 1/kobs versus l/[glu-e] 
(Intercept) 1 = 1 /k 
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Therefore , k =1/(Intercept) 1= 1.328x lO'^ sec"' 
(Slope), =l/kK,K2[HY+ 1/k 
(ii) From the plot of 1/kobs versus 1/[H^]' 
(Intercept)2 = 91.37 = 1/ kK,K2[Glu-e] + 1 / k 
From (Intercept) 1,the value of k = 1.328x lO'^ sec"' 
Hence, 
91.37= 1/1.328X 10"^xK2x2.0 10"^ + 1 / 1.328x 10"^  
1+K2(2.0xl0"^) = 91.37 X 1.328X 10"^K2x2.0 10"' 
1+.02 K2 =.0242678 K2 
K2 = 234.31 dm W r ' 
(Slope )2 = 812.2 = 1/ kK,K2[Glu-e] 
812.2 = 1/ 1.328X 10"^  X 234.31dm^moi'' x 2.O 10"^ x K, 
K, = 1.978x lO'^dmVor^ 
At 35°C: 
K, = 1.978x 10''dm^mor^ 
K2 = 234.3 Idm^mol"' 
k=1.328x 10"^ sec-' 
Similarly k, Ki and K2 were calculated at different temperatures (Table 
2). Van't Hoff plots were made (log K] versus 1/T and log K2 versus 1/T). The 
AH, AS and AG were calculated for the first and second equilibrium steps 
(Scheme 2). A comparison of these values (Table 2) with those obtained for the 
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slow step refer to the rate limiting step, supporting the fact that the reaction 
before the rate determining step is fairly fast and involves a high activation 
energy [37-39]. An increase in the volume of acetic acid leads to an increase in 
the reaction rate. A plot of log^o ,^ versus 1/D was linear with positive slope 
which is contrary to the convention. Perhaps the effect is countered 
substantially by the formation of active species to a greater extent in a low 
dielectric constant medium leading to the net increase in the rate [40]. The 
mechanism is also supported by moderate values of AH and AS . The negative 
AS value indicates that the complex (C) is more ordered than the reactants [41]. 
The observed modest enthalpy of activation and a higher rate constant for the 
slow step indicates that the oxidation, presumably occurs via an inner-sphere 
mechanism. This conclusion is supported by observations [42-44] made earlier. 
CONCLUSION 
The reaction between Glu-e and QDC is very slow in low perchloric 
acid concentration at room temperature.The oxidant, chromium(VI) exists in 
acid medium as H2Cr04, which takes part in the chemical reaction. The rate 
constant of slow step and other equilibrium constants involved in the 
mechanism are evaluated and activation parameters with respect to slow step of 
reaction were computed. The overall mechanistic sequence described here, is 
consistent with the products formed. 
Page 94 
Kineitc Study of 2-ammopentanedioic acid by quinoliniumdichromatre^ 
2.6 n 
1.6 
0.6 
320 370 420 470 
W avelength 
520 570 
Fig.l Spectral changes during the oxidation ofGlu-e by QDC in aqueous 
perchloric acid at 25''C; QDC =8.0^ lO'^/mol drn\ [Glu-e] =2.0^ 
ICr^/mol dm\ [Ha04J = 3.0, and I =2.80/mol dm^ (scanning 
time interval 1.0 min) 
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0.8 
0.6 
^ 0.4 
0.2 
10 15 
T i m e ( i n i n ) 
25 
Fig.2 Plot of log a/(a-x) versus time in aqueous perchloric acid at 25 "C, 
Glu-e = 2.0x 10~\ [HCIO4J = 3.0,1 = 2.80 mol dm'^ and QDC = (A) 2.0 
(B) 6.0, (C) 8.0, and (D) 10.0 mol dm'^ 
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Fig.3 FT-IR spectrum of the product of oxidation ofGlu-e by QDC 
0.1 0.6 1.1 
]I\W\' dm ' m ol ' 
1.6 2.1 2.6 3.1 3.6 
« . 4 5 0.3 
0 . 3 5 
0,3 
0.2 5 
0.2 
0 . 1 5 
0.1 • ^ 
20 
A 
.—• 
' 
70 
^^^"^ • / ^ 
' 
120 
l / | ( ; iu -e |d i i i 'm I 
170 
1 ' 
0.2 
0 . 1 5 
220 
Fig.4 Verification of rate law (7) in the form ofEq.9 ( Table 1) 
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• 1 ! 
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Fig. 5 Effect of ionic strength on the oxidation of Glu-e by QDC in aqueous 
perchloric acid medium at 25''C 
l/D I 10 
Fig.6 Effect of dielectric constant on the oxidation of Glu-e by QDC in 
aqueous perchloric acid medium at 25''C 
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Tablel. Effect of variation ofQDC, Glu-e, and perchloric acid on the 
oxidation of glu-e by QDC in perchloric acid medium at 1 = 2.80 mol 
dm'^ and at 25°C (Scheme.2) 
[QDC] X 
lO'* 
(mol dm'^) 
[Glu-e] X 
10' 
(mol dm" )^ 
Variation of [QDC] 
2.0 
6.0 
8.0 
10.0 
16.0 
20.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
Variation of [Glu-e] 
8.0 
8.0 
8.0 
8.0 
8.0 
8.0 
0.5 
1.0 
2.0 
3.0 
4.0 
5.0 
Variation of [HCIO4] 
8.0 
8.0 
8.0 
8.0 
8.0 
8.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
[HCIO4] 
(mol dm" )^ 
3.00 
3.00 
3.00 
3.00 
3.00 
3.00 
3.00 
3.00 
3.00 
3.00 
3.00 
3.00 
1.50 
2.50 
3.00 
3.50 
4.00 
4.50 
kobs X 10"' 
(s-') 
6.24 
6.31 
6.19 
5.98 
6.36 
6.34 
2.41 
3.96 
6.87 
8.15 
8.96 
9.30 
3.71 
5.36 
6.78 
7.47 
8.16 
8.73 
kcal X 10"' 
(s-') 
6.35 
6.35 
6.35 
6.35 
6.35 
6.35 
2.43 
3.56 
7.36 
8.18 
8.93 
9.31 
3.71 
5.36 
6.78 
7.47 
8.16 
8.73 
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Table 2. Activation parameters and titermodynamic quantities of the 
oxidation ofglu-e by QDC in aqueous percftloric acid medium. 
Temperature (K) kxio^(s-') logk 1/TxlO^ 
(a) Effect of temperature with respect to slow step of the Scheme 1 
293 
298 
303 
308 
6.500 
7.360 
11.32 
13.28 
0.716 
0.866 
1.053 
1.120 
Parameters 
(b) Activation parameters 
Ea(kJmor ' ) 
AH* (kJ mol"') 
AS*(JK''mor') 
AG*(kJmor') 
58.2 
51.7 
-62.3 
59.1 
(c) Temp. (K) K, x lO^dm^ mol"^ 
mof' 
293 
298 
303 
308 
6.34 
4.66 
3.12 
1.97 
3.413 
3.356 
3.300 
3.246 
Values 
K2 xlQ-^dm^ 
1.32 
1.45 
1.63 
2.34 
(d) Thermodynamic using Ki values using K2 values 
Parameters 
AH* (kJ mol"') 
AS*(J K'' mol"') 
AG*(kJmol 
-71.2 
-251 
-1.70 
21.3 
119 
-14.1 
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Kinetic Studies of Hexacyanoferrate(II)^^_EDTA_ 
Kinetics of Substitution of Hexacyanoferrate(II) by 
EDTA catalysed with Mercury(II) 
INTRODUCTION 
During the last decade, many novel methods for the determination of 
mercury(II) have been developed [1-6]. It has been demonstrated that of all the 
heavy metals mercury(II) easily forms bond to cyanide and slowly removes it 
from hexacyanoferrate(II). Kinetics and mechanism of ligand replacement in 
low spin Fe(II) complex has been done, although it is limited to the study of 
pentacyano(L)ferrate(II) complex[l-7]. Few studies have been done in aqueous 
electrolyte and micellar media to acquire an in depth knowledge of the 
mechanism [8-9]. The kinetics of oxidation of the hexacyanoferrate(II) 
complex by various reagents in acidic and basic media have been studied and, 
all these investigations have been applied to specific analytical problems [10-
13]. K4[Fe(CN)6''"] hardly undergoes exchange reaction as CN" itself is a very 
strong ligand although slow exchange of labelled CN" group or aminopyridine 
is slow but under the action of u.v. light reversible aquation occurs leading to 
the formation of [Fe(CN)5H20]'[14]. However, only monosubstituted 
[Fe(CN)5L] • has been obtained either through photochemical or dissociation 
reaction or by metal catalysed substitution reaction[15]. 
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[Fe(CN)6'"]+H20 >- [Fe(CN)5H20]'"+CN- (1) 
Hexacyanoferrate(II) reacts with EDTA according to the following equation 
[Fe(CN)5H20]'- + EDTA *- [ Fe(CN)5EDTA]^- + H2O (2) 
CN" +H2O >• HCN + OH" (3) 
Mercury(II) readily forms complex with cyanide ion but decomposes in uv 
light. 
Hg'" + [Fe(CN)6'-] + H2O *- [Fe(CN)5H20]^- + HgCN" (4 ) 
j+ HgCN" + H" *- HCN + Hg'" (5 ) 
In the present work we have studied the kinetics of substitution of CN" 
by EDTA, catalysed by Hg^^ A probable mechanism has been proposed. Any 
attempt to study the substitution of CN" by phenanthroline, pyridine, hydrazine 
and piperazine resulted in precipitation even in low concentration. 
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EXPERIMENTAL 
Double distilled, de-ionized water was used throughout.The chemicals 
used were of analytical grade. Stock solutions of the compounds were wrapped 
with carbon paper to protect them from photodecomposition. The mercury(II) 
and hexacyanoferrate(II) solutions were diluted just before use. The desired 
pH= 5 of the reaction mixture was maintained by KHP-NaOH buffer [16]. The 
ionic strength was maintained at 0.1 M by adding appropriate amount of KNO3 
Procedure 
A mixture of 2.0 ml of each EDTA, phthalate buffer of pH = 5.0 and 
mercury(II) chloride were mixed in a flask thermally equilibrated for about 30 
minutes at 25"C and left to stand for 10 min to ensure completion of reaction. 
Finally, 2.0ml of [Fe(CN)6]''' was added to this mixture and the wavelength of 
maximum absorption (365 nm) was determined (Fig.l). 
RRSULTS AND DISCUSSION 
Effect ofpH 
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The reaction was studied tlrst by fixed time kinetic metiiod in the pH 
range 1-13. (measured at t =5 and 10 minutes after mixing the reagents ) Fig.2 
shows plots of absorbance versus pH of the reaction mixture. It was found that, 
the absorbance increases with increasing pH and attains a maximum between 
pH 5.0 and 5.5. However, above this pH the absorption decreases which is due 
to the deficiency of protons. The rate is reduced at low pH due to the formation 
of various protonated forms of [Fe(CN)6]''" which are less reactive than 
[Fe(CN)6 "^] itself [17]. 
Effect of EDTA 
The complex formation with EDTA is influenced by a change in pH of the 
solution which is either perhaps due to ionization of the metal complex at low 
pH or hydrolysis of the metal ion at higher pH. The effect of EDTA was 
examined as a function of its concentration at 5 pH. A plot of initial rate versus 
EDTA shows slow change in rate constant (Fig. 3) in varied 2 xlO''^  to 7x10'^  
M and finally decreases at still higher concentrations. A fixed concentration of 
was thus selected as optimum. 
Effect of[Fe(CN)6f' on the initial rate 
The initial rate were evaluated as a function of [Fe(CN)6'''] by changing 
its concentration from 5x10"* to 2x10'^ M, keeping all other parameters 
constant. The plot of log Vi versus log [Fe(CN)6'''] (Fig 4) indicates variable 
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order of dependence in [Fe(CN)6'''] is exhibited ranging from first order to 
higher concentration but certainly not tending towards zero order. 
Effect of[Hg^^] on initial rate 
The concentration of mercury(II) was varied between (1x10"^  to 2x10" 
"'M) and those of the [Fe(CN)6''"] and EDTA were kept constant. The pH and 
temperature were maintained at 5 and, 25°C respectively (Fig. 5). The large 
variation in [Hg ]^ was selected in order to test the linearity between initial rate 
and [Hg ] for its analytical application. A plot of the absorbance measured at 
an interval of one min versus [Hg^ ]^ as a function of pH (Fig. 5) indicates that 
the rate increases linearly until the ratio of the [Fe(CN)6''"] and [Hg *^] reaches 
1:1.When the concentration of [Hg^ ""] exceeds that of [Fe(CN)6''"] the 
absorption begins to diminish and follows a non -linear pattern. The intercept 
computed from the initial linear portion of the fig.5 provides the rate due to the 
uncatalyzed path. However, decline in the rate of reaction at higher [Hg^ ""] is 
probably due to the formation of a binary adduct, [Fe(CN)6''". 2HgCl2]. In a 
separate experiment it was observed that a white precipitate is formed 
immediately after mixing [Fe(CN)6'''] with [Hg^ ]^ in 1:2 molar ratio which 
rapidly turned blue, confirming the formation of a binuclear complex. A similar 
observation has also been made by Beck [18]. 
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Effect of temperature and ionic strength 
.2+T „ „ ^ „ i 1 i: I „ „ i u „ * ri:?„//^xT\ 4-n The rate of the [Hg" ] catalyzed Hgand exchange between [Fe(CN)6'] 
and EDTA was studied as a function of temperature in the range 20-30°C. The 
higher temperature was avoided due to the possibility of decomposition of 
[Fe(CN)5EDTA]"'". The Arrhenius equation was used to determine the 
activation energy (Ea) for the catalyzed reaction. The enthalpy (AH )^ and 
entropy of activation (AS'^ ) were calculated using Eyring equation. The values 
of activation parameters were found to be Ea = 78.2 KJ mof', AS'' = -48.67 K' 
'Jmole'' and AH* = -52.5 KJ mole'.The effect of ionic strength on the initial 
rate of reaction was also studied by varying the ionic strength between 0.015 
and 0.2 M range. The higher ionic strength was avoided due to the limited 
solubility of (KNO3). When KCl was used to maintain the ionic strength the 
rate was found to decrease considerably. This is probably due to a subsequent 
decrease in [Hg^ ]^ or [HgCr] along with the ion-pair formation between 
[Fe(CN)6'-]and[Hg'^][19]. 
The following scheme for the mercury(II) catalyzed ligand exchange 
between [Fe(CN)6''"] and EDTA has been proposed: 
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[Fe(CN)6]>Hg^' + H s O ^ ^ - * [Fe(CN)6^-... [Hg^')...( H2O )] (6) 
v^ 1, H2O 
uncatalyzed path 'CNHg (CN)5Fe: 
O^H 2 J = / ^ 
k2 (slow) 
.-.-, 0-[Fe(CN)5H20] 
-H2 0 
Fast 
+EDTA 
K3 , 
[Fe(CN)5EDTA] 
(7) 
(8) 
(9) 
(10) 
+ . u + HgCN%H -^Hg^ ' + HCN (11) 
Formation of the complex, [Fe(CN)5EDTA]' through the catalyzed path can be 
written as: 
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d [ Fe(CN)5EDTA]^7 dt = K2 [A ]^ (12) 
while that for the uncatalyzed path the 
rate=k'|Fe(CN)6'l (13) 
where, k' is a composite rate constant involving a concentration term. If the rate 
determining step is taken to be the composition of the activated complex (A'^ ), 
the activity of the mercury(II) at low concentration can be easily explained by 
the above mechanism. The overall rate for uncatalyzed reaction can be 
expressed through equation (13) using a non limiting concentration of EDTA . 
Rate = d [ Fe(CN)5EDTA]^7 dt = k'[Fe(CN)6^) (14) 
+ k.KfFe(CN).-'-llHg^1[H.OI 
1+K [Fe(CN)6'l 
The second term in the above equation refers to the rate of the catalyzed 
reaction and explains the variable order dependence in [Fe(CN)6''']. K. is 
defined as the equilibrium constant for the association of the mercury(II) with 
water and [Fe(CN)6 "]. Since water is in a large excess, the equation (14 ) is 
reduced to equation (15) 
Rate=k'[Fe(CN)6'l+k'2K|Hg'1[Fe(CN)6-'l (15) 
Now equation (15) yields the observed rate constant (kobs) as expressed by 
equation (16) 
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k„bs=k'+k'2K[Hg'1 (16) 
where, k'2 = k2+ [H2O]. 
A plot of the initial rate versus [Hg"^] at low [Fe{CN)(/'] is given in tlg.6. 
In case of higher [Fe(CN)6'''], equation (14) takes the form of equation (17). 
Rate = k' [Fe(CN)6'"l + ki'lHg'"] (17) 
The value of the initial rate (Vj) as a function of [Hg^^] at low [Fe(CN)6''"] is 
listed in table l.The k" and k2' have been calculated from fig.6 of initial rate 
versus [Hg^ ""] using equation (17) at specified experimental condition. The rate 
constant k' and k2 are found to be 4.17 x lO'-' S"' and 2.50 S"' respectively, at 1 = 
O.IM, pH - 5, temp = 25 °C. The value of k,' and kj so obtained are substituted 
in equation (17) to evaluate the equilibrium constant K at various [Hg^ ""] at low 
[Fe(CN)6''"]. The K (Table 1) and the average value of log K (2.80) in our case 
is comparable with that reported by Beck for [Fe(CN)6''".Hg(CN)2] complex 
(log = 2.38) [17]. Although the values of k2 have been calculated employing 
high [Fe(CN)6'*"] using equation (17) it can be obtained even at low [Fe(CN)6"'' 
] using equation (18). 
k2= Rate - k^lFe(CN)/] 
K(Fe(CN)6'] [Hg^1 [H2OI •iT7 (18) 
Page 1 13 
Kinetic Studies of Hexacyanoferrate(II) by EDTA 
However, the values calculated from this equation are almost idemical. The 
ionic 
behavior of [Hg"^] may be represented by the following reactions. 
Hg2^ + CI ^ = 1 ^ HgCr 
Hgcr +cr -^ -'^ g-— HgCl2 
It has been shown that when Hg(N03)2 reacts with [Fe(CN)6'''] in solution 
the resultant was Hg2[Fe(CN)6'''] [20], which has also been verified from the 
absorption spectra of both the reacting components and the eventual product. 
This is quite obvious because the [Hg^*] is more electropositive than K^ ion. 
The activation energy calculated for this reaction is lower than those reported 
[21-22] for the replacement of CN" in nearly similar reaction systems. The 
entropy of activation is negative which is obvious if the virtual solvations of 
the activated complex and its highly charged dissociation products are 
considered. Thus, the activation parameters provide further support to the 
proposed mechanism. 
CONCLUSION 
In the present work we have studied the kinetics of substitution of CN' 
by EDTA catalyzed by [Hg^"]. A probable mechanism of the reaction has been 
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proposed. The results presented here clearly demonstrate that the chelating 
agent EDTA was used for the neutralization of CN" in complex formation 
which is more effective and inexpensive. The values of thermodynamic 
parameters are Ea = 78.2 KJ mol"', AS^ = -48.67 JK'' mole"' and AH^ = -52.5 
KJ mole-1. The negative value of the parameters show the exothermic nature of 
reaction. 
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200 250 300 350 400 450 500 
Wavelenth 
Fig.l Absorption spectra of react ants and products: (A) jEDTA I = IXlff^M; 
(B)IFe(CN)/ =5Xl(r'M(C) fFe(CN)/ (4X1 ff'M) +/EDTA/(4Xl(r'M) 
+ [Hg^* 1(3X1 ff^ M)atpH = 5.0 
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PH 
Fig.2 Effect of pH on Hg^^ catalysed substitution of CIV in 
hexacyanoferrate(II) by EDTA , lFe(CN)tl = SXKT^M , EDTA = 
XIa'M, / / / / V = SXlff' M , Temp = 25^C and I = 0.1M (KNO^). 
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> 
[EDTA], M 
Fig.3 Effect of EDTA on initial rate, lFe(CN)t] = 3.5X1 a^M, /Hg^^J 
3x10'^ M, pH = 5, Temp =25''C and I = 0.1M (KlWOj) 
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Fig.4 Dependence of the initial rate on [Fe(CN)t] in presence of[Hg^*] 
[EDTA] 3xlff'M, [Hg'*J = 3xlff' M, pH 5.0, temp = 25"Cand 0.2 M 
(KNO3). 
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16 21 1 6 11 
[HgChI, M 
Fig.5 Dependence of the initial rate of substitution of CIV in /FefCN)^'''/ by 
EDTA on [HgCh], [Fe(CN)tl =3.5xl(r' M, [EDTA] = Sxia" M, pH = 
5, temp = 25"C and I = 0.1 M (KNO^. 
•o 
1 
Hg-
Fig.6 Effect of variation of/Hg^^/ on initial rate (Vi) at high concentration of 
lFe(CN)t] under the condition lFe(CN)t] = S^lff^ M , IEDTA]= 
5x10"^M,pH=5, temp. = IS'^C, 1=0.1 M(KNO3). 
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Table 1. Calculation ofK by varying [Hg ] at constant fFefCN)^ J. 
[Fe(CN)6'''] = SxlCr" M, fHg^^J = 5X10^' M, pH = 5, temp= 25^C and I 
= 0.1 M (KNOj). 
[Hg^^] X 10-'' (M) Vi X 10'* K(calcd.) 
2 3.5 709.07 
4 5.9 660.02 
6 7.9 610.60 
8 10.6 625.80 
10 12.6 601.80 
Average log k =2.80 
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A Kinetic and Mechanistic Approach ofCaptopril by exacyanoferrate(III)^ 
Spectrophotometric interaction of the Oxidation of 
Captopril by Hexacyanoferrate(III) in Alkaline 
Medium: A Kinetic and Mechanistic Approach 
INTRODUCTION 
Captopril,(25)-l-[(25)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-
carboxylic acid (CPL) (Fig. 1) is a well-known prescribed for the treatment of 
hypertension and heart failure [1-2]. It inhibits the active sites of a zinc 
glycoprotein, the angiotensin I converting enzyme (ACE), blocking the 
conversion of angiotensin 1 to angiotensin II, whose levels are elevated in 
patients with hypertension. CPL has three different potential donor groups 
(Sthioh Oacid, and Oamide) which may bind metal ions. It has been shown that the 
ratio of the metahdrug in the complex varies with change in pH of the mediam. 
The drug forms 1:1 acidic and 1:2 complex in nearly basic media respectively 
[3]. There exists an equilibrium between cis and trans isomers of the drug, 
however, the trans isomer is the active form when bound to the enzyme [4]. On 
the other hand the sulfhydryl group in the drug acts as a free radical scavenger 
[5-6]. Several methods have been reported, for the analysis of CPL in 
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pharmaceutical preparation. It has also been assayed spectrofluorimetrically 
after reacting with fluorogenic reagents [7-8] 
The chemistry of hexacyanoferrate(III) in alkaline medium is well 
understood, in particular its capacity to oxidise inorganic and organic 
compounds [9-17]. Since there is no report on the oxidation of CPL by 
hexacyanoferrate(III) in alkaline medium, we have under taken this work to 
investigate the redox chemistry of hexacyanoferrate(III) in this medium and 
arrive at a suitable mechanistic pathway for the process. 
EXPERIIMENTAL 
Reagents and Materials 
Reagent grade chemicals and double-distilled water were used 
throughout. An aqueous solution of K3[Fe(CN)6] (BDH) in water and was 
standardized iodometrically [18]. CPL (Across organics), NaOH. (Merck Ltd, 
India), NaCl and HCl (Ranbaxy fine chem. Ltd, India) were used as received. 
Kinetic Measurements 
A mixture of [Fe(CN)6]"' , and [CPL] containing required amounts of 
NaOH, and NaCl was thermostated. The progress of the reaction was followed 
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by a decrease in absorbance maximum, 420 nm, of [Fe(CN)6]'^ ~ as a function of 
time. The spectrophotometer was attached to a desktop computer with the 
required program to evaluate the kinetic data. The Beer's law (420 nm) was 
obeyed in concentration range (8.0 x 10"^  to 8.0 x 10"* mol dm'^  ) {e = 1060 + 
1.5% dm'' mof' cm"'). The pseudo-first-order rate constant o^bs was calculated 
from the slopes of log absorbance versus time plot and, was reproducible 
within (5%).The plots were linear up to 80% completion of reaction (Fig.2). 
RESULTS AND DISCUSSION 
Effect ofCPL Concentration 
The effect of the CPL concentration on the rate of its oxidation was 
investigated by alkaline [Fe(CN)6^"], pH (7.8) and ionic strength ( 0.50 mol 
dm'^  ) was investigated at 25'^ C. The concentration of [Fe(CN)6'"] were kept 
constant and, that of CPL was varied (1.0 x 10'" -1.0 x lO'-' mol dm""'). It was 
found that the kobs increases with increasing concentration of CPL (Table 1). 
Effect ofNaOH Concentration 
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Keeping all other conditions constant. [OH] was varied (0.05 to 0.40 
mol dm'^ ).It was noticed that with increasing [OH] the rate of reaction was 
also increases (Table 1). 
Effect of [Hexacyanoferrate(ni)] 
The effect of [Fe(CN)6] ^~ concentration (8.0 x IQ-^ -g.O x 10"" mol dm'^  
)was found to be unity as the plot of log [Fe(CN)6^~] versus time was linear 
with non- variation in slopes for different [Fe(CN)6] ^ ~ (Table 1). 
Polymerization Study 
The oxidation of organic compounds by [Fe(CN)6]^" is expected to 
occur the free radical generated by CPL. The formation of free radical during 
the reaction was ascertained by an initial addition of monomer, acrylonitrile 
followed by dilution with methanol, which resulted in a copious precipitation. 
Reaction Orders 
The order of the reaction was determined from a plot of the slope of log 
koXis vs log of drug (concentration). The CPL concentration was varied ( 1.0 x 
10" -1.0 X 10' mol dm'^ ) a plot of log (absorbance) vs time was linear up to 
80% completion of the reaction as (Fig 2.). It indicates a unit order dependence 
on [Fe(CN)6]^ ~ concentration. It was also confirmed by varying [Fe(CN)6]^ ~ 
concentration which did not result in any change in the pseudo-first-order rate 
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constants, o^bs (Table 1). The o^bs increases with increasing in concentration of 
CPL (Table 1). The effect of alkali on the reaction was studied in the range of 
0.05 to 0.4 mol dm""' at constant concentrations of CPL, [Fe(CN)6]"^ " and ionic 
strength. The rate constant increases with increasing alkali concentration and, 
the order was found to be less than unity. 
Stoichiometry of the reaction 
Five set of reaction mixture containing CPL,OH' and [Fe(CN)6]^" were 
taken .The mixture was left to stand for 24 h at 25°C and then absorbance was 
measured. The A,max (420nm) was determined (Fig. 3). The stoichiometr}' of 
the reaction was studied adopting the limiting logarithmic method [19]. The 
ratio of the reaction between log Abs versus log [CPL] and log [Fe(CN)6]-'' 
were calculated by dividing the slope of [Fe(CN)6]^" by the slope of the CPL 
curve. It was found that, the ratio was 1:3 .The proposed pathway as shown in 
eq.l. 
\ l F OSCH, .» P 
1.T—c—c N ^ II 
HSCH2 
C H T - Y - C 
N. ^H + 3|Fe(CN)6|-'-. H ,0 
'""C—OH 
o 
CH-i—C—C 
C/t- OH 
O 
3|Fe(CN)6l'*-+ SH-" (1) 
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Evaluation ofEa, Mf, ^G* and A5* 
The oxidation of CPL by [Fe(CN)6]"'~ was investigated constant pH and 
ionic strength at four temperatures (Table 2). Ea was calculated from the 
Arrhenius plot of log o^bs vs l/T, (81.0 ±.02 kJ.mof') indicate positive higher 
activation energy showes the rate increases at higher temperature. Other 
thermodynamic parameters were calculated applying Eyring equation 
Log K/T = [ log kb/h + S/2.302R] - AH/ 2.303R1/T 
AH" was evaluated from the slope (-AH/ 2.303R1/T) and AS^ from the intercept 
[log kb/h + S/2.302R] of the compiled Eyring plot. The Gibbs free energy of 
activation was determined by tsG* = -2.303 RTlogK at room temperature 
(Table.2). 
Effect of Ionic Strength and Dielectric Constant 
The ionic strength was varied (0.1 and 0.9 mol dm'" )^ by the addition of 
sodium chloride keeping the concentrations of other components constant. The 
apparent first-order rate constant showed a nearly ten-fold increase (Table 3). A 
plot of log koh% versus /was linear with a unit positive slope (Fig 4). 
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The dielectric constant {D) of the medium was varied by varying the 
tert-h\xiy\ alcohol / H2O percentage (v/v). Since the D for various percentage 
compositions was not available in literature, they were computed by using IheirD 
in pure state. The plot of log k^bs versus \ID was found to be linear with 
positive slope (Fig 4) and showed that as D decreases the /tobs increased 
(Table 3). 
Keeping all other conditions constant the concentrations of the oxidant 
HCF(III), substrate (CPL) and alkali was varied. The reaction fallowed the 
first-order. Based on the experimental results, a mechanism can be proposed 
for which all the observed orders for each constituent such as [oxidant], 
substrate and [OH"] may be well accommodated. Oxidation of CPL by 
HCF(III) in NaOH medium is a non-complementary reaction with oxidant 
undergoing six equivalent changes. 
The substrate with HCF(III) formed complex C in alkali medium 
decomposes in slow step to a free radical, further reacts with one mol of 
HCF(III) in aqueous medium to give an intermediate product of CPL and 
HCF(II). The intermediate product of CPL reacts with one mol of HCF(III) in 
fast steps to give the product, (25)-l-[(25)-2-methyl-3-sulfinyl propanoyl] 
pyrrolidine-2-carboxylic acid and HCF(II). Another two mole of free radical of 
CPL in fast step to form the final products, (2S,2-S)-1,1-
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[disulphanediylbis[(2S)-2-ethyl-1 -oxopropane-3,1 -diyl]-bis[pyrrolidine-2-
carboxylic] acid (captopril-disulphide) satisfying the stoichiometry. The results 
can be accommodated by Scheme 1. 
HSCHj 
CH, 
H O 
S i 
- c — c 
,!) H + |Fe(CN)J^ 
\_f"'C-OH 
Comlex C + CN 
Comlex C 
Alka l i 
SCHj H O 
k (Slow) o<' H + |Fc(CN),p- + H j O C OH 
SCHj H p 
CH 
-C C 
O 
Formation of free radical 
H O 
< ^ N ^ + |Fe(CN),|^- + HjO 
\_J "C —OH, 
HOSCHj ~ 11 
F a s t CHj - ^ c C + |Fe(CN)«l'_^ ^ 
O' H C OH II O 
HOSCH2 " [? 
CH, C C 
I 
OSCHj H O 
V 
|Fe(CN),|J-
P a S l CH3 — ^ C — C + |F'^(CN),|'- + H 
Cf"-C OH 
O 
o; OH 
Fast 
|Fc(CN)5|->- + CN - ^ |Fc(CN)J-'-
SCHj H p 
H O 
CH3 ^C—C 
O' Fast 
| ^ ^ C H , S - S C H , _ y / _ | 
H ^ N 
C OH 
II 
O OH - .>0 C/v -OH 
SCHEME. 1 
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The probable structure of the complex is 
. 2-
O 
N H OH 
CH3 C — C 
HSH2C H o 
' < Ne CN 
CN 
Complex (C) 
The results can be verified by Spectrophotometric measurements of the 
complex c (A hypsochromic shift, of complex C ca. 10 nm from 350 to 360 nm 
is observed together with hyperchromicity at 360 nm). Analogous effects upon 
complex formation between a substrate and an oxidant have been observed in 
other investigations [20]. Further, the formation of complex is also proved 
kinetically by the non-zero intercept of the plot of 1/^ obs vs 1/[0H"] and l//tobs 
vs 1/[CPL] (Fig. 5). The modest enthalpy of activation, relatively low entropy 
of activation, and higher rate constant for the slow step, indicate that the 
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oxidation presumably occurs by tlie use of an inner-sphere mechanism [21]. 
Scheme 1 is in accordance with the generally accepted principle of non-
complementary oxidation taking place in sequence of one electron step. 
The rate law for the mechanism (Scheme 1) may be derived as-
d[Fe (CN)63-] ^ ^ t^e (CN)63-][CPL] [OH"] 
Rate = = (2) 
dt (1+ /qPe (CN)62-])(1+ K[CPL]) 
/cK[Fe(CN)6^-][CPL][0H-] 
Rate = (3) 
1+ KICPL] + K[Fe (CN)6^-](1+ K[CPL]) 
or 
/f K [Fe (CN)63l[CPL] [OHT 
Rate = (4) 
1+ K[CPL] + K[Fe (CN)6^-]+ K[CPL]K[Fe (CN)6^T 
or 
k K [Fe (CN)63l[CPL] [OHT 
Rate = (5) 
1+ K[CPL] + K [Fe (CN)6^1+ K^[CPL] [Fe (CN)6^1 
Since the terms K[Fe(CN)6^"] and K^[CPL] [Fe(CN)6 '^] in the denominator in 
Eq. (5) are negligible compared to unity in view of the low concentration of 
[Fe(CN)6'-] . 
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The Eq. (5) becomes 
Rate = 
kK [Fe (CN)6^-][CPL] [0H-] 
1+fqCPL] 
(6) 
Rate , ^K[CPL1[0HT ._, 
[Fe(CN)6^T 1+K[CPL] 
The rate law (7) can be rearranged to (Eq 8.) 
1 
+ —r 
(8) 
^obs kKICPL] [0H-] 
According to Eq. (8), the plots of 1/^ obs vs 1/[0H"] and 1/^ obs vs 1/[CPL] should 
be linear, (Fig.5).The slope and intercept of such plot the reaction constants, K 
and k were calculated as 10.2x10'^  dm^mol'', 2.67x10^ dm"* mof' s~', 
respectively. Using these values rate constants under different experimental 
conditions were calculated and compared with experimental data (Table 1). 
There is a reasonable agreement between them. The effect of increasing ionic 
strength on the rate explains qualitatively the reaction between two negatively 
charged ions, as seen in complex C (scheme 1). The negative value of the 
entropy of activation indicates that the complex is more ordered than the 
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reactants [22]. The observed modest activation energy and large entropy of 
activation supports a transition state in the reaction. 
CONCLUSION 
In summary, the commercially more valuable CPL can be oxidized by 
hexacyanoferrate(III) in alkaline medium. The rate constant of the slow step 
and other equilibrium constants involved in the mechanism are evaluated and 
activation parameters with respect to the slow step of reaction were computed. 
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HSCHo I I? 
C H P C - C 
Fig.l Structure of captopril 
u 
c 
n 
SI 
o 
< 
O 
+ 
F/^.2 First-order plots for the oxidation ofCPL by Hexacyanoferrate(in) in 
an aqueous alkaline medium at 25°C: fCPLJ = 4.0x I0~^ mol dm'\' 
[OK] = 0.10 mol dm'^ andl = 0.5 mol dm'\' fFefCNj/'x 10'" mol dm'^ 
(A) 1.0, (B) 3.0 and (C)5.0. 
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1.4 n 
o 
c 
O (0 
XI 
< 
300 400 500 600 
Wavelength 
Fig.i Spectral scan of the reaction mixture offFefCN)^/', and CPL 
IFe(CN)(,f = 4.0^ 10" mol dm\ fCPL/= 4.0 x 10^ mol dm\ Ionic 
Strength = 0.5 mol dm'' (NaCl), and /OfT/ = 0.10 mol dm'^at 25°C 
(scan after Imin) 
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I '^^ mole d m ' 
0.011 0.013 0.015 0.017 
1 / D 
Fig. 4 Effect of ionic strength and dielectric constant on the oxidation of 
CPL by hexacyanoferrate(III) in allialine medium at 25°C. 
0.7 
X 
55; 
4 6 
1 / [OH"] (mol«dm ) 
8 10 12 14 16 18 
H 1 1 1 1 H-
20 
— » — 0.413 
0.406 
- - 0.399*^0 
0.392 >L 
-- 0.385 
- - 0.378 
- - 0.371 
-- 0.364 
0.357 
110 
1 / [CPL] X 10"' (mol -dm' ) 
Fig.5 Verification of rate law eq 3 at a different [OH~] and [CPL] on 
oxidation of CPL by Hexacyanoferrateflll) in an aqueous alkaline 
medium at 25°C. 
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Table 1. Effect of Variations oflFe(CN)tl, fCPLJ, and [OITJ on the 
Oxidation ofCPL by [Fe(CN)t] at 30 °C, 1 = 0.80 mol-dnf^ 
[Fe(CN)6'"]x 
10^ 
[CPL] X lO-* [OH"](nioldin^) kobs X lO' (S"') 
Observed Calculated 
Variation fFe(CN)/'J(mol-dm^) 
0.8 
1.0 
2.0 
4.0 
6.0 
8.0 
4.0 
4.0 
4.0 
4.0 
4.0 
4.0 
0.10 
0.10 
0.10 
0.10 
0.10 
0.10 
2.61 
2.66 
2.65 
2.67 
2.69 
2.65 
2.67 
2.67 
2.67 
2.67 
2.67 
2.67 
Variation fCPLJ (mol-dm^) 
4.0 
4.0 
4.0 
4.0 
4.0 
4.0 
1.0 
2.0 
3.0 
4.0 
6.0 
8.0 
0.10 
0.10 
0.10 
0.10 
0.10 
0.10 
1.46 
1.95 
2.31 
2.64 
2.87 
3.00 
1.47 
1.99 
2.35 
2.67 
2.88 
3.04 
Variation fOH~J(mol-dnt^) 
4.0 
4.0 
4.0 
4.0 
4.0 
4.0 
4.0 
4.0 
4.0 
4.0 
4.0 
4.0 
0.050 
0.075 
0.10 
0.20 
0.30 
0.40 
2.46 
2.55 
2.67 
2.76 
2.75 
2.77 
2.47 
2.58 
2.67 
2.73 
2.76 
2.79 
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Table 2. Activation and thermodynamic parameters for the oxidation ofCPL 
by hexacyanoferrate(III) in aqueous alkaline medium with respect 
to the slow step of Scheme 1. 
(a) Effect of temperature: 
Temp. (K) 
298 
303 
308 
313 
(b) Activation parameters: 
Ea (kJ-mor') 
AG" (kJ-mor') 
AH* (kJ-mor') 
AS** (J'tC' mar') 
k^l(f (dm^ mar' s~') 
2.67 
2.83 
2.96 
3.00 
81.0±.02 
76.5 ±.02 
37± 10 
-73.4 ±.02 
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Table 3. Effect of Ionic Strength and Dielectric Constant on the 
Oxidation ofCPL by Hexacyanoferrate(III) in alkali medium at 
25 °C. 
ionic strength I 
D)80.0 
I 
0.1 moldm"^ 
0.3 mol dm"^  
0.5 mol dm"^  
0.7mol dm"^  
0.9mol dm'^  
k„ts X 10" 
2.04 
2.38 
2.67 
3.03 
3.39 
dielectric constant D 
I) 0.5 mol dm" 
D 
80.0 
75.0 
70.0 
65.0 
60.0 
kohs X 10" 
2.67 
2.73 
2.78 
2.89 
2.92 
Note: [Fe(CN)6^ ] = 4.0 x 10-4, [CPL] = 4.0 x j0-3 and [OH'] = 0.1 / mol dm-3 
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Abstract The kinetics and mechanism of oxidation of 
levofloxacin (LF) by manganese(VII) in alkaline medium 
at constant ionic strength was studied spectrophotometri-
cally. The reaction exhibits 2:1 Mn.LF stoichiometry and is 
first order in permanganate but fractional order in both LF 
and alkali. Decrease in the dielectric constant of the med-
ium results in a decrease in the rate of reaction. The effects 
of added products and ionic strength have also been 
investigated. The main products identified were hydroxyl-
ated LF and Mn(VI). A mechanism involving free radicals 
is proposed. In a composite equilibrium step, levofloxacin 
binds to Mn04~ to form a complex that subsequently 
decomposes to the products. Inve.stigations of the reaction 
at different temperatures allowed the determination of the 
activation parameters with respect to the slow step of the 
proposed mechanism. 
Introduction 
Potassium permanganate is widely used as an oxidizing agent 
as well as in analytical chemistry. These reactions are gov-
erned by the pH of the medium. Of all the oxidation states of 
manganese from +2 to -f 7, permanganate, manganese(VII), 
is the most potent oxidant in acid as well as in alkaline media. 
Permanganate oxidation finds exten,sive applications in 
organic synthesis [1,2], especially since the advent of phase 
transfer catalysis [3-5]. Kinetic studies are important sources 
of mechanistic information on such reactions, as demonstrated 
A. A. P. Khan A. Mohd • S. Bano A. Husain 
K. S. Siddiqi (El) 
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by the results referring to unsaturated acids both in aqueous 
[3-6] and in non-aqueous media [7]. The mechanism of oxi-
dation depends on the nature of the substrate and pH of the 
system [8]. In strongly alkaline medium, the stable reduction 
product [9-11] of permanganate is manganate ion, MnOa^". 
Mn02 appears only after long time, i.e., after the complete 
consumption of Mn04"~. No mechanistic information is 
available to distinguish between a direct one-electron reduc-
tion to Mn(VI) and a mechanism in which a hypomanganate 
ion is formed in a two-electron reduction followed by its rapid 
re-oxidation [12, 13]. 
Levofloxacin (LF), (-)-(S)-9-fluoro-2,3-dihydro-3-methyl-
IO-(4-methyl-l-piperazinyl)-7-oxo-7H pyrido [1,2,3-de]-
l,4-benzoxazine-6-carboxylic acid hemihydrate, is one of 
the commonly used fluoroquinolone antimicrobials, being 
the active S-isomer isolated from racemic ofloxacin. Lev-
ofloxacin pos.ses.ses a broad spectrum of activity against 
various bacteria, including Gram-positive and Gram-
negative microorganisms [14]. It is al.so active against the 
causes of atypical respiratory infection such as Chlamydia 
pneumoniae and Mycoplasma pneumoniae [15]. Because of 
its effective antibacterial activity and low frequency of 
adverse effects on oral administration, levofloxacin has 
been widely used for the treatment of infectious diseases, 
such as community-acquired pneumonia and acute exac-
erbation of chronic bronchitis [16]. The antibacterial action 
of the quinolones is not lineariy proportional to their con-
centration, and the optimum concentration must be main-
tained to prevent the surviving bacteria from regrowing 
[17]. The intrinsic fluorescence of fluoroquinolones is u.sed 
for their determination in biological samples after their 
preliminary extraction with organic .solvents [18]. A 
method was proposed for determining the.se antibiotics in 
biological fluids using a mixed-ligand complex formed by 
terbium and triphenylphosphine oxide [19]. The interaction 
^ Spri nger 
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of fluoroquinolones with metal ions has attracted consid-
erable interest not only for the development of analytical 
techniques, but also to provide information about the 
mechanism of action of the pharmaceutical preparation 
[20]. Since the metal ions cause fluorescence quenching of 
the drug, spectrofluorimetric methods for the quantitative 
determination of the quinolone type drugs have been 
developed [21] besides titrimetric [22], spectrophotometric 
[23], electrochemical [24], electrophoretic [25] and chro-
matographic [26] techniques. The accumulation of fluoro-
quinolone antibiotics in aquatic environments, even in low 
concentrations, may cause threats to the ecosystem and 
human health by inducing multiplication of drug resistant 
bacteria as a result of long-term exposure. Chemical oxi-
dation of pollutants in drinking and waste water by per-
manganate ion has been widely used. The present .study is 
an attempt to explore the mechanism of oxidation of lev-
ofloxacin by permanganate in alkaline medium on the basis 
of kinetic parameters. 
concentration range, and f: was found to be 2083 ± 50 dm'' 
mor ' cm"' (compared to the literature, E = 2200 [9]). The 
first-order rate constants k,,^^ were evaluated from plots of 
log [permanganate] versus time. The plots in all ca.ses were 
linear up to 75% of the reaction (Fig. 1), and i<,bs values were 
reproducible at 526 nm, notwithstanding the increasing 
absorbance of Mn(VI) at 610 nm during the course of the 
reaction (Fig. 3). The effect of dissolved oxygen on the rate 
of reaction was checked by following the reaction in nitrogen 
atmosphere. No significant difference between the results 
obtained under nitrogen and in the presence of air was 
ob.served. In view of the all-pervading contamination of basic 
solutions by carbonate, the effect of carbonate on the reaction 
was al.so studied. Added carbonate had no effect on the 
reaction rate. Nevertheless, fre.sh solutions were used during 
the experiments. Regression analysis of the experimental data 
to obtain the regression coefficient r and the standard devia-
tion S was performed using Micro.soft Excel 2(X)7. 
Experimental 
All chemicals used were of analytical reagent grade, and 
double distilled water was used throughout the work. A 
solution of levofloxacin (Sigma-Aldrich) was prepared by 
dissolving a known amount of its hydrochloride salt in 
di.stilled water. The permanganate (Ranbaxy Fine Chem. 
Ltd, India) solution was prepared and standardized again.st 
oxalic acid by a .standard procedure [27]. Potassium man-
ganate solution was prepared as described by Carrington 
and Symons [28]. KOH (Merck Ltd.) and KNO, (Merck 
Ltd.) were employed to maintain the pH and ionic strength, 
respectively. 
The absorption spectra were obtained with an Elico-SL-
169 double beam UV-vis spectrophotometer. All potenti-
ometric measurements were carried out with an Elico-LI-
120 pH meter, and the products were analyzed using a 
Nicolet 5700-FT-IR spectrometer (Thermo, USA). 
Kinetic measurements and procedure 
The oxidation of LF by permanganate was followed under 
pseudo first-order conditions where LF was greater than 
manganese(VII) at 25 °C. The reaction was initiated by 
mixing thermally equilibrated solutions of Mn04~ and LF 
that also contained the required quantities of KOH and 
KNOj to maintain alkalinity and ionic strength, respec-
tively. The reaction was monitored by the decrease in 
absorbance of Mn04~ at its absorption maximum of 526 nm. 
It was verified that there is no interference from other 
reagents at this wavelength. Beer's Law was obeyed in this 
Results 
The reaction orders were determined using the slopes of 
'og o^bs versus log (concentration) plots by varying the 
concentration of the reductant and OH" while keeping 
other factors constant. With fixed concentrations of LF, 
1.0 X 10"'' mol dm"\ and alkali, 2.0 x 10"^ mol dm"\ 
at constant ionic strength, 0.10 mol dm"\ the permanga-
nate concentration was varied in the range of 4.0 x 10"^ to 
6.0 X 10" mol dm"\ All kinetic runs exhibited identical 
characteristics. The linearity of plots of log (ab.sorbance) 
versus time, for different concentrations of permanganate, 
indicates that the order in Mn(VII) is uniform (Fig. 1). This 
was also confirmed by the constant values of the pseudo 
first-order rate constants, /:„hs, for different Mn(VII) 
2.6 
2.4 
^ 2.2 
o 
I 1.8 
JO 
< 1.6 
° 1.4 
+ 
^' 1.2 
1 
0.8 
0.3 0.8 
Time (min) 
2.3 
Fig. 1 Firsi-order plols of the oxidation of levofloxacin by perman-
ganate in aqueous alkaline medium. [LF] = I x lO"-*, [OH") = 
2 X 10"' and ; = 0.10/mol d m " \ [Mn04")xlO'' mol dm"' = (A) 
0.4, (B) 0.8, (C) 1.0, (D) 2.0 and (E) 3.0 
^ Spri inger 
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Table 1 Effects of [LF], [Mn04" 1 and (OH"] on the oxidation of 
levofloxacin by permanganate in aqueous alkaline medium at 25 "C 
and ionic strength /=0. lO/moI dm" 
10" X [MnOri 10' X [LF] lO' x [0H-] *,-»! x 10' k„t„ x lO' 
moldm- ' moldm"' mol dm"' ' ^ - " '^"" 
0.4 
0.8 
1.0 
2.0 
3.0 
3,0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
0.4 
0.6 
0.8 
1.0 
4.0 
6.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
0.4 
0.8 
1.0 
2.0 
4.0 
6.0 
4.12 
4.12 
4.12 
4.12 
4.12 
3.67 
3.76 
3.12 
4.28 
5.38 
5.41 
2.19 
2.39 
2.84 
3.32 
3.61 
4.43 
4.10 
4.10 
4.10 
4.10 
4.10 
3.65 
3.74 
4.10 
4.25 
5.35 
5.40 
2.18 
2.38 
2.82 
3.30 
3.60 
4.41 
concentrations (Table 1). The LF concentration was varied 
in the range of 4.0 x 10"" to 6.0 x 10"'' mol dm"-* at 
constant alkali and permanganate concentrations and con-
stant ionic strength of 0.10 mol dm"-' at 25 °C. The *„hs 
values increased with increase in LF over the concentration 
range shown in (Fig. 4). At low concentration of LF, the 
reaction was first order in LF and at high concentration of 
LF, the reaction was independent of LF. The effect of alkali 
on the reaction was studied at constant concentrations of 
LF and permanganate and a constant ionic strength of 
0.10 mol dm"' at 25 °C. The alkali concentration was var-
ied in the range of 1.0 X 10"-'to1.0 X 10"-mol dm"\The 
rate constant increased with increase in alkali concentration 
(Fig. 5), indicating a fractional-order dependence of the rate 
on alkali concentration, 
Stoichiometry and product analysis 
Different reaction mixtures containing LF and an excess of 
Mn04" with constant OH" and KNO3 concentration were 
kept in closed vessels under nitrogen atmosphere at room 
temperature. After 2 hours, the Mn(VII) concentration was 
Table 2 FT-IR frequencies 
Compound 
Levofloxacin 
Oxidation Product 
WOH) 
3411 
3305 
(cm" ' ) 
i (C=0) 
1722 
1626 
y,,,y„, (COO) 
1622 
1586 
.•,„„(COO) 
1462 
1442 
assayed by measuring the absorbance at 526 nm. The 
results indicated a 1:2 stoichiometry, as given in Scheme 1. 
The main reaction products, Mn(Vl) and 9-fluoro-2,3-
dihydro-3-methy 1-5-hydroxy-10-(4-methy 1-1 -piperazinyl)-
7-0X0-7H pyrido [l,2,3-de]-l,4-benzoxazine-6 carboxylic 
acid, were isolated and identified with the help of TLC 
and characterized by FT-IR. The FT-IR spectra of LF 
and its complexes are similar. The (C=0) band appears at 
1,722 cm"' in the spectrum of LF; the complexes show this 
band at ca. 1,626 cm"', suggesting that the coordination of 
the ligand occurs through the carboxylate oxygen atom. A 
carboxylate ligand can bind to the metal atom as a mono-
dentate ligand, giving changes in the relative positions of 
the antisymmetric and symmetric .stretching vibrations with 
the aim of deducing the coordination mode [29, 30]. The 
FT-IR spectra of the complex (Table 2) give a separation 
>100 cm"', suggesting monodentate bonding for the car-
boxylate group. 
Effects of ionic strength, dielectric constant 
and temperature 
The effect of ionic strength was studied by varying the 
pota.ssium nitrate concentration from 0.01 toO.IO mol dm"' 
at constant concentrations of permanganate, LF and alkali. 
Increasing ionic strength had no effect on the rate constant. 
The effect of the dielectric constant (D) was studied by 
varying the f-butanol-water content (v/v) in the reaction 
mixture with all other conditions held constant. The rate of 
reaction increases with increasing /-butanol volume. The 
plot of log <:„hs versus \/D was linear with positive slope 
(Fig. 2). 
The kinetics was al.so studied at four different temper-
atures with varying concentrations of LF and alkali, 
keeping other conditions constant. The rate constants were 
found to increase with increase in temperature. The rate of 
the slow step was obtained from the slopes and intercepts 
of 1/A:„hs versus 1/[LF] and l/k„t,^ versus I/[OH"] plots at 
four different temperatures (25-37 °C). The activation 
energy corresponding to these rate constants was evaluated 
Scheme 1 Formation of 
hydroxylated LF and Mn(Vl) ° 9 
+ 2Mn04 + 2 0H ' 
o o 
" 1 '"-OH 
\3H + 2 Mn04 + H2O 
•• \ 
<fi Spri nger 
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l/D 10 
Fig. 2 Effect of dielectric constant on the oxidation of levofloxacin 
by alkaline Mn04" at 25 °C 
from the Arrhenius plot of log k versus 1/7 froin which 
other activation paraineters were also obtained (Table 3). 
Test for free radicals 
500 550 500 
Wavelength (nni) 
Fig. 3 Spectral changes during the oxidation of levofloxacin (LF) by 
MnOj" in alkaline medium at 25 X : (MnOa"] = 1 x 10"", 
[LF] = I X IO- \ [0H"1 = 2 X 10"' and / = O.IO/mol dm"' 
To test for the involvement of free radicals, acrylonitrile 
was added to the reaction mixture, which was then kept for 
Table 3 Activation and thermodynamic parameters for the oxidation 
of LF by alkaline permanganate with respect to the slow step of the 
reaction Scheme 2 
Temperature(K) 10\ (S"') 
Effect of Temperature with respect to the slow step of Scheme : 
293 10.6 
298 11.8 
303 12.2 
310 13.5 
Value 
Activation parameter 
Ea (kJmole'') 
AH (kJmole"') 
AS ± (Jk"'mole"') 
AG ±(kJmole~') 
14.9 
11.9 
-143.2 
63.10 
Effect of temperature (K) lO-^ /Ca (dm' moP ' ) 10"'^2 (dm' mol"') 
Equilibrium constants K^ and K2 at different temperatures 
293 5.44 6.17 
298 7.59 6.69 
303 9.62 5.32 
310 12.43 4.34 
Thermodynamic parameters 
AH (kJmole"') 
AS ± (Jk"'mole"') 
AG ± (kJmole"') 
Kt values 
58.1 
123.5 
-8.7 
Af2 values 
-78.6 
-89.7 
-8.35 
24 h under nitrogen. Addition of methanol, resulted in the 
precipitation of a polymer, suggesting the involvement of 
free radicals in the reaction. The blank experiment of 
reacting either permanganate and LF alone with acryloni-
trile did not induce polymerization under the same condi-
tions. Initially added acrylonitrile decreased the rate of 
reaction [31]. 
Discussion 
Under our experimental conditions at pH > 12, the 
reduction product of Mn(Vll), i.e., Mn(VI), is stable, 
and no further reduction is initially observed [10]. 
However, on prolonged standing, the green Mn(VI) is 
reduced to Mn(IV) under our experimental conditions. 
Permanganate ion in alkaline medium exhibits various 
oxidation states, such as Mn(VlI), Mn(V) and Mn(VI). 
During this reaction, color changes from violet Mn(VII) 
to dark green Mn(VI) through blue Mn(IV) were 
observed. It is clear from Fig. 3 that the concentration of 
Mn04~ decreases at 526 nm, while increases at 610 and 
460 nm are due to Mn(VI). As the reaction proceeds, a 
yellow turbidity slowly develops, and after keeping for a 
long time the solution decolourises and forms a brown 
precipitate. This suggests that the initial products might 
have undergone further oxidation resulting in a lower 
oxidation state of manganese. It appears that the alkali 
combines with permanganate to give [Mn040H]^" [32. 
33]. In the .second step, [Mn040H]"~ combines with 
levofloxacin to form an intermediate complex. The var-
iable order with respect to LF most probably results 
^ S p i rmger 
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from the complex formation between oxidant and LF 
prior to the slow step. A plot of \lk„h„ versus 1/[LF] 
(Fig. 1) shows an intercept in agreement with complex 
formation. Further evidence for complex formation was 
obtained from the UV-vis spectra of reaction mixtures. 
Two isosbestic points were ob.served for this reaction 
(Fig. 3), indicating the presence of an equilibrium before 
the slow step of the mechanism [34, 35]. In our pro-
posed mechanism, in the complex one electron is 
transferred from levofloxacin to Mn(VII). The cleavage 
of this complex (C) is assigned as the slowest step, 
leading to the formation of an LF radical intermediate 
and Mn(VI). The radical intermediate reacts with 
another Mn(VII) species, [Mn040H]^~, to give the final 
products, Mn(VI) and the alcohol (Scheme 2). The effect 
of the ionic strength and dielectric constant on the rate 
is consistent with the involvement of a neutral molecule 
in the reaction. The suggested .structure of complex (C) 
is given in Scheme 2. 
From Scheme 2, the rate law (Eq. 7) can be derived as 
follows: 
Rate = 
-dlMnO" 
dt kKiK, (Mn04-],[LF],.10H- ;i) 
[Mn04-],= [Mn04 ] | + [Mn04 • OH]^- -f [Complex] 
= [MnO;],.+ [Mn04-]lOH-] 
+ kK|K2[Mn04] [LF][OH-J 
[MnOj-],= [MnO;],.(l + K| [OH-]+ KiK^lLF] [OH-]) 
^ n O j ] , 
[MnO,-],. 
I + K | [OH-]+ K|K2[LF][0H-
(2) 
The total [Mn04 ] can be written as 
where "t" and "f' stand for total and free. Similarly, total 
[0H~] can be calculated as 
[0H-], = [OH-],-i- [Mn04 OHJ^" + [Complex] 
(OH-l = ^^Ll! (3) 
' " I + K| [MnO^-] + K|K2[LF] [MnO^] 
In view of the low concentrations of MnOa" and 
levofloxacin used in the experiment, in Eq. 3, the terms 
A'|[Mn04"] and A'|A'2[Mn04~] [LF] are neglected. Thus, 
[0H-1,.= [0H-], (4) 
Similarly, 
[LF|,.= [LF], (5) 
Substituting Eq. 2, 4, and 5 in Eq. I we get 
Scheme 2 Proposed 
mechanism for the oxidation of 
levofloxacin by alkaline Mn04 
M n 0 4 + 0 H , IMnOj.OHl^ 
Complex (C) 
o o % ? > 
Mn 
y-H \ 
IMnOj.OHI-
MnOj- * H , 0 
+ IMnO^.OHl-" MnOj^ 
^ Springer 
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[Mn04-],.= + K|[OH-] + K|K2[LF][OH-
1 +K|[OH-
Rate 
MnO; r r ~ '^hs — 
+ K|K2[LFl[0H-
kK|K2[LF] [0H~ 
1 +K|[OH-] + K'K^[LFj |0H-
(6) 
(7) 
Equation 7 is consistent with the observed orders with 
respect to different species, which can be verified by 
rearranging to Eq. 8. 
1 
+ : 
1 1 
K„M icK|K2[LF][0H-] K,K2[LF] K (8) 
According to Eq. (8), other conditions being constant, 
plots of l/*„bs versus l/[LF] and l/^ obs versus 1/[0H~] 
should be linear (Figs. 4 and 5). The slopes and intercepts 
of such plots lead to the values of ^ i , K2 and k (Table 3). 
With these values, the rate constants were calculated under 
different experimental conditions, and there is a reasonable 
agreement between the calculated and experimental 
values [36] (Table 1). The thermodynamic quantities for 
the first and second equilibrium steps of Scheme 2 can be 
evaluated. The [LF] and [0H~] (as in Table 1) were varied 
at four different temperatures. Van't Hoff s plots of logAf, 
versus \IT and \0gK2 versus 1/T gave the values of 
enthalpy of reaction AH*, entropy of reaction AS* and free 
energy of reaction AG, calculated for the first, and second 
Fig. 
I/ILFI 10 (dm mol ) 
4 Plots of 1/A;„hs versus 1/[LF] at four different temperatures 
Fig. 
l/fOH] 10"- (dm mole ) 
5 Plots of l/^ ohs versus 1/[0H~] at four different temperatures 
equilibrium steps (Table 3). A comparison of the latter 
values (from Kz) with tho.se obtained for the slow step of 
the reaction shows that they mainly refer to the rate-
limiting step, supporting the fact that the reaction before 
the rate determining step is fairly fast and involves low 
activation energy [37, 38]. The moderate values of AH* 
and AS* were both favorable for electron transfer pro-
cesses. The value of AS* that is within the expected range 
for radical reactions has been ascribed to the nature of 
electron pairing and unpairing processes and the loss of 
degrees of freedom formerly available to the reactants upon 
the formation of a rigid transition state [39]. The negative 
value of AS* indicates that complex (C) is more ordered 
than the reactants [40,41 ]. The enthalpy of activation and a 
relatively low value of the entropy and a higher rate 
con.stant of the slow step indicate that the oxidation most 
probably occurs via inner-sphere mechanism [42, 43]. 
Conclusion 
It is noteworthy that the oxidant species [Mn04"] required 
the pH 12, below which the system gets disturbed and the 
reaction proceeds further to give a more reduced of Mn(lV) 
product, which slowly develops yellow turbidity. In this 
reaction, the role of pH is crucial. The rate constant of the 
slowest step and other equilibrium constants involved in 
the mechanism were evaluated and activation parameters 
with respect to the slowest step were computed. The pro-
posed mechanism is consistent with product, mechanistic 
and kinetic studies. 
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Abstract: Kinetics and mechanism of substitution of cyanide ion in 
hexacyanoferrate(II) by EDTA catalysed by mercury(II) has been studied 
spectrophotometrically at 365 nm in potassium hydrogen phthalate buffer of pH 
= 5.0 and ionic strength, I = 0.1 M, maintained by (KNO3) at 25 °C. Effect of the 
pH and concentration of the EDTA, [Fe(CN)'*"6] on the rate of reaction has been 
studied. The kinetics and mechanism of the reaction has been shown through 
dissociative mechanism. The mechanism of iigand substitution in the complex 
together with the kinetic data has been shown. The catalytic activity of 
mercury(II) has also been studied as a function of its concentration. The 
maximum reaction product was detected at pH = 5 after which a decline in 
absorption occurs followed by precipitation. It is an inexpensive method to 
identify and remove the cyanide ion in solution even in very low concentration of 
the order of 10"" M. 
Keyword: Kinetics, Hexacyanoferrate(II), EDTA, Mercury(II), Thermodynamics, Mechanism. 
Introduction 
It has been demonstrated that of all the heavy metals mercury(II) easily forms bonds to 
cyanide and slowly removes it from hexacyanoferrate(II). Kinetics and mechanism of Iigand 
replacement in low spin Fe(II) complex has been done, although it is limited to the study of 
pentacyano(L)ferrate(II) complex'"^. Few studies have been done in aqueous electrolyte and 
micellar media to acquire an in depth knowledge of the mechanistic scheme*" .^ The 
oxidation kinetics of the hexacyanoferrate(II) complex by various reagents in acidic and 
basic media have been studied and all these investigation have been applied to specific 
analytical problems'""'^. K4[Fe(CN)6''"] hardly undergoes exchange reaction as CN' itself is a 
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very strong ligand although slow exchange of labelled CN' group or aminopyridine has been 
demonstrated. Under UV light reversible aquation occurs leading to the formation'' of 
[Fe(CN)5H20]''". However, only mono substituted [Fe(CN)5L]''" have been obtained either 
through photochemical or by dissociation reaction or by metal catalysed substitution reaction'''. 
[Fe(CN)f,'"] + H2O >- [Fe(CN)5H20]'+CN" (1) 
Hexacyanoferrate(II) reacts with EDTA according to the following equation 
[Fe(CN)5H20]'" + EDTA *- [ Fe(CN)5EDTA]'" + H.O (2) 
CN- +H2O >• HCN + OH" (3) 
Mercury(II) readily forms complex with cyanide ion but decomposition occurs in UV 
light. 
Hg^% [Fe(CN)6'] + H2O >- [Fe(CN)5H20]'" + HgCN^ (4) 
HgCN* H^ • HCN + Hg'^ (5) 
In the present work, we have studied the kinetics of substitution of CN by EDTA, 
catalysed by Hg'* A probable mechanism of the reaction has been proposed. Any attempt to 
study the substitution of CN" by phenanthroline, pyridine, hydrazine and piperazine resulted 
in precipitation even in low concentration. 
Experimental 
Double distilled, de-ionized water was used throughout. The chemicals u.sed were of analytical 
grade. Stock solutions of the compounds were wrapped with carbon paper to protect them from 
photodecomposition. The mercury(II) and hexacyanoferrate(II) solutions were diluted just 
before use. The desired pH= 5 of the reaction mixture was maintained by adding KHP-NaOH 
buffer'". The ionic strength was maintained at 0.1 M by adding appropriate amount of KNO3. 
Apparatus 
The absorption spectra were obtained with double beam UV-vis spectrophotometer (Elico-
SL-169). pH-metric measurements were done with Elico-LI 120 pH meter. 
Procedure 
All the solutions were thermally equilibrated for about 30 minutes at 25 "C and 2.0 mL of 
each EDTA, phthalate buffer of pH = 5.0 and mercury(II) chloride were mixed in a flask 
and left for 10 min to ensure complete reaction. Finally, 2.0 mL of [Fe(CN)(,]'*- was added to 
this mixture and the wavelength of maximum absorption (365 nm) was determined (Figure 1). 
EjfectofpH 
The reaction was studied first by fixed time kinetic method in the pH ranges 1-13. Figure 2 shows 
plots of absorbance (measured at t =5 and 10 minutes after mixing the reagents) versus pH of the 
reaction mixture. It was found that, with increasing pH the absorbance increases and attains 
a maximum between pH 5.0 to 5.5. However, above this pH the absorption decreases which 
is due to the deficiency of protons. The rate is reduced at low pH value due to the formation 
of various protonated forms of [Fe(CN)6]''- which are less reactive than [Fe(CN)6''-] itself'^ . 
Effect of EDTA 
The complex formation with EDTA is influenced by a change in the pH of solution which is 
perhaps due to ionization of the metal complex at low pH and hydrolysis of the metal ion at 
higher pH. The effect of EDTA was examined as a function of its concentration at a fixed 
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pH 5. A plot of initial rate versus EDTA is shown in Figure 3. Almost constant rate was 
obtained in the concentration range 2x10"^ to 7x10"^ M and finally decrease at still higher 
concentrations. A fixed concentration 4x 10'" M was thus selected as optimum. 
1.5- ^C 
< 
200 500 300 400 
Wavelenth 
Figure 1. Absorption spectra of reactants and products: (A) [EDTA] = IXIO'^ (B) [Fe(CN)5]''' 
= 5X10"'M (C) [Fe(CN)6f = 4X10""M, [EDTA] = 4X10"^  M, [Hg'1 = 3X10"' M and pH = 5.0 
1.90 
< 
6 
pH 
11 16 
Figure 2. Effect of pH on Hg'* catalysed substitution of CN" in hexacyanoferrate(II) by 
EDTA ion at [Fe(CN)6""] = 5X10"' M, EDTA = 5X10"' M, [Hg^l = 3X10"' M, Temp = 25 "C 
andI = 0.1M(KNO3). 
10 
w 
> 
10 15 
[EDTA], M 
20 
Figure 3. Effect of EDTA on initial rate at [Fe(CN)6""] = 3.5X10"^ M, [Hg^^] = 3x10"' M, 
pH = 5, Temp =25 °C and I = 0.1 M (KNO3) 
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Effect of[Fe(CN)fif' on the initial rate 
Dependence in [Fe(CN)6'*"] was found, changing from first order at lower concentration to 
higher concentration not zeroth order. Keeping all parameters constant, effect of the 
concentration of [Fe(CN)6'''] on the reaction rate was studied in the concentration range 
5x10"" to 2x10" M, Figure 4.A variable order . 
0 1 
0.5 • 
1 • 
j 
1.5-1 
> 2\ 
2. 2.5 
3 
3.5 • 
4 • "T I I " \— -\-' 1 ^ 1 1 
o o o o o o o o o 
c o c \ j T - p c q i n c o c \ i - r ^ 
c o o o c o c o c \ i c N J c v i c \ i c \ i 
-log[Fe (CN)6] 
, 
05 P 
oi 
q 
c\i 
o q 
CM 
1 
o 
03 
• ^ 
o q 
-^ 
Figure 4. Dependence of the initial rate on fFe(CN)6''] in presence of [Hg'*] at [EDTA] 
3xlO"'M, [Hg-^] = 3x10"^ M, pH 5.0, temp = 25 "C and 0.2 M (KNO,). 
Effect of [Hg^*] on initial rate 
The concentration of mercury(II) was kept between 1x10'^  to 2X10"'M and tho.se of the 
[Fe(CN)6 '] and EDTA were kept constant. The pH and temperature were maintained at 5 
and 25 C respectively. The results are shown in Figure 5. The large variation in [Hg"^ *] was 
selected in order to test the linearity between initial rate and [Hg"*] for its analytical 
application and also the changing role in [Hg"*] mixture. A plot of the absorbance measured 
after an interval of one min versus [Hg^*] as a function of pH is given in Figure 5. 
1.25 T 
[HgOj], M 
Figure 5. Dependence of the initial rate of substitution of CN" in [Fe(CN)6'*"1 by EDTA on 
[HgCl:] at [FeCCWf,'] =3.5x10' M, [EDTA] = 3xlO' M, pH = 5, temp = 25 "C and I = 
0.1 M (KNO3). 
It clearly indicates that the rate increases linearly until the ratio of the [Fe(CN)f,''"] and [Hg"^ ] 
reaches 1:1 .When the concentration of [Hg^*] exceeds that of [Fe(CN)6''"] the absorption begins to 
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decrease and follows a non-linear pattern. The intercept computed from the initial linear 
portion of the Figure 5 provides the rate due to the uncatalyzed path. However, decline in the 
rate of reaction at higher [Hg^*] is probably due to the formation of a binary adduct, 
[Fe(CN)6'*'. HgCl2]. In a separate experiment it was observed that a white precipitate is 
formed immediately after mixing [Fe(CN)6''"] with [Hg^*] in 1:2 molar ratio which rapidly 
turned blue, confirming the formation of a binuclear complex. A similar observation has also 
been made by Beck'^ 
Ejfect of temperature and ionic strength 
The rate of the [Hg'^] catalyzed ligand exchange between [Fe(CN)(,'' ] and EDTA was 
studied as a function of temperature in range 20-30 "C. The higher temperature was 
avoided due to the possibility of decomposition of [Fe(CN)5EDTA]''". The Arrhenius 
equation was used to determine the activation energy (Ea) for the catalyzed reaction and 
the other activation parameters, viz. enthalpy of activation (AH'*) and entropy of activation 
(AS*) were calculated using Eyring equation. The values of activation parameters are 
found to be Ea = 78.2 kJ mol' , AS'' = -48.67 JK"' mole' and AH* = -52.5 kJ mole'.The 
effect of ionic strength on the initial rate of reaction was also studied employing (KNO3) 
for maintaining ionic strength in the 0.015 to 0.2 M range. The higher ionic strength was 
avoided due to the limited solubility of (KNO3). When KCl was used to maintain the ionic 
strength the rate was found to decrease considerably. This is probably due to a subsequent 
decrease in [Hg^*] or [HgCr] along with the concentration of an ion-pair formation 
between [Fe(CN)6^] and [Hg^^]'^ 
Results and Discussion 
The following Scheme for the mercury(ll) catalyzed ligand exchange between [Fe(CN)6'^ '] 
and EDTA has been proposed: 
[Fe(CN)6]^^-+Hg^* + H j C ^ i i -
k-1 
-H2O 
uncatalyzed path 
K 1, H2O 
(slow) 
^ [Fe(CM)6 (Hg^^) ( H 2 O ) ] (6) 
xCNHg 
(CN)5Fe: ' 
J = ^ 
-HgCN kj (slow) 
3-[Fe(CN)5H20] 
-H2O 
Fast I K3 
[Fe(CN)5EDTA] 
+EDTA 
3-
(7) 
(8) 
(9) 
(10) 
HgCN* + H*. Hg^* + H C N (11) 
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Formation of the complex, [Fe(CN)5EDTA]^" through the catalyzed path can be written as: 
d [ Fe(CN)sEDTA]^ 
dt K2 [Al 
(12) 
While, that for the uncatalyzed path the 
rate = k'[Fe(CN)6^] (13) 
where, k' is a composite rate constant involving a concentration term. If the rate 
determining step is taken to be the composition of the activated complex (A*), the activity of 
the mercury(II) at low concentration can be easily explained by the above mechanism. The 
overall rate for uncatalyzed reaction can be expressed through equation (13) using a non 
limiting concentration of EDTA. 
Rate 
d [Fe(CN)5EDTA]^' 
dt 
, k2K [Fe(CN)ft'][Hg'l[H20] (14^ 
= k'[Fe(CN)f,'] + —^—'^-^ ^ ^'^^ l+K[Fe(CNV] 
The second term in the above equation refers to the rate of the catalyzed reaction and 
explains the variable order dependence in [Fe(CN)6']. K is defined as the equilibrium 
constant for the association of the mercury (II) with water and [Fe(CN)6''"]. Since water is in 
a large excess, the equation (14) is reduced to equation (15) 
Rate = k'[Fe(CN)6'] + k'2K[Hg'1[Fe(CN)6'] (15) 
Now equation (15) yields the observed rate constant (k^ bs) as expressed by equation (16) 
kobs = k'+k'2K[Hg'1 (16) 
where, k'2 = k2+ [H2O]. 
A plot of the initial rate versus [Hg"*] at low [Fe(CN)6''] is given in Figure 6. In case of 
higher [Fe(CN)(,'*'] , equation (14) takes the form of equation (17). 
Rate = k' [Fe(CN)6''"] + k2'[Hg-1 (17) 
15 
13 
00 
10 
Hg^  |2+ 
Figure 6. [Fe(CN)6 ] = 8x10^ M, [EDTA] = 5X10"^  M, pH = 5, temp. = 25 "^ C, I = 0.1 M (KNO3). 
The value of the initial rate (V|) as a function of [Hg'"^ ] at low [Fe(CN)6''"] is listed in 
Table 1. The value of the k' and k2' have been calculated from the plot Figure 6 of initial rate 
versus [Hg^*] using equation (17) at specified experimental condition. The rate constant k' and 
k2 are found to be 4.17x10'^ s ' and 2.50 s ' respectively, at 1 = O.I M, pH = 5, temp = 25 ''C 
.The value of k/ and k2S0 obtained are substituted in equation (17) to evaluate the equilibrium 
constant K at various [Hg^l at low [Fe(CN),s''']. The K (Table 1) and the average value of 
log K (2.80) in our case is comparable with that reported by Beck for |Fe(CN)6'' . Hg(CN)2] 
complex (logK = 2.38)'^. Although the values of k2 have been calculated employing high 
[Fe(CN)6''"] using equation (17) it can be obtained even at low [Fe(CN)(,'*] using equation (18) 
Spectroscopic and Substitution Kinetic Studies SI09 
Table 1. Calculation of K by varying [Hg^l at constant [Fe(CN)6'']. [FeCCN);,' ] = 8x10"^ M, 
[Hg^l = 5X10^ M, pH = 5, temp= 25 "C and I = 0.1 M (KNO3), 
[Hg^ lx lO ' .M VixlO" 
2 3.5 
4 5.9 
6 7.9 
8 10.6 
10 12.6 
Average log K =2.80 
k,- Rate-k'rFe(CNk' 
K(calcd.) 
709.07 
660.02 
610.60 
625.80 
601.80 
: 
K[Fe(CN),/l [Hg-I [H,0] 
(18) 
However, the values calculated from this equation are almost identical. The ionic 
behavior of [Hg"""^ ] may be represented by the following reactions. 
Hg2^  + Ci ^ ^ ^ HgCr (19) 
HgCI' + Cf ^-"^a— HgCIa (20) 
It has been shown that when Hg(N03)2 reacts with [Fe(CN)6''] in solution the resultant 
was Hg2[Fe(CN)6''"]'^ , which has also been verified from the absorption spectra of both the 
reacting components and the eventual product. This is quite obvious because the [Hg'^] is 
more electropositive than K* ion. The activation energy calculated for this reaction is a little 
less than the reported values in the literature^"'^' for the replacement of CN" in nearly similar 
reaction systems. The entropy of activation is negative and is expected if the virtual 
solvations of the activated complex and its highly charged dissociation products are 
considered. Thus, the activation parameters provide further support to the proposed 
mechanism. 
Conclusion 
In the present work we have studied the kinetics of substitution of CN' by EDTA catalyzed 
with [Hg"^]. A probable mechanism of the reaction has been proposed. The results presented 
here clearly demonstrate work, EDTA as a chelating agent was used for the neutralization of 
CN' in complex formation which is more effective and inexpensive. The values of 
thermodynamic parameters for complex formation are found to be Ea = 78.2 kJ mol'', AS'^  = 
-48.67 JK" mole" and AH = -52.5 kJ mole''. The negative value of shows the exothermic 
nature of reaction. 
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3. ^. iVAj -fl-ofl o]]A] Ca'\ Mg'\ Mn'\ Fe", Co'\ Ni'', Cu'* °*1 Zn'^sj- Cefpodoxime proxetil (CFP)^ ^j-
i^-^-§-^ ^^>4]-^^,5.^ 3iA].tV ^ 4 1:1 ^v°.o] ^Aj^-i- o^ - o24 ^ ^ t } '>-}^^ ^ ^ ^ ^ S . 2 j - g -
2704 345 nm<H)Ai ^ ^fl^ ^^^^V-§-it 5^1-2151^4. "^^i pH^WM ^^^^^^^^^S] isosbestic ^j(305 
4 330 nm)^ 4 4 ^ 1 5 1 4 . "^l^-§-^Jj^oHMi ^^S] ^HJEi oj^o] ^ ^ n ^ ^ 5^  H ^ Vi^. i ^ f l - ^ i ^ ^ 
^o],^<>))^^ CFP^l ^^l-*y-t ^^-M-Sj-ar chelating enhancement fluorescence(CHEF)X4'Hl 5^ «)1 «i^ J-7j-
i 7 ] - ^ 7 l - ^ ^ "t ^ Sa5}4. *-]-^ fl5| Sl-*l-^t^-^ Job'-sSf Benesi-HildebrandwJ-'y«Hl s]^ 7|vt^5]5c|cf. -^I 
1^S] ^M i ^ 4 ^ u-^14 ^0-4. Ca'* < Mg'^  < Co'* < Ni'* < Zn-* < Mn'* < Cu"* < Fc'\ 
^M\0\: CFP; ^7j-2.7j-; ov^ j^ ^ j - ^ . ^^fl^ AJ. CHEF 
ABSTRACT. Spectrophotometric investigation of the interaction of Cefpodoxime proxetil (CFP) with Ca'*, 
Mg^ Mn'\ Fe^\ Co'', Ni'', Cu'* and Zn'* in acidic medium showed the formation of 1 :l complex. The ab-
sorption spectrum of pure drug exhibits two prominent peaks at 270 and 345 nm. Its spectra scanned at several 
pH exhibited two isosbestic points (305 and 330 nm) indicating the presence of zwitterionic condition of drug 
in solution phase. The fluorescence emission spectra of CFP in presence of different concentrations of metal 
ions showed enhancement in fluorescence intensity which is ascribed to chelating enhancement fluorescence 
effect (CHEF). The stoichiometry of the complexes was determined by Job's and Benesi-Hildebrand method. 
The stability of the complexes follow the order Ca'*< Mg'*< Co''< Ni''< Zn'*< Mn-*< Cu'*< Fe'^ 
Keywoitte: CFP, Fluorescence enhancement. Stability constant. Complex formation, CHEF 
INTRODUCTION 
Cefpodoxime proxetil (CFP) is a semisynthetic 
p-lactum antibiotic known as (RS)-l(isopropox-
ycarbonyloxy) ethyl (+)-(6R, 7R)-7-[2-(2-amino-
4-thiazolyl)-2-{(Z) methoxyimino} acetamido]-
3-methoxymethyl-8-oxo-5-thia-l-azabicyclo 
[4.2.0] oct-2-ene-2-carboxylate. It is an ester pro-
drug of cefpodoxime acid where a proxetil radical 
is attached to cefpodoxime acid (Fig. 1). It is the 
third generation cephalosporin ester, used in the 
treatment of upper respiratory tract and urinary 
tract infection. In biological system cefjjodoxime 
undergoes ester hydrolysis and converted into cef-
podoxime acid to exhibit its antibiotic activity. ' It 
has an asymmetric carbon at position 4 and is sup-
plied as racemic mixture of R and S-enantiom.ers. 
Only a few methods are reported to quantify 
-152-
.v>J£^^ 
01-&-21- CFP ^b^i^-[-^ i ^ ^3 j - -gJj-yJcHl S]^ r^f o l^ i - l - CFP21 'Hr ^^ y 153 
Fig. 1. Structure Cefpodoxime Proxetil (CFP). 
CFP,'"'* nevertheless the analytical methods of de-
tection of CFP are handful, and they employ RP-
HPLC. These methods are based on separation of 
the R- and S-isomers. However, both the isomers 
are reported to exhibit similar biological activity,' 
the use of highly sophisticated and time-consum-
ing methods is not always required for routine 
analysis of CFP from the different dosage forms. 
The discovery of cephalosporin from C.acrem-
onium culture by Brotzu and demonstration of its 
remarkable stability towards aqueous solution 
even at pH 2 as well as its excellent in vitro activity 
against penicillin-resistant organisms by Abraham 
and Newton, were major breakthroughs in the 
history of P-lactam antibiotics. The realization that 
fungi might be a good source for novel antibiotics 
spurred microbiologists to develop novel soil-
screening programmes for the investigation of mi-
crobial culture leading to the discovery of several 
non-classical |3-lactams like carbapenem^ and 
oxacephems. The reactivity of p-lactam anti-
biotics is fundamentally linked to antimicrobial 
activity, it led Woodward'" to design and synthe-
size carbapenem group of compounds for evalua-
tion of their antibacterial activity through system-
atic screening of the soil microorganism. Numerous 
of these compounds show broad-spectrum anti-
microbial activity as predicted earlier and it was 
further substantiated by the subsequent discovery 
of thienamycin. It is unstable in its pure form and 
hence its derivatives are used which also led to the 
introduction of imipenem, which is regarded as 
one of the most effective drugs among the P-lactam 
antibiotics. Although several methods have been 
developed to determine the drug in biological flu-
ids and pharmaceutical preparations no effort 
seems to have been made to investigate the inter-
action of the drug with metal ions. 
In the present work an earnest effort has been 
made to study the interaction of the CFP with met-
al ions by fluorescence emission and absorption 
spectrophotometric measurements. Since quench-
ing or enhancement in fluorescence intensity of 
the drug in presence of metal ions occurs, the spec-
tra of the drug in presence of different concen-
trations of metal ions such as Ca^ *, Mg *, Mn *, 
Fe^ C o ^ N i ^ C u ^ and Zn^' were scanned. The 
ratio of the drug to metal ions was determined by 
Job's method and Benesi-Hildebrand methods.'^ ''"* 
The absorption spectra of the drug in the pH range 
2.32-11.50 were run to see the zwitterionic con-
dition, apparent ionization constant and the iso-
sbestic point which indicate the presence of differ-
ent species in solution. The stability constant of 
the complexes formed between the drug and metal 
Table 1. Stability constant and other thermodynamic parameters of CFP complexes (Job's method) 
Metal — 
Ca=^ 
Mg^^ 
Mn^^ 
Fe^^ 
Co^^ 
Ni'^ 
Cu^^ 
Zn^^ 
logK 
25 °C 35 °C 
5.600 
5.915 
6.200 
6.287 
5.983 
6.130 
6.211 
6.184 
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5.846 
6.044 
6.289 
6.356 
6.122 
6.276 
6.315 
6.297 
Gibbs energy change 
(-AG)(kJ.mor') 
31.95 
33.75 
35.38 
35.87 
34.13 
34.97 
35.44 
35.28 
Enthalpy change 
(AH) (J.mol') 
270.22 
164.93 
49.97 
260.34 
244.95 
178.43 
240.25 
190.29 
Entropy change 
(AS) (J.mof' K"') 
108.13 
113.82 
118.91 
121.22 
115.38 
117.97 
119.93 
119.04 
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Table 2. Stability constant, Gibbs energy change of 
CFP complexes (Benesi-Hildebrand method) at 25 "C 
Metal 
Ca^ ^ 
Mg^ ^ 
Mn '^ 
Fe'^ 
Co^ ^ 
Ni^ ^ 
Cu^ ^ 
Zn^ ^ 
logK 
6.854 
6.869 
6.886 
6.919 
6.883 
6.884 
6.896 
6.889 
Gibbs energy change 
(-AG) (kJ.mol"') 
39.11 
39.19 
39.29 
39.48 
39.27 
39.28 
39.34 
39.30 
R-
0.9843 
0.9784 
0.9769 
0.9914 
0.9807 
0.9845 
0.9668 
0.9706 
ion was also evaluated. 
EXPERIMENTAL 
nm. The ratio of metal to CFP was determined by 
Job's method. The linearity of CFP was found in 
the range 2x 10 ' to 6x 10"^  mg/ml and the correla-
tion factor (R^) 0.9236. 
Fluorescence study 
Solution of the CFP (7x10"'' M) and those of 
metal ions (I x 10"* to 7x 10"* M) were prepared. To 
prepare dilute solutions, an aliquot of stock sol-
ution was placed in a 10 ml volumetric flask and 
made up to the mark with distilled water. Spectra 
were recorded immediately after sample prepara-
tion in the optimum wavelength range 370-430 nm 
at optimum excitation wavelength of 335 nm. For 
calibration curve an aliquot of stock solution 
(Ixl0*to3x|0" mg/ml) was prepared which showed 
linearity with correlation factor (R") 0.9652 
Instruments 
The absorption spectra were obtained with 
Elico-SL-169 double beam UV-visible spectro-
photometer Fluorescence emission spectra were 
scanned with Hitachi-F-2500FL-spetrophotometer 
All potentiometric measurements were done with 
Elico-LI-120pH meter. 
Methods and materials 
Double distilled water was used throughout 
Cefpodoxime proxetil (Lupin pharmaceutical Ltd, 
India), sodium hydroxide and metal chloride 
(Merck Ltd, Mumbai, India) and HCl (Ranbaxy 
fine chem. Ltd, India) were used as received. 
Preparation of solution 
Stock solution of Cefpodoxime proxetil and 
metal salts of I x 10"^  M were prepared in 1 x i Q- M 
HCl. Stock solution of drug was stored at 4 "C. 
Spectrophotometric method 
Solutions of equimolar concentration (IxlO^ 
M) of CFP and metal ions were prepared. The pH 
of the drug was adjusted between 2.32 to 11.50 by 
adding sodium hydroxide and hydrochloric acid 
(IX10'' M and IX10""^  M respectively). The absorp-
tion spectra were recorded in the range 250-380 
RESULTS AND DISCUSSION 
Spectrophotometric study 
The absorption spectrum of CFP (IxlO"* M) 
was run in the region 250-380 nm. It exhibited two 
peaks at 270 and 345 nm (Fig. 2). Since the first 
peak is very strong it was selected for further ab-
sorption studies. 
When the spectra of the drug were run at vary-
ing pH in the region 250-380 nm two isosbestic 
points, one at 305 nm and another at 330 nm were 
observed which indicated the presence of zwitter 
ionic condition in solution (Fig. 3).''' The appa-
1.6 n 
f 0.8 
250 270 290 310 330 350 370 
Wavelength (nm) 
Fig. 2. Absorption spectrum of CFP (Ix 10'" M)at pH 
5.15. 
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Wavelength (nm) 
Fig. 3. Absorption Spectra of CFP (1x10 M) in (2.32-
11.50) pH range. 
rent ionization constant (pKa') of the drug was cal-
culated (8.92) by the following equation. 
pKa' = pH+log{(A|-AM)/(A-AM)} (1) 
where, A| = absorbance of drug in basic medium, 
AM = absorbance of drug in acidic medium, A= 
absorbance of drug in aqueous medium. 
The absorption spectra corresponding to the 
metal, drug and complexes were obtained in acidic 
medium. The concentration of cations and drug 
(CFP) were IxlO" M. The stoichiometry of the 
complexes was obtained by Job's methods'^''^ a 
sample of resulting plots is shown in Fig. 4. The 
stability constant of chelate formed is calculated 
by following equation 
K = A/A„Cv 
(C„ -A/A„C, ) (C , -A /A„CJ (2) 
where, K is the stability constant of the metal che-
late formed in the solution, M = metal, L = ligand, 
X = mole fraction of the ligand at maximum 
absorption. A/Aex is the ratio of the absorbance to 
that indicated by the tangent for the same wavelength. 
Cx, CM and Cu are the limiting concentration of 
complex, metal ion and the drug respectively. 
The stability constant is related to the standard 
enthalpy changes AH and other thermodynamic 
function by the equation: 
AG = -2.303RTIogK = AH-TAS (3) 
where R is the gas constant T is the experimental 
I"' 
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Fig. 4. Continuous variation curves of CFP and metal 
complexes. 
temperature, K is the binding constant at the corre-
sponding temperature. 
From the value of stability constant at different 
temperature the enthalpy changes can be calcu-
lated by using the equation: 
LogK7/K,= [IAr(-lAr2]AH/2.303R (4) 
The negative value of AG for the complexation 
process suggests spontaneous nature of such 
process. ' The positive value of AH suggests 
that these processes are endothermic and are fa-
vourable at higher temperature. Also it is entropi-
cally favourable. The positive value of H and S in-
dicates that hydrophobic force may play a major 
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H , N ^ ^ c / NOCH3 
Ayr 
1-^ ^y NOCH 
Metal chloride 
Fig. 5. Mechanism of binding of CFP with metal ions: 
A. CFP, B. CFP-metai complex, C hydrolyzed form of 
complex. 
role in the interaction.'* It is reasonable to think, 
on the basis of these results that the metal ions 
form a five membered chelate ring with CFP. 
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Fig. 6. Fluorescence enhancement (at Xex 335nm) of 
CFP in presence of metal ions. 
Fluorescence study 
The fluorescence emission spectrum of the pure 
drug is markedly different from its absorption 
spectrum in UV region. The emission spectrum 
run between 350-450 nm at excitation wavelength 
of 335 nm showed a peak at 400 nm. The addition 
of metal ions to the drug causes enhancement or 
quenching in the fluorescence spectrum. We have 
noted an enhancement in fluorescence intensity at 
400 nm in each case (Ca^\ Mg^\ Mn '^, Fe'', Co^\ 
Ni *, Cu * and Zn *) {Fig. 6) although the shape 
and position of emission spectrum remains 
unchanged. 
The stoichiometry and stability constant of the 
complexes was determined by Benesi-Hildbrand 
method.'^ The Benesi-Hildebrand plots were ex-
amine to further characterize the stoichiometry of 
the CFP-metal complexes. In case of a 1:1 com-
plex, the following equation is applicable: 
I /F-Fo = 1 /(F„- Fo)K [Me]o + 1 /(F.- Fo) (6) 
In this approach, a graph of l/(F - Fo) versus 
l/[Me]o, was made where F is the observed fluo-
rescence at each concentration tested, Fo is the flu-
orescence intensity of analyte in the absence of 
metal ion, Fx is the maximum fluorescence in-
tensity in presence of metal ions and [Me]o is the 
concentration of metal ion. A linear plot is re-
quired for this double reciprocal plot in order to 
conclude 1:1 stoichiometry. In such cases, a linear 
relationship has to be obtained when 1/(F - Fo) 
versus l/[Me]o is plotted. The stability constant is 
determined by dividing the intercept by the slope 
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Fig. 7. Benesi-Hildebrand's plots for 1:1 (CFP: metal 
complexes) 
of the straight line obtained in the double-recip-
rocal plot. {Fig. 1) 
as a visible emission. 
The reason of this enhancement lies in strong 
perturbation of the excited state upon coordination 
of the metal ion. A low lying internal charge trans-
fer state due to the presence of electron donor and 
acceptor group in the CFP is the lowest excited 
state, this state is however, a less emitting state and 
in equilibrium with the n-n excited state of the 
molecule, upon coordination with metal cation the 
PCT interaction becomes weaker since the elec-
tron withdrawing group is now electron rich moi-
ety due to the deprotonation of-NH group neces-
sary for coordination of metal cation. 
In the present work, an attempt has been made to 
study the interaction of the CFP with metal ions by 
fluorescence emission, absorption spectrophoto-
metric and measurements. Since enhancement in 
fluorescence intensity of the CFP in presence of 
the metal ions occurs, the spectra of the drug in 
presence of different concentrations of several 
metal ions were scanned. The ratio of the drug to 
metal ions was determined by Job's and Benesi-
Hildbrand method. The absorption spectra of the 
CFP was run at different pH to see the zwitterionic 
condition, apparent ionization constant and the 
isosbestic point indicating the presence of differ-
ent species in solution. The stability constant of 
the complex formed between the drug and metal 
ion was also evaluated. 
Influence of metal ion concentrations 
The influence of metal ions concentration was 
studied in the range of 1 xiO" -^10x 10"*M. The flu-
orescence study of interaction CFP with metal 
ions in acidic aqueous medium showed 1:1 
stoichiometry. Both these study also support the 
formation of 1:1 CFP:Metal complex, with the 
possibility of metal ions chelating with CFP by p-
actum carbonyl carbon and acidamide nitrogen. 
In general, the phenomenon of enhancement is 
observed because the complexation by cations 
causes increase in the redox potential of the donor 
so that the relevant HOMO energy decreases to a 
level lower than that of fluorophore. Consequently 
the excited state energy of fluorophore is dumped 
CONCLUSION 
In this paper the nature and magnitude of the in-
teraction of CFP with biologically important metal 
ion was investigated by fluorescence spectra and 
UV spectra. The experimental result indicated the 
formation of 1:1 complex of CFP with metal ions 
in acidic medium by Job's and Benesi-Hildbrand 
method. The absorption spectra at different pH 
showed the presence of two isosbestic point in-
dicating the existence of zwitterionic condition. 
The thermodynamic parameters showed that the 
interaction between CFP and metal ion was spon-
taneous, and that the hydrophobic force was a ma-
jor factor in the interaction. 
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ABSTR\CT. A Kinetics pathway of oxidation of Cefpodoxime Proxetil by peimanganate in alkaline medium 
at a constant ionic strength has been studied spectrophotometrically. The reaction showed first order kinetics in 
permanganate ion concentration and an order less than unity in cefpodoxime acid and alkali concentrations. 
Increasing ionic strength of the medium increase the rate. The oxidation reaction proceeds via an 
alkali-permanganate species which forms a complex with cefpodoxime acid. The latter decomposes slowly, 
followed by a fast reaction between a free radical of cefpodoxime acid and another molecule of permanganate 
to give the products. Investigations of the reaction at different temperatures allowed the determination of 
activation parameters with respect to the slow step of proposed mechanism and fallows first order kinetics. The 
proposed mechanism and the derived rate laws are consistent with the observed kinetics. 
Keywords: Cepfodoxime proxetil. Permanganate, Kinetics, Themodynamics 
INTRODUCTION thiazol-4-yl)-2-methoxyiminoacetamido]-3-meth 
oxymethyl-3-cephem-4-carboxylic acid) {Fig. 1). 
Ceipodoxime proxetil (CFP) is one of the several CFP is an ester prodrug of Cefjxxioxime acid (CFA), 
new cephems administered orally as inactive esters where a proxetil radical is attached to CFA. It is an 
of the antibiotic Cefpodoxime. It is (l-[isopropoxy- orally absorbed, broad spectrum, third generation 
carbonyl) oxy] ethyl ester of (z)-7-[2-(2-amino-1,3- cephalosporin ester implicated in the treatment of 
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Fig. 1. Structure of Cefpodoxime Proxetil (CFP). 
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Fig. 2. Degradation Pathway of Cefix»doxime Proxetil to 
Cefpodoxime acid. 
Iron reduction followed by a quick reaction. ' In 
this paper a simple and sensitive kinetic spectropho-
tometric method has been developed to establish 
the thermodynamic parameters of Cepfodoxime 
acid. The method is based on the oxidation of the 
drug by permanganate in alkaline medium. The 
present studies is aimed at checking the reactivity 
of CFA toward permanganate, at determining the 
redox chemistry of the Mn(VlI) in such media, and 
at arriving at a plausible mechanism. 
EXPERIMENTAL 
Apparatus 
AShimadzuUV-visible 1601 spectrophotometer 
was used for all spectral measurements, pH-metric 
measurements were done with Elico-Li 120 pH 
meter and a water bath shaker NSW 133, India was 
used to control the temperature. 
upper respiratory tract and urinary tract infections. 
In the biological system, CFP undergoes ester hy-
drolysis and is converted into CFA to exhibit its 
antibiotic activity.'' CFP has an asymmetric carbon 
at position 4 and is supplied as racemic mixture of 
R- and S-enantiomers. Few methods are reported 
to quantify CFA.' The p-lactum antibiotic is known 
to degrade by hydrolysis in alkaline solution (Fig. 
2).' Hydrogen peroxide is used for degradation 
study in the development of pharmaceuticals. The 
HCI, NaOH, NH2OH and H2O2 at appropriate con-
centration were evaluated as degradation agents 
for cleaning or decontamination. Permanganate ion 
oxidizes a larger variety of substrate and finds ex-
tensive application in organic synthesis.'"'" During 
oxidation permanganate is reduced to various oxi-
dation states in acidic, alkaline and neutral media. 
The mechanism of oxidation depends on the sub-
strate and medium.''' The process Mn(Vl]) to Mn(I V) 
can be divided into a number of partial steps and 
examined discretely. The MnCh appears only a after 
the complete consumption of Mn04'. No mechanistic 
information is available to distinguish between a 
direct one-electron reduction of Mn(VIl) to Mn(Vl) 
or a hypopermanganate ion is formed in a two-eiec-
Materials 
The Cepfodoxime Proxetil was obtained from 
(Lupin pharmaceutical Ltd, India). Pharmaceutical 
preparations containing the studied compounds 
were purchased from commercial sources in the local 
market. The permanganate solution was prepared 
and standardized against oxalic acid.'^ Potassium 
permanganate solution was prepared as described 
by Carrington and Symons.'^ NaOH (Merck Ltd, 
Mumbai, India) and NaCI04 (Ranbaxy fine chem. 
Ltd, India) were employed to maintain the required 
alkalinity and ionic strength, respectively. 
Reagents 
Double distilled, de-ionized water was used th-
roughout. The chemicals used were of analytical 
grade. Stock solutions of the compounds were 
wrapped with carbon paper to protect them from 
photodecomposition. 
Kinetic procedure 
The oxidation of (CFA) by permanganate ion was 
followed under pseudo- first order conditions where 
CFA concentration was greater than manganese 
(VII) at 25 "C. The reaction was initiated by mixing 
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previously thermostated solutions of Mn04 and 
(CFA), which also contained required quantities of 
NaOH and NaCI04 to maintain alkaline medium 
and ionic strength, respectively. The temperature 
was maintained at 25 °C: The reaction was moni-
tored by a the decrease in absorbance of Mn04", at 
its absorption maximum of 525 nm. Earlier it was 
verified that there is no interference from other 
reagents at this wavelength. Application officer's 
Law for permanganate at 525 nm had earlier been 
verified, giving e, was found to be 2083 ± 50 dm' 
mol' cm"'. The reaction was followed more than 
three half lives The first order rate constants kobs 
were evaluated by plots of log [Mn04] vs. time. 
The first order plots in almost all cases were linear 
up to 85% of the reaction and kobs were reproducible 
at 525 nm and an increasing absorbance of Mn(Vl) 
at 610 nm during the course of the reaction {Fig. 5). 
The effect of dissolved oxygen on the rate of reac-
tion was checked by preparing the reaction mixture 
and following the reaction in nitrogen atmosphere. 
No significant difference between the results obtain-
ed under nitrogen and in the presence of air was 
observed. Added carbonate had also no effect on 
the reaction rate. Regression analysis of experi-
mental data to obtain the regression coefficient r 
and the standard deviation S of points from the 
regression line wias performed using a Microsoft 
excel-2007 program. 
RESULTS 
The absorption spectrum of CFP was exhibited 
two peaks at 270 and 345 nm {Fig. 3).'^ After addi-
tion of potassium permanganate in the same medium 
is oxidized the (CFA) and exhibits a green colour 
of manganate ion, appears which absorbs at 610 
nm. It was empirically found that the blue colour 
originated from a mixture of violet Mn04" and green 
250 270 290 310 330 
Wavelength 
350 370 
Fig. 3. Absorption spectrum of CFP. 
colour Mn04 "^ rather than form the formation of 
hypopermanganate. The formation of Mn (VII) was 
also evidence by the decrease of the absorbance of 
Mn(VII) at 525 nm and the increase of that of Mn(VI) 
at 610 nm during the course of reaction {Fig. 5).The 
intensity of the colour increases with time and hence 
a kinetic method based on the spectrophotometric 
measurement was developed. 
Stoichiometiy of the reaction 
The reaction mixture containing an excess of 
permanganate over (CFA) were mixed in the pre-
sence of 5.0 X 10"^  mol dm'NaOH and at constant 
ionic strength / = 0.10 mol dm' were kept in a 
closed container under a nitrogen atmosphere at 25 
°C. After I h the manganese (VII) concentration 
was assayed by measuring the absorbance at 610 
nm. The results indicated that 2 mols of manganese 
(VII) consumed 1 mol of (CFA). Therefore, the 
reaction mechanism is proposed on the basis of the 
literature background and our experimental study 
as shown in eq 1. 
Reaction order 
The reaction order were evaluated from the slope 
of log kobs versus log concentration plots by the 
varying concentration of (CFA) and alkali keeping 
other factors constant. 
N H J — k J +2Mn04-+2 0H-
O 
2(m,yol.53,No.6 
O^^OH 
N H - L J ^ J + Mn042- H2O (1) 
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Si 
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Fig. 4. First order plots for the oxidation of CFA by alka-
line MnO'at 25 "C; [CFA ] = 1.0 x 10"'; [0H-] = 2 x 
IO'V = O.IO/niol dm'. [Mn(VII)] x lO'mol dm': (I) 
0.6, (2) 0.8, (3) 1.0, (4) 2.0, and (5) 3.0. 
H 
400 450 500 550 600 
Wavelength 
650 700 
Fig. 5. Spectral changes during the oxidation of [CFA ] by 
alkalineMnO'"at25°C;[Mn(VII)]= 1.0 x 10^ [CFA] = 
1.0 X 10"'[OH"] = 2 X 10"^/ = O.IO/moldm"'. 
Effect of Concentration of Manganese (VII) 
At constant concentration of (CFA), 1.0 x 10' mol 
dni'"\ and alkali, 5.0 x 10"^  mol dm"'\ and at constant 
ionic strength, 0.10 mol dm'^ . The oxidant KMn04 
concentration was varied in the range of 6 x 10'^-
6x10 mol dm'". All kinetic runs exhibited identical 
characteristics. The linearity of plots of log(absor-
bance) vs time, for different concentrations of per-
manganate, indicates order in manganese(VII) con-
centration as unity (Fig. 4). This was also confirmed 
by the constant values of pseudo first order rate 
constants, o^bs, for different manganese(VlI) con-
centrations {Table 1). 
Effect of NaOH Concentration 
The effect of increasing cone of alkali on the 
Table 1. Effect of variation of [KMn04] ,[CFA] and 
[OH] on the oxidation of cefpodoxime acid by alkaline 
[KMn04] at 25°C and ionic strength / = 0.10/mol dm"' 
lO'x 
[KMn04] 
mol dm 
IO'x[CFA] 10'x[OH'] lO'kcte lO'kcal 
mol dm"' mol dm' (S"') (S"') 
0.6 
0.8 
1.0 
2.0 
3.0 
4.0 
6.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
0.6 
0.8 
1.0 
1.2 
1.4 
1.6 
1.8 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
0.6 
0.8 
1.0 
1.2 
1.4 
1.6 
1.8 
1.08 
1.09 
1.08 
1.07 
1.10 
1.08 
1.09 
0.984 
1.05 
1.06 
1.37 
1.60 
1.72 
1.99 
0.984 
1.03 
1.07 
1.06 
1.60 
1.75 
2.02 
1.09 
1.09 
1.09 
1.09 
1.09 
1.09 
1.09 
0.983 
1.06 
1.07 
1.36 
1.58 
1.73 
1.98 
0.985 
1.04 
1.06 
1.07 
1.59 
1.76 
2.01 
reaction was examined at constant concentration 
of drug and permanaganate ion at 25 °C. The alkali 
concentration was varied in the range of 0.6 x 10"^  
to 1.0 X 10' mol dm". The A:obs values increased 
with increase in concentration of alkali. 
Effect of {CFAl 
The effect of (CFA) concentration on the reaction 
was studied at constant concentrations of alkali and 
permanganate and at a constant ionic strength of 
0.10 mol dm"^  at 25 "C. The substrate, (CFA) was 
varied in the range of 5.0 X 10-^-5.0 X 10""^  mol 
dm"". The kobs values increased with increase in 
concentration of (CFA) (Table 1). 
Effect of Ionic Strength 
The effect of ionic strength was studied by vary-
ing the NaC104 concentration from 0.01 to 0.10 mol 
dm' at constant concentrations of permanganate, 
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Scheme 1 
(CFA), and alkali, it was found that increasing ionic 
strength had no effect on the rate of reaction. 
Eff'ect of temperature 
The kinetics was studied at four different tem-
peratures under varying concentrations of (CFA), 
and alkali, keeping other conditions constant. The 
rate constants were found to increase with increase 
in temperature. The rate constant (k) of the slow 
step of Scheme 1 were obtained from the slopes 
and intercepts of \/kobiVersus 1/[CFA] and 1/kobs 
versus 1/[0H"] plots at four different temperatures. 
The energy of activation corresponding to these rate 
constants was evaluated from the Arrhenius plot of 
log k versus 1/T and from which other activation 
parameters were obtained (Table 2). 
Polymerization Study 
The possibility of free radicals was examined as 
follows: the reaction mixture, to which a the reaction 
mixture with methanol, precipitate resulted, sugge-
sting that the there was participation of free radicals 
in the reaction. 
DISCUSSION 
At the observe experimental condition at pH > 
12 the reductant product of Mn(VII) might be stopp-
ed. Although During our study the colour of the 
solution undergoes a series of change from blue to 
green. It is probable that green color originated from 
the permanganate ion. The spectrum of green solu-
Table 2. Activation and Thermodynamic parameters for 
the oxidation of cefipodoxime acid by K.Mn04 in alka-
line medium and / = 0.10/mol dm" with respect to slow 
step of Scheme 1 
Temperature (K) lO^k(S') 
(a) Effect of Temperature 
293 
298 
303 
308 
(b) Activation Prameter 
Ea(kj mole') 
AH (kj mole') 
AS* (jk'mole') 
AG"^  (kj mole"') 
2.7 
2.9 
4.8 
5.1 
values 
65.4 
61.7 
-120.4 
19.11 
Temperature (K) Ki ( dm mol ) 10'K: (dm' mol ) 
(c) Effect of Temperature 
293 15.41 
298 17.74 
303 19.55 
308 21.71 
30.14 
26.69 
20.54 
18.76 
Thermodynamic 
Parameters using Ki values using K? values 
AH(kjmole ) 
AS'(jk'mole') 
AG*(kj mole ) 
76.5 
128 
-5.6 
-61.7 
-63.2 
-6.71 
tion was identical to that of Mn04"'". It is probable 
that the blue color originated from the violet of 
permanganate and the green from manganate, ex-
cluding the accumulation of hypomanganate. It is 
evident from the {Fig. 5) that the concentration of 
MnO " decreases at 525 nm due to Mn(VII) and 
increases at 610 nm due to Mn( VI). As the reaction 
proceeds, slowly yellow turbidity develops, and 
after keeping for a long time the solution decolorizes 
and forms a brown precipitate. This suggests that 
the products formed might have undergone further 
oxidation resulting in a lower oxidation state of 
manganese. The results imply that first the alkali 
combines with permanganate to give an alkali-
permanganate species [Mn04 • OH]'" in a prior 
equilibrium step, which is in accordance with lite-
rature '^""'' and also experimentally observed order 
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in OH' ion concentration. In tlie second step [Mn04-
OH]^'combines with CFAto form an intermediate 
complex. The fractional order with respect to CFA 
presumably results from the complex formation 
between oxidant and substrate prior to the slow step. 
The reaction between permanganate and CFA is 
supported by Michaelis-Menten plot which is linear 
with positive intercept which is in agreement with 
complex formation. Within the complex one-elect-
ron is transferred from CFA to Mn(VII). Then this 
complex (C) decomposes in a slow step to form a 
species derived from CFA. All the results indicate 
a mechanism as given in Scheme I. 
Rate= -'^^^"°* 1 = kKiK2[Mn04lf[CFAHOH-], (2) 
dt ^ ' 
The total [MnO "] can be written as 
[MnOvJt = [MnO^lf + [Mn04.0H]2 + [Complex] 
= [MnO -^Jf + [Mn04-](OH-J +KiK2[Mn04-][CFA)(OH-J 
= [Mn04-], (1+ Ki[OH-] + KiK2[CFA][0H-]) 
[MnOa 
1+Ki[OH-] + KiK2[CFA][OI-r] (3) [Mn04-),= 
where "t" and " f stand for total and free. Si-
milarly, total [OH"] can be calculated as 
[OH'l, = (OH-]f + [Mn04,OH]2-+ [Complex] 
[OH], 
[0H-],: 
(4) 
1+ Ki[Mn04-] + KiK2[CFA][Mn04-] 
In view of the low concentrations of Mn04" and 
CFA used in the experiment, in eq 4 the terms 
KilMnOi] and ^iA:2[Mn04'][CFA] can be neglect-
ed in comparison with unity. 
Thus, 
[0H-], = [OH], 
Similarly, 
[CFA], = [LFA], 
(5) 
(6) 
Substituting equation 3, 5, and 6 in equation 2 
and omitting the subscripts, we get 
Rate = 
kKiK2[Mn04][CFA][OH-] 
1+ K,[OH-] + KiK2[CFA][OH-] 
(7) 
Equation 7 confirms all the observed orders with 
respect to different species, which can be verified 
by rearranging to eq 8. 
' • = - (8) kobs kK,K2(CFA][OH] kKzfCFA] k 
According to eq 8, other conditions being con-
stant, plots of ]/kohs versus I/[CFA] and 1/tobs 
versus I/[OH] should be linear and are found to be 
so {Figs 6a and 6b). The slopes and intercepts of 
such plots lead to the values ofK\,K2, and k(Table 
2). The value of A^i is in good agreement with the 
literature Using these constants, the rate constants 
were calculated over different experimental condi-
tions, and there is a reasonable agreement between 
the calculated and the experimental values, which 
for the proposed mechanism (Table 1). The thermo-
dynamic quantities for the first and second equili-
brium step of Scheme I can be evaluated as follows: 
The [CFA] and [OH"] as in Table 1 were varied at 
four different temperature. The spectral evidence of 
the complex formation was obtained from UV-Vis 
sisectral study." It is also proved kinetically by the 
non zero intercept of the plots of l/lcobs versus 1/ 
[CFA] (r > 0.9997, S < 0.0148) (Fig. 6b). Accord-
ing to the rate law the plots of I /kobs versus l/[OH"] 
(r > 0.9987, S < 0.0124) and 1 /kobs versus I /[CFA] 
(r > 0.9998, S < 0.0151) should be linear (Figs 6a 
and b) from the slope and intercept, the value of k, 
Ki and K2 could be derived as 2.87 x 10"^ , 13.8 dm^ 
mole', and 22.36 dm" mole"' respectively. The rate 
constant were calculated fi-om these values (Table I) 
which supports the proposed mechanism. The re-
action rate of CFA increased with increasing inten-
sity of the complex. The kinetics was studied at four 
different temperature and concentration of CFA and 
NaOH keeping all other conditions constant. The 
rate constant was found to increase with increasing 
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Fig. 6. (a) Rate law plots 1/kobs versus 1/ [OH] of oxi-
dation of cefpodoxime acid by KMn04 in alkaline me-
dium at different temperatures (circumstance as in Table 
1). (b) Rate law plots 1 /kobs versus 1 / [CPP] of oxidation 
of cefpodoxime acid by KMn04 in alkaline medium at 
different temperatures (circumstance as in Table I). 
temperature. The rate constant k of the slow step of 
Scheme 1 were obtained from the slope and inter-
cept of 1/kobs versus 1/[CFA] and 1/kobs versus 1/ 
[OH] plots at four different temperatures. The 
activation parameters corresponding to these con-
stant were evaluated from the Arrhenius plot of log 
k versus l/T and are listed in Table 2. The experi-
mental value of AH* and AS* were both favorable 
for electron transfer process. The high negative 
value of AS* indicate that interaction of the reaction 
ions of similar charges form an activated complex 
and is more ordered than the reactants due to loss of 
degree of freedom. The hydroxy! ion concentration 
i.e. Table 1 was verified at four different temperature 
and the K| value were determined from a (Fig. 6a) 
as shown in Table 2. Similarly CFA concentration 
as in Table 1 was varied at four different temp and 
K2 values were determined at each temp (Fig. 6b) 
as listed in Table 2. The effect of temp on reaction 
rate is well known and important in the various 
activation parameters of the reaction product. A 
Arrehenius plot was made for the variation of Ki 
with temperature (i.e. log Ki versus 1 /T). The values 
of the enthalpy change of the first equilibrium step 
Ki of the reaction (AH), enthalpy of the reaction (AS) 
and free energy of raction (AG) were calculated as 
listed in Table 2. Similarly thermodynamic para-
meters for second step K? are calculated such as 
enthalpy; entropy and free energy of activation of 
the reaction product were calculated using Eyring 
equation. 
Log K/T = [log kb/h + S/2.302R] - AH/2.303Rl/r 
The plot of log K2/T versus I /T was linear with 
correlation coefficient of-0.9996 AH^  was evaluated 
from the slope (- AH/ 2.303R1 /T) and AS^  from the 
intercept [log kb/h + S/2.302R] of the compiled 
Eyring plot. The Gibbs free energy of activation 
was determined by AG*" = -2.303 RT log K at room 
temperature. These values are given in Table 2.The 
proposed mechanism supported by the above ther-
modynamic parameter. A comparison of the later 
values (from K2) with those obtained for the slow 
step of the reaction shows that these values mainly 
refer to the rate-limiting step, supporting the fact 
that the reaction before rate determining step is 
fairly fast and involves low activation energy."' 
The negative value of indicate that the complex 
(C) is more ordered than the reactant.^ * A detailed 
mechanistic explanation is given in Scheme 2. 
CONCLUSION 
It is interesting to note that the oxidant species 
[MnO '] required a pH > 12 below which the system 
becomes anxious and the reaction proceeds to 
Mn(I V) which slowly develops yellow turbidity. The 
oxidant, manganese(VII), exists in alkali media as 
alkali-permanganate species [Mn040H]^", which 
takes part in the chemical reaction. The role of 
hydroxy! ions is essential to the chemical reaction. 
2009, Vol. 53, No. 6 
716 Aftab Aslam Parwaz Khan, Ayaz Molid, Shaisia Bano. and K. S. Siddiqi 
,'' .-> A1,,, 
/ NM.J...-1 .1 
Scheme 2. Mechanistic Interpretation for the Oxidation 
of CFAby Alkaline Permanganate 
The given mechanism is consistent with all the 
experimental evidence. The rate constant of slowest 
step involved in the mechanism are evaluated and 
activation parameters with respect to slowest step 
of reaction were computed. The overall mechanistic 
sequence described here is consistent with the final 
product, mechanistic and kinetic studies. 
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SPECTROSCOPY 
Fluorescence Enhancement of Levosulpiride 
Upon Coordination with Transition Metal Ions 
and Spectrophotometric Determination of 
Complex Formation 
K. S. Siddiqi, Shaista Bano, Ayaz Mohd, and 
Aftab Aslam Parwaz Khan 
Department of Chemistry, Aligarh Muslim University, Aligarh, India 
I Abstract: Absorbance and fluorescence spectral pattern of levosulpiride in 
g absence and presence of first row transition metal ions (Mn-Zn) has been studied 
I at room temperature under physiological condition. The fluorescence spectra of 
^ the drug in presence of different concentrations of transition metal ions showed 
" enhancement in fluorescence intensity of levosulpiride. The photophysical 
1^ changes owing to the direct interaction between metal ion and the amide nitrogen 
•g of levosulpiride has been described in terms of CHEF (chelating enhancement 
S fluorescence) effect. The absorption spectra of the drug at different pH exhibited 
§ two isosbestic points at 255 and 275 nm respectively, indicating the presence of 
° three chemical species in solution. The ratio of the drug to metal ions is found 
to be 2:1 and the logK of the resulting complex was determined spectrophotome-
trically and potentiometrically. The apparent ionization constant of levosulpiride 
is found to be 8.98. The low value of stability constant suggests that complexes 
may dissolve and the drug can be absorbed. 
Keywords: Absorption study and stability constant, fluorescence enhancement, 
levosulpiride 
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1. INTRODUCTION 
Levosulpiride, a levo enantiomer of sulpiride, chemically known as 
5-(amino sulfonyl)-N-[( 1 -ethyl-2-pyrrolidinyl)methyl]-2-methoxy benza-
mide is used as antipsychotic, antidyspeptic and antiemetic medicine 
(Fig. 1). This drug has also been used for the treatment of male sexual 
disorder and a dose of 25mg/day for 60 days resulted in complete 
recovery. The studies are mainly concerned with the validation and 
determination of levosulpiride in human beings. The drug is fairly stable 
in human serum and urine which has been tested in different patients. It 
has been found that the drug can be detected in a concentration range of 
0.25-200 ng/ml in human serum and 0.2-20 |ag/ml in urine by HPLC 
(Cho and Lee 2003; Geo, Balbi, and Speranza 2002). The bioavailability 
of the drug at a dose of 100-200 mg/day is approximately 20-30% only 
(Jin et al. 2004). Levosulpiride has both antiemetic and prokinetic prop-
erties because it antagonizes dopamine receptor in the central nervous 
system and gastro-intestinal tract (Mansi et al. 2000; Nagahata et al. 
1995). Recently, it has been shown that levosulpiride has moderate 
agonistic effect on 5HT4 receptors in the nervous system and is useful 
in the treatment of depression or Schizophrenia (Tonini et al. 1999). 
Patients treated for functional dyspepsia over a period of one month 
did not show any adverse effect. The doses of levosulpiride range between 
50-75 mg/day over a period of 30 days and showed no adverse effect 
except for fatigue, headache, and drowsiness (Lozano et al. 2007). It is, 
therefore, considered an effective and safe drug in the treatment of 
dyspepsia. It has been shown that the levosulpiride does not interfere 
with most of the drugs, but drinking during this period should be 
avoided. As a precaution, the drug should be avoided in pregnancy 
and during lactation period. 
The major work done on the sulpiride thus far, concerns its identi-
fication, determination, and efficacy against dyspepsia, psychosis, and 
male sexual disorder. However, absorption and fluorescence emission 
spectrophotometric behavior of the drug under physiological condition 
and its interaction with several cations has not been studied so far. 
CH. 
• O C H -
Figure 1. Structure of levosulpiride. 
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In this communication, we are, therefore, reporting the electronic 
and fluorescence emission spectra of the drug in the presence and absence 
of transition metal ions at different* pH, ranging from 2.38 to 10.6 in 
order to find the effect of pH on the absorption of drug in aqueous 
medium. Fluorescence emission spectra of the drug in presence and 
absence of metal ion has been recorded to examine if quenching or 
enhancement in fluorescence intensity occurs. Stability constant and 
other physical parameters of the complexes formed in solution have also 
been calculated. 
2. EXPERIMENTAL 
2.1. Instruments 
The absorption spectra were obtained with Elico-SL-169 double beam 
UV-visible spectrophotometer. Fluorescence emission spectra were 
scanned with Hitachi-F-2500FL-spectrophotometer. All potentiometric 
measurements were done with Elico-LI-120 pH meter. 
2.2. Methods and Materials 
Double distilled water was used throughout. Levosulpiride (Sun 
Pharmaceutical Industries, Jammu, India), sodium hydroxide (Merck 
Ltd, Mumbai, India) anhydrous zinc chloride (SDH Pvt. Ltd India), 
and HCl (Ranbaxy Fine Chem. Ltd, India) were used as received. 
2.3. Preparation of Solution 
Stock solution of levosulpiride and metal salts of 1 x 10~^M were 
prepared in double distilled water. Stock solution of drug was stored 
at 4°C. 
2.4. Spectrophotometric Method 
Solution of equimolar concentration (1 x 10"'* M) of levosulpiride and 
metal ions was prepared. The pH of the drug was adjusted between 
2.31 to 10.6 by the use of only sodium hydroxide and hydrochloric acid 
(I X 1 0 ~ ' M to 1 X 10~^M) to avoid interactions with buffer solution. 
The absorption spectra were recorded in the range 200-330 nm. The ratio 
of metal to levosulpiride was determined by Job's method. 
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2.5. Potentiometric Method 
For potentiometric study the following solutions were titrated against stan-
dard NaOH. The ionic strength was maintained at 0.1 M by NaCl and the 
total volume was kept at 50 ml by adding appropriate amount of water. 
(a) 5ml (1 X 10-' M) HCl + 5ml (1 x lO"' M) NaCl + 40ml water. 
(b)5ml(l X 10- 'M)HCl + 5ml(l x 10"'M) NaCl + 10 ml (5 x lO^^M) 
drug + 30 ml water. 
(c)5ml(l x 10- 'M)HCl + 5ml(l x lO"'M) NaCl +10ml (5 x 10"-^  M) 
drug+ 20 ml (5 x lO-'^M) metal ions+ 10 ml water. 
2.6. Fluorescence Spectrophotometric Method 
Solution of the levosulpiride (7xlO-^M) and those of metal ions 
(1.2 X 10"^ M to 8.4 X 10"^ M) were prepared. The steady state fluores-
cence spectra of the drug were recorded in the /.gm = 270-430 nm with 
excitation at the maximum centered on /,exc = 275nm. This wavelength 
was chosen in order to avoid the inner-filter effect and to obtain the most 
complete as possible emission spectrum. 
3. RESULTS AND DISCUSSION 
3.1. Spectrophotometric Study 
The levosulpiride solution (1 x IO ' ^ 'M) was prepared in double distilled, 
demineralized water, and its absorption spectrum was run in the region 
200-330 nm. It exhibited two peaks at 216 and 295 nm (Fig. 2). Since 
the first peak is very strong, it was selected for further absorption studies. 
When the spectra of the drug were run at varying pH in the region 
200-330 nm, two isosbestic points, one at 255 nm and another at 
275 nm, were observed which indicated the presence of three chemical 
species in solution in equilibrium with each other (Fig. 3) (Park et al. 
2000). 
The apparent ionization constant (pKa') of the drug was calculated 
(Table 1) by the following equation: 
pKa' = pH + log{(A, - A M ) / ( A - AM)} (1) 
where Ai = Absorbance of drug in basic medium. AM = Absorbance of 
drug in acidic medium, and A = Absorbance of drug in aqueous medium. 
2196 K. S. Siddiqi et al. 
200 230 260 290 
Wavelength (nm) 
320 
Figure 2. Absorption spectrum of levosulpiride (1 x 10 '^ M) at room tempera-
ture (pH 5.6). 
The metal to levosulpiride ratio was determined by continuous 
variation method (Fig. 4) at their respective Amax (Table 1). It was found, 
in each case, that two moles of the drug are bonded to one mole of the 
metal ion which seems quite reasonable because, of all the donor groups. 
l.pH2.31 
2. pH 5.60 
3. pH 6.31 
4. pH 7.40 
5.pH8.35 
6. pH 9.60 
7. pH 10.60 
200 230 260 290 
Wavelength (nm) 
320 
Figure 5. Absorption Spectra of levosulpiride (1 x 10 "^ M) at different pH (room 
temperature). 
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Table 1. Apparent 
Potentiometrically 
8.753 
ionization constant (pKa ') of the d: rug 
Spectrophotometrically 
8.98 
the amide nitrogen appears to be the most plausible site for coordination 
as it is the proper combination of hard acid and hard base. 
The stability constant of the complexes were calculated by the follow-
ing equation: 
K^ A/AexCx 
(CM - A/AexCx)(CL - nA/Ae.Cx)" ^ ^ 
where K is the stability constant of the metal chelate formed in solution, 
M = metal, L = drug, n = X/(l - X ) , and X is the mole fraction of the 
ligand at maximum absorption. A/Agx is the ratio of the observed absor-
bance indicated by the tangent for the same wavelength. Cx, CM. and CL 
are the limiting concentrations of the complex, metal ion, and the ligand, 
respectively (Salem 2005; El-Kommas et al. 2007). The value of log K is 
shown in Table 2. 
3.2. Potentiometric Study 
To calculate the stability constant of metal chelates, the acid dissociation 
constant of the drug was first determined from the titration curve for HCl 
0 0.2 0.4 0.6 0.8 1 
Molefraction of drug 
-•-Mnai) -^Fe(III) -"-CoCII) 
-^Ni(II) ^—Cu(II) -^Zn(II) 
Figure 4. Continuous variation curve of levosulpiride with metal ions. 
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Table 2. The stability constant potentiometrically and spectrophotometrically 
Metal ions 
Mn(II) 
Fe(IIl) 
Co(II) 
Ni(II) 
Cu(II) 
Zn(II) 
Potentiometrically 
logK 
8.82 
8.907 
9.028 
8.895 
9.174 
9.045 
-AG (KJ/mol) 
50325.57 
50821.39 
51512.39 
50753.51 
52345.44 
51609.39 
Spectroph( 
logK 
9.3965 
9.3981 
9.4328 
9.4000 
9.5413 
9.4396 
Dtometrically 
-AG (KJ/mol) 
53615.00 
53652.32 
53822.12 
53634.90 
54441.20 
53860.92 
in the presence and absence of the drug. The average number of proton, 
n^ associated with levosulpiride at different pH was calculated and max-
imum value of ITA is 1 which suggests that it has one dissociable proton. 
The formation curve was obtained by plotting the average number of 
ligand attached per metal ion (n) versus free ligand exponent (pL) (Jeragh 
et al. 2007; Irving and Rassotti 1953). The apparent ionization constant 
and the average value of stability constant are shown in Tables 1 and 2, 
respectively. According to average value in Table 2, the following general 
remarks can be made: 
1. The maximum value of n was about 2, so it is presumed that complex 
is formed in a 2:1 (Drug: Metal) ratio. 
2. The very low concentration of metal ion solution used in the present 
study was 5 x 10~'*M and precludes the possibility of formation of 
polynuclear complexes (Sanyal and Sengupta 1990). 
3. The metal titration curve is displaced to the right hand side of the 
Hgand titration Curves along the volume axis (Fig. 5), indicating a 
proton release upon complex formation. 
4. All calculation of stability constant has been successful for the low pH 
region. Therefore the formation of hydroxo species (e.g. [ML (OH)], 
[MSx_i (OH)]"^ where L is ligand, S is the solvent molecule, and x is 
the number of solvent molecule bound) could be neglected. 
The value of AG is -ve indicating that chelation process proceeds 
spontaneously. This is evaluated by both method potentiometrically 
and spectrophotometrically. 
3.3. Fluorescence Study 
The fluorescence emission spectrum of the pure drug is markedly 
different from its absorption spectrum in the UV region, which is 
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^|s|wiiM* 
Acid Tiration 
Ugand Titration 
Complex Tiration 
withMn([I) 
Complex Titration 
withNi(U) 
Complex Titration 
withFc(llD 
Complex Titration 
withCo(ll) 
C 0 mp lex Titral io n 
withZn(ll) 
•Complex Titration 
withCii(ID 
0 1 2 3 4 
Volume of NaOH (ml) 
Figure 5. Potentiometric titration curve of levosulpiride with metal ions. 
attributed to its different geometry in the ground and excited states 
(Fig. 6). When the emission spectrum of the pure drug is run between 
270-430 nm at an excitation wavelength of 275 nm, a strong peak at 
300 nm and two weak emission peak at 342 and 406 nm were observed 
(Fig. 7). The 5-aminosulfonyl 2-methoxy benzamide group of levosulpir-
ide acts as an electron acceptor where as the pyrrolidinyl group acts as 
electron donor. The peak in absorption spectra is due to the intramolecu-
lar charge transfer between the acceptor and donor groups. The addition 
of the metal ion to the drug can cause either enhancement or quenching 
in the fluorescence emission spectrum (Quang et al. 2007). We have noted 
an enhancement of fluorescence intensity at 300 nm in each case 
(Mn-Zn). The shape and position of emission spectrum of levosulpiride 
in presence and absence of transition metal ions remains unchanged, 
which suggests no significant change in the overall electronic structure 
of drug upon addition of metal ions (Fig. 8). The relative enhancement 
in the fluorescence intensity I/Io is shown in Table 3. 
The enhancement in emission intensity of levosulpiride in the 
presence of various metal ions follows the order Fe^ "*" > Ni*^ "^  > Cu^ "^  > 
Zn^ "*" > Co"^ "*" > Mn^ "*" (Fig. 9). The enhancement in emission intensity 
does not follow any trend from Mn-Zn, although it is minimum in the 
case of Mn, probably due to its half filled 'd' orbital. Although the transi-
tion metal ions are known to effectively quench fluorescence (Ghosh and 
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+ 
OH 
^OCH, 
Anion 
+ 
H 
O, .O > 0 V ^ 
-CHj 
^OCHj 
Zwitterion 
Figure 6. Showing different ionic species in the solution at different pH. 
Bharadwaj 1996; Varnes, Dodson, and Wehry 1972; Rurack et al. 1993; 
Kemlo and Shepherd 1977), we observed over two fold increase in inten-
sity as a consequence of photo induced charge transfer besides the chela-
tion of the amide nitrogen resulting in CHEF (Chelating enhancement 
fluorescence) effect (Choi et al. 2006; Kim et al. 2007; Kim et al. 2003). 
300 1 
270 320 370 
Wavelength(nm) 
420 
Figure 7. Fluorescence Emission spectra of levosulpiride (7 x 10~^M) at room 
temperature. 
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Figure 8. Fluorescence enhancement (at 300 nm) of levosulpiride with Mn(II), 
Fe(III), Co(II),.Ni(II), Cu(II), and Zn(II) at room temperature. 
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Table 3. The relative intensity and limiting concentration 
Metal ions 
Mn(II) 
Fe(III) 
Co(II) 
Ni(ll) 
Cu(II) 
Zn(II) 
I/Io 
1.24 
3.13 
1.52 
2.41 
2.37 
1.53 
Limiting concentration 
3.6 (im 
3.6|am 
3.6|.im 
3.6 urn 
3.6|am 
3.6|.im 
It is accepted that aromatic compounds having amide groups are strongly 
quenched by intersystem crossing to a triplet state and/or by the rota-
tional relaxation linked to excited state rotation around the CO-NH 
and N-alkyl bonds. This may explain why, when complexed by cations, 
these rotors are less available for relaxation (Kawakami et al. 2002). 
An increase of rigidity of the system by metal cation complexation may 
therefore be an explanation for the fluorescence enhancement. In general, 
the phenomenon of enhancement is observed because the complexation 
by cations causes increase in the redox potential of the donor so that 
M 
G 
<U 
o 
6 
IMn(II) IFe(III) BCoOl) INiOO 
Tran<;if.im met.al 
ICu(II) HZnClI) 
Figure 9. The enhancement in emission intensity of levosulpiride in presence of 
various metal ions follows the order Fe^ "^  > Ni^ "^  > Cu^ "^  > Zn^ "^  > Co^+ > Mn^^. 
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the relevant HOMO energy decreases to a level lower than that of 
fluorophore. Consequently the excited state energy of fluorophore is 
dumped as a visible emission (Quang et al. 2007). The reason for this 
enhancement lies in strong perturbation of the excited state upon 
coordination of the metal ion. A low-lying internal charge transfer state, 
due to the presence of electron donor and acceptor group in the levosul-
piride, is the lowest excited state. This state is, however, a less emitting 
state. And, in equilibrium with the n-n* excited state of the molecule, 
upon coordination with metal cation, the PCT interaction becomes 
weaker since the electron withdrawing group is now an electron rich moi-
ety due to the deprotonation of-NH group necessary for coordination of 
metal cation. 
In the present work, an attempt has been made to study the interac-
tion of the drug with metal ions by fluorescence emission, absorption 
spectrophotometric, and potentiometric measurements. Since quenching 
or enhancing in fluorescence intensity of the drug in presence of the metal 
ions occurs, the spectra of the drug in presence of different concentra-
tions of several metal ions were scanned. The ratio of the drug to metal 
ions was determined by Jobs method. The absorption spectra of the drug 
was run at different pH to see the zwitterionic condition, apparent ioniza-
tion constant, and the isosbestic point indicating the presence of different 
species in solution. The stability constant of the complex formed between 
the drug and metal ion was also evaluated. 
4. CONCLUSION 
The effect of cation binding on the photophysical properties of levosul-
piride was studied. A dramatic fluorescence enhancement was observed 
upon binding of transition metal ions. This was interpreted in term of 
the control of photoinduced charge transfer (PCT) and CHEF. The sta-
bility constants, which is calculated by spectrophotometrically and poten-
tiometrically, suggest that the complexes are fairly stable in solution. 
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Binding Interaction of Captopril with IVIetal Ions: 
A Fluorescence Quenching Study 
SIDDIQI, K. S.* BANO, Shaista MOHD, Ayaz KHAN, Aslam Aftab Parwaz 
Department of Chemistry, Aligarh Muslim University. Aligarh-2()200l. India 
The binding interaction of captopril (CPL) with biologically active metal ions Mg^*, Ca^*, Mn^\ Co^*, Ni^ *, 
Cu^ * and ZT?* was investigated in an aqueous acidic medium by fluorescence spectroscopy. The experimental re-
sults showed that the metal ions quenched the intrinsic fluorescence of CPL by forming CPL-metal complexes. It 
was found that static quenching was the main reason for the fluorescence quenching. The quenching constant in the 
case of Cu"' was highest among all quenchers, perhaps due to its high nuclear charge and small size. Quenching of 
CPL by metal ions follows the order Cu^''>Ni^*>Co^*>Ca^*>Zn^*>Mn^*>Mg^". The quenching constant K^„, 
bimolecular quenching constant K^. binding constant K and the binding sites ' V were determined together with 
their thermodynamic parameters at 27 and 37 "C. The positive entropy change indicated the gain in configiirational 
entropy as a result of chelation. The process of interaction was spontaneous and mainly A5-driven. 
Keywords captopril (CPL), fluorescence quenching, metal-drug complex, stability constant 
Introduction 
Captopril, 1 -[2(5)-3-i'nercapto-2-methyl-1 -oxopropyl]-
Z,-proline (Figure 1), is an angiotensin converting en-
zyme inhibitor drag for the treatment of hypertension, 
heart failure following myocardial infarction and dia-
betic nephrotherapy.' It inhibits the active sites of a zinc 
glycoprotein, the angiotensin converting enzyme (ACE), 
blocking the conversion of angiotensin(I) to angio-
tensin(II), the level of which is elevated in patients with 
hypertensions. CPL has three different potential donor 
groups (Sthioi, Oacid and Oamidc) which may bind with 
metal ions to form 1 : 1 complexes in acidic medium 
and 1 .' 2 complexes^ in nearly basic medium (pH 6— 
8.2). The key functional group in the metabolism of 
CPL is the sulfhydryl group. CPL is oxidized at its 
sulfhydryl group after dissolution in water to form its 
disulfide and is found in human urine after CPL admini-
stration. It has an equilibrium conformation between cis 
and trans isomers, however, the trans isomer is the ac-
tive form when bound to the enzyme." It also acts as a 
free radical scavenger. 
o 
H O O C ' ' ^ 
Figure 1 Structure of CPL. 
Over the last decade, close attention has been paid to 
the interaction of CPL with various metal ions^ as drug 
metal interaction may result in the formation of a stable 
metal-drug complex, which may deplete the blood with 
trace element. On the other hand the side effect that can 
arise during CPL treatment may well be caused by the 
interaction of CPL with other metal ions present in the 
plasma. Therefore, to gain a deeper insight into the 
mechanism of the inhibition and side effect of CPL, 
equilibrium and structural studies were earlier per-
formed with several metal ions.' Studies have also been 
done on the use of transition metal ions for quantitative 
spectrophotometric determination of CPL in pharma-
ceutical formulations.'" CPL has also been assayed 
spectrofluorimetrically after reacting with fluorogenic 
reagents" or reducing Ce(IV) to fluorescent Ce(IIl).'^ 
The fluorescence spectroscopy has been widely used 
to monitor the molecular interaction because of its high 
sensitivity, reproducibility and relatively easy use. Since 
no detailed fluorescence study on the binding interac-
tion of CPL with Mg'"", Ca-"", Mn^^ Co^\ W*, Cu^ "" 
and Zn has been done so for, a thorough investigation 
was therefore made using this technique. Such interac-
tions between CPL and these metal ions can cause fluo-
rescence quenching. Therefore, valuable information 
such as binding mechanism, binding constant, and 
binding sites can be obtained using fluorescence 
quenching study of CPL by these metal cations. In addi-
tion the thermodynamic parameters of the process were 
also proposed in this work. 
Experimental 
Instruments, methods and materials 
The fluorescence emission spectra were scanned 
with a Hitachi-F-2500FL spectrophotometer. The phase 
modulation method was used to obtain fluorescence 
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lifetime by an SLM48000S spectrofluorometer (SLM 
Aminco, Rochester, NY). The procedure for lifetime 
measurement was described in reference. Doubly dis-
tilled water was used throughout. CPL (Across organ-
ics), sodium hydroxide, metal chloride (Merck Ltd, 
Mumbai, India), and HCl (Ranbaxy Fine Chem. Ltd, 
India) were used as received. 
Preparation of solution 
The stock solution of CPL in aqueous acidic medium 
(1 X 10"' mol'L"') was stored at 4 °C and metal salts 
of 1X10"' mol'L"' were prepared in doubly distilled 
water. 
The working solution of theCPL (8X 10~« mol'L]') 
and those of metal ions ( I X I 0 S 0 I 8 X I O * mol'L ') 
were prepared. The steady state fluorescence spectra of 
the drug were recorded in the X^m of 320—360 nm with 
excitation at the maximum centered at Acx = 305 nm. 
The excitation wavelength was chosen such that ab-
sorbance at this excitation wavelength was less then 
0.02 to minimize the inner-filter effect and to obtain the 
most complete emission spectrum as possible. 
Results and discussion 
Figure 2 shows the emission spectra of CPL in the 
presence of metal ions of various concentrations. It was 
observed that the fluorescence intensity of captopril de-
creased regularly with the increasing concentration of 
metal ions without any change in emission maxima and 
shape of peaks. As there was no significant Aem shift 
with the addition of metal ions, it was indicated that 
metal ion could quench intrinsic fluorescence of CPL 
and that the interaction between CPL and metal ion in-
deed existed without inducing any conformational 
change in it under the condition studied here. 
Quenching can occur by a variety of molecular in-
teractions, viz. excited-state reactions, molecular rear-
rangement, energy transfer, ground state complex for-
mation (static quenching) and coUisional or dynamic 
quenching. Static and dynamic quenching can be dis-
tinguished by their different dependence on temperature 
and excited state life time. Dynamic quenching is diffu-
sion controlled because the quencher must diffuse to the 
fluorophore during the life time of excited state. Since 
high temperature will result in large diffusion coeffi-
cient, the bimolecular quenching constants are expected 
to increase with temperature. If the K^,, decreased with 
increased temperature, it could be concluded that the 
quenching process was static rather than dynamic.'^''* 
Static quenching implies either the existence of a sphere 
of effective quenching or the formation of a ground 
state non-fluorescent complex, whereas collisional or 
dynamic quenching involves the collision and subse-
quent formation of a transient complex between an ex-
cited state fluorophore and a ground state quencher. The 
excited state complex dissociates upon radiative and 
non-radiative deactivation. In order to confirm the 
quenching mechanism the procedure of fluorescence 
quenching was first assumed to be dynamic. For dy-
namic quenching the mechanism can be described by 
the Stern-Volmer equation." 
Fo/F=l+Vo[Q]=l+/Csv[Q] (1) 
where, F^ and F are the fluorescence intensities in the 
absence and presence of the quencher, respectively, A^q 
is the bimolecular quenching rate constant, K^^ is the 
dynamic quenching constant and ro is the average life 
time of the molecule without quencher. Figure 3 dis-
plays the Stern-Volmer plots of quenching of CPL by 
different metal ions and at different temperatures. 
Based on the experimental data in Figure 3, the dy-
namic quenching constants and bimolecular quenching 
constants at different temperatures are shown in Table 1. 
It is evident from the table that the A^q values in each 
case are considerably larger than those possible for dif-
fusion controlled quenching in solution (about 10 L* 
moT'^ns"'). Usually, large K^ beyond the diffu-
sion-controlled limit indicates that some type of binding 
interaction exists between fluorophore and quencher.' 
It was observed that K^... decreased with increasing tem-
perature for all metal ions. It can be therefore, con-
cluded that the quenching is not initiated by a dynamic, 
but probably by a static process. Among all the metal 
quenchers, Cu'* quenches CPL the most effectively. 
The quenching constant by Cu * is larger than those by 
other metal quenchers and that of Mg^ is the minimal, 
which follows the order Cu^''>Ni''^^>Co^''>Ca^''> 
.2+ -2 + .2 + Zn >Mn >Mg . Cu is well known as a strong 
quencher because of its electronic structure (d'). 
Quenching by this type of substance most likely in-
volves the donation of an electron from the fluorophore 
to the quencher, and the ion dipole interaction between 
Cu^^ and the molecule will also be strong due to the 
large nuclear charge and the relatively small size com-
pared with other metals. Cu^' usually introduces easily 
accessible low energy levels, which can give rise to en-
ergy and electron transfer processes and is capable of 
quenching the fluorescent excited state of the mole-
Table 1 
27 and 37 
Stem-Vol 
•c 
KJ(\.-
27 "C 
liner and bimo 
•mol'') 
37 -C 
ilecular quenching 
/r</(L'mor' 
27 "C 
constant 
•s"') 
37 "C 
al 
Ca 2.82X10" 2.57X10" 8.47X10'^ 7.71X10'^ 
Mg 1.36X10" 1.21x10" 4.08X10'- 3.63X10'^ 
Mn 1.89X10" 1.83X10" 5.67X10'^ 5.49X10'^ 
Co 3.05x10" 2.73x10" 9.16X10'^ 8.19x10'^ 
Ni 4.11x10" 3.66X10" 12.34X10'^ 10.99x10'^ 
Cu 6.42X10" 5.09X10" 19.3XI0'^ I5.28XI0'^ 
Zn 2.66X10" 2.32X10" 7.98X10'^ 6.96X10'^ 
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Figure 2 Fluorescence enhancement (at X„ 305 nm) of CPL with Ca(II), Mg(II), Mn(II), Co(II), Ni(II), Cu(II) and Zn(Il) at rooin tem-
perature. 1: 7.0 nmol'L"' CPL, from 2 to 8: 2, 3, 6, 8, 10, 12, 18 nmol-L"' of metal ions. 
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Figure 3 Stem-Volmer plots of CPL with Ca(II), Mg(II). Mn(II), Co(II), Ni(II), Cu(II) and Zn(II) at 27 and 37 "C. 
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2 + 
cule. The larger K^^ and /Cq values of Ni' in com-
parison to Co '^^ , Mn^ "^  and Zn^^can be explained in 
terms of its smaller ionic radius and larger nuclear 
charge. In cases of Mn^ "^  and Zn^ "^  the A^sv and A^q are 
quite small due to their half filled and completely filled 
"d" orbitals, respectively. The K^v and K^ values for 
Ca^ '^  are larger than those of Mg^^ probably because 
of its higher reactivity and lower ionization potential. 
Binding constant and binding sites 
For static quenching, the relationship between inten-
sity and the concentration of quencher can be described 
by the binding constant formula. 18.19 
lg(Fo-F)/-F=lg/:+«lg[Q] (2) 
where K is the binding constant, and n is the number of 
binding sites per CPL. After the fluorescence quenching 
intensities of CPL at 340 nm were measured, the dou-
ble-logarithm algorithm was assessed by Eq. (2). Figure 
4 shows double-logarithm curve and Table 2 gives the 
corresponding calculated results. The linear correlation 
coefficients for all the curves are larger than 0.970, in-
dicating that the interaction between the metal ions and 
CPL agrees well with the site-binding model underlying 
Eq. (2). The value of binding constant for these 
CPL-metal complexes follows the same order as men-
tioned in cases of ^sv and K^ values and is in agreement 
with the Irving-Williams series in cases of transition 
metal series. 
Table 2 Binding 
cient at 27 and 37 
Ig 
27 "C 
; constant, 
•c 
K 
37 •c 
binding 
n 
27 V 
site and 
37 •c 
regression 
27 
R 
V 
coeffi-
37 •c 
Ca 
Mg 
Mn 
Co 
Ni 
Cu 
Zn 
2.319 
1.359 
1.285 
2.887 
3.416 
4.811 
2.535 
2.580 
1.492 
1.710 
2.828 
3.450 
5.049 
2.922 
0.58 
0.39 
0.35 
0.65 
0.74 
1.00 
0.58 
0.61 
0.43 
0.44 
0.66 
0.76 
1.07 
0.68 
0.996 
0.998 
0.985 
0.998 
0.999 
0.999 
0.999 
0.997 
0.960 
0.993 
0.997 
0.998 
0.998 
0.997 
Thermodynamic parameters and nature of binding 
forces 
Considering the dependence of the binding constant 
on the temperature a thermodynamic process was con-
sidered to be responsible for this interaction. Therefore, 
the thermodynamic parameters dependent on tempera-
ture were analyzed in order to further characterize the 
forces acting between CPL and metal ions. The ther-
modynamic parameters enthalpy changes (A//), entropy 
changes {AS), and free energy changes (AG) are the 
main evidences to determine the binding mode. If the 
temperature does not vary significantly, the enthalpy 
changes (AH) can be regarded as constant. The free en-
ergy change (AG) can be estimated from the following 
equation, based on the binding constant at different 
temperatures. 
AG=-2.303/?71gA: (3) 
where R is the gas constant, T is the experimental tem-
perature, and K is the binding constant at the corre-
sponding temperature. 
From the values of stability constant at different 
temperatures the enthalpy changes can be calculated by 
using equation: 
ig(A'2/A:i) = (I/r, - I/r:)A///2.303/? (4) 
The entropy changes can be calculated by using 
equation: 
AG=AH-mS (5) 
The thermodynamics parameters for the interaction 
of metal ions and CPL are shown in Table 3. The nega-
tive value of AG means that the interaction process is 
spontaneous. The positive AS value obtained for all in-
vestigated complex is characteristic of chelation, which 
occurs because the water molecules that are normally 
arranged in an orderly fashion around the CPL and 
metal ions have acquired a random configuration as a 
result of chelation. This is referred as gain in configura-
tional entropy." The positive value of AH indicate that 
the processes are endothermic and binding between the 
metal ions and CPL is mainly AS-driven, with little con-
tribution from the enthalpy factor. 
Table 3 Thermodynamics parameters at 27 and 37 'C 
Metal -
A(7/(kJ'mol~') 
27 'C 37 "C 
-A///(kJ-mor')- AS'/(kJ'mo)"''K~') 
27 'C 37 "C 
Ca -13.32 -14.82 
Mg -7.808 -8.575 
Mn 
Co 
Ni 
Cu 
Zn 
-7.386 -9.828 
-16.58 -16.24 
-19.62 -19.82 
-27.63 -29.00 
-14.56 -16.78 
46.59 
23.76 
75.50 
67.59 
6.160 
42.32 
68.93 
0.199 
0.105 
0.276 
0.280 
0.085 
0.233 
0.261 
0.I98I 
0.1043 
0.2752 
0.2704 
0.0838 
0.3371 
0.2604 
Conclusion 
In this paper we have investigated the nature and 
magnitude of the interaction of CPL with biologically 
important metal ions Mg"^, Ca'*, Mn"*, Co^*, Ni^*, 
Cu ' and Zn"' by fluorescence spectroscopy. Since the 
Stern-Volmer quenching constants, K^M in all cases are 
inversely proportional to temperature, it indicates that 
probable quenching mechanism is initiated by static 
quenching. Cu^' is the best quencher among all the 
metal ions. The thermodynamic parameters showed that 
the interaction between CPL and metal ions was spon-
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taneous and entropically favored in which entropy in-
creased and Gibbs free energy decreased. The positive 
value of A5 indicates the gain in configurational en-
tropy. 
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Binding Constant: Fluorescence Quenching of 
Ciprofloxacin with Fe(III) and Zn(II) 
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Absorbancc and fluorescence spectral pattern of ciprofloxacin in 
absence and presence of Fedll) and Zn(II) has been studied at loom 
temperature and under physiological condition. The lluorescence s|xctra 
of the drug in presence of the ditterent ciuantitics and different concen-
trations of (he Fe(IlI) and Zn(/I) showed (he quenchinj; of ciprofloxacin. 
It was observed that with increasing quantity of the quencher the emission 
intensity decreases with negligible variation in the peak position. The 
absorption spectra of the drug at different pH e.xhibits two isosbesiic 
points at 320 and 350 nm indicating the presence of three chemical 
species in solution. The ratio of the two reacting components, the daig 
and the metal ions was determined by absorption and fluorescence spectro-
photometrically. 
Key Words: Ciprofloxacin, HCI, Fluorescence quenching, Binding 
constant. Stability constant. 
INTRODUCTION 
Ciprotloxacin is [ 1 -cyclopiopy 1-6-nuoro-1,4-(Jihydio-4-oxo-7-(piperazinyl)-
quinolone-3-carboxylic acidj one of the fluoroquinolones used as broad spectrum 
drug against gram positive and gram negative bacteria. It has been found that the 
activity of quinolone drugs is completely lost if consumed with antacids containing 
aluminum or magnesium because the drug is neutralized. At higher pH precipitation 
occurs and the drug is made unavailable for absorption' •*. The mechanism of inter-
action of quinolone with metal ions is based on the chelation of the metal with the 
carbonyl and cai'boxyl groups of the drug (Fig. 1). The antibacterial activity of the 
drug has also been found to be reduced manifold after chelation' of the metal ions 
via these groups. 
Fig. I. Stiucttire of ciproflo.xacin 
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The interaction of fluoroquinolones with metal ions has attracted considerable 
interest not only for the development of analytical techniques but also to provide 
infonnation about the mechanism of action of the pharmaceutical preparation*'. 
Since the metal ions cause fluorescence quenching of the drug, spectrofluorimetric 
method for quantitative determination of the quinolone type drugs has been devel-
oped^" besides titrimetric' spectrophotometeric'", electrochemical", electrophoretic'-
and chromatographic''' techniques. 
The maximum solubility of the ciprofloxacin has been reported at 37 'C. which 
also happens to be the normal temperature of human body although the interaction 
of drug with metal ions has been studied in a wide range of temperature between 25 
-60 ^ c'^ '^ Since we have to mimic the biological system under physiological condi-
tion we have studied, the interaction of Fe(IlI) and Znfll) with ciprofloxacin at 
room temperature using absorption and fluorescence emission spectrophotometry 
at pH 3.98. The stability of the Fe(lll) and Zn(ll) complexes has been calculated by 
.spectrophotometric and fluorescence emission spectrophotometric techniques. The 
fluorescence spectroscopy has been widely used to monitor the molecular interaction 
because of its high sensitivity, reproducibility and relatively easy u.se. Since no 
detailed fluore.scence study on the binding interaction of ciprofloxacin with Fe(III) 
and Zn(II) has been done so for, a through investigation was therefore made using 
this technique. Such interactions between ciprofloxacin and the,se metal ions can 
cause fluorescence quenching. Therefore, valuable information's such as binding 
mechanism, binding constant and binding sites can be obtained using fluorescence 
quenching study of ciprofloxacin by these metal cations. In addition the thermody-
namic parameters of the process were also proposed in this work. 
EXPERIMENTAL 
Fluorescence emission spectra were scanned using a Hitachi-F-2300 FL-spectro-
photometer. The absorption spectra were obtained with Elico-SL-169 double beam 
UV-Vis spectrophotometer. All potentiometric measurements were cairied out with 
Elico-LI-12()pH meter. 
Ciprofloxacin was purchased from Windlas Biotech. Ltd.(India). All solvents 
and chemicals were of analytical grade. Double distilled water was used throughout. 
Sodium hydroxide, Fe(N03):-,.9H:0 (Merck Ltd., Mumbai. India) ZnCI: (anhydrous) 
(SDH Pvt. Ltd. India) and hydrochloric acid (Ranbaxy fine chem. Ltd., India) were 
used as received. 
Preparation of .solutions: The stock solution of ciprofloxacin HCl (5 x 10 - M) 
prepared in 1 x 10^ M HCl was stored at 4 °C and those of the metal salts (1x10^ M) 
were prepared in double distilled water, respectively. All working solutions were 
prepared by dilution with double distilled water. 
Spectrophotometeric methods: Solutions of equimolar concentration (I x 
lO"* M; of ciprofloxacin HCl and metal ions were prepared. The pH of the drug was 
adjusted between 2.12 to 10.50 by adding sodium hydroxide and hydrochloric acid 
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(1 X 10 ' M to 1 X 10^ M). The absorption spectra were recorded in the range 230-
360 nm. The ratio of metal to ciprofloxacin.HCl was determined by Job's method. 
The linearity of ciprofloxacin HCl was found in the range 3.5 x 10'*-7.5 x 10"^  mg/mL 
and the correlation factor (R )^ 0.9629. 
Fluorescence spectrophotometeric methods: Solution of the ciprofloxacin 
(5 X 10''M)and those of metal ions (1 x lO'^Mto 10.5x lO* M) were prepared. To 
prepare dilute solutions, an aliquot of stock solution was placed in a 10 niL volumetiic 
flask and made up to the mark with distilled water. Spectra were recorded immedi-
ately after sample preparation in the optimum wavelength range 3()0-6(X) nm at 
optimum excitation wavelength of 315 nm. For calibration curve an aliquot ofstock 
solution (5 X I0"^ -1 x 10" mg/mL) was prepared which showed linearity with corre-
lation factor (R') 0.9739. 
RESULTS AND DISCUSSION 
Absorption .studies: The absolution spectrum of ciprofloxacin run at room 
temperature and at constant pH 3.98 displayed a strong peak at 272 nm and a weak 
absorption at 315 nm (Fig. 2). When the UV spectra of the drug were run at vaiying 
pH, at room temperature and, under physiological condition, the strong peak was 
shifted to lower wavelength while the broad peak was shifted to higher wavelength. 
The decrease in the position and intensity of the first peak is attributed to the extent 
of ionization of the carboxylic group while the increase in the intensity and height 
of the peak at 315 nm occurs as a consequence of protonation of the piperazinyl 
nitrogen on 7-carbon atom. Two isosbestic points appearing at 320 and 350 nm 
indicated the presence of three chemical species in solution (Fig. 3) similar to those 
observed bv Bark and Barrell'"'. 
230 260 290 320 
Wavelength (nn^ 
350 
Fig .2. Absorption spectrum of ciprofloxacin 
(i X 10-'M)atpH.3,98 
I pH2.12 
2. pH.\98 
i.pHS.M 
4.pH6.31 
5. pH7.41 
6.pH8.35 
T.pH9.?A 
S.pHlO.'iO 
260 290 320 
Wavelength (nm) 
Fig. 3. Absorption spectra of ciprofloxacin 
(1 X 10"" M) at different pH (2.12-10.50) 
at 25 "C 
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The apparent ionization constant (pKa') of the drug was.calculated (6.871) by 
the following equation. 
pKa' = pH + log ((Ai - AM)/(A - AM) ) (1) 
where, Ai = Absorbance of drug in basic medium. AM = Absorbance of drog in 
acidic medium, A = Ab.sorbance of drug in aqueou,s medium. The pure drug ha.s 
maximum .solubility at pH 5 although it increases in the presence of Fe(Il) and 
Fe(ill) ions'". 
Tile stability constant of the complexes were calculated by the continuous vaiiation 
method using the following equation: 
r^ A/A„Cx ^ 
(CM-A/A„Cx)(CL-nA/A„Cxr '"^ 
where, K is the stability constant of the metal chelate formed in solution, M = 
metal, L = ligand. n = X/( 1-X) where X is the mole fraction of the ligand at maximum 
absorption. A/A,., is the ratio of the observed absorbance to that indicated by the 
tangent for the same wavelength. Cx. CM and Ci. are the limiting concentration, 
metal ion concentration and the ligand concentrations, respectively. 
The continuous variation curves are shown in Fig. 4. The ratio of ciprofloxacin: 
metal, is 2:1, which is quite obvious. The fairly large value of log k of the two 
complexes (Table-1) suggests that they are pretty stable in acidic medium only. 
The dnig under this condition mu.st be acting as ionophore since the .solubility of 
the drug is maximum in presence of Fe(III). However, precipitation occurs when 
the solution becomes alkaline'^'\ 
1,8 
1.6 
1.4 
^ 1-2 
1 
0,8 
0.6 
Fig. 4. Continuous variation curves of equimolar solutions of ciprofloxacin and (A) Fe(lll) 
and (B) Zn(II) at 25 "C 
Fluorescence study: The absorption spectrum of the daig is markedly different 
from its emission spectrum, which is attributed to different molecular geometries 
(Fig. 5) in ground and excited states. The piperazir.yl group of ciprofloxacin acts as 
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TABLE-1 
STABILITY CONSTANT (log K AND -AG OF THE FORMED 
CHELATES AT 25 °C BY ABSORPTION STUDY 
Metal logK AG(kJmol') 
Fe(Ill) 
Zn(ll) 
9.378 
9.381 
-53.509 
-53.526 
Basic medium 
Zwitterion 
Acidic medium 
Increasing acidity 
Zwitter ion condition decreasing 
Fig. 5, Zwitterion formation and intramolecular charge transfer of drug in solution phase 
at var>'ing pH 
electron donor while the keto group acts as electron acceptor. Since all investigations 
were done in acidic medium, ciprofloxacin exists in zwitter ionic form. The peaks 
in the absorption spectra are due to intramolecular charge transfer, the greater the 
number of resonating suuctures the strongc" the fluorescence emission. 
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The fluorescence spectra are very sensitive to the nature of the metal quencher, 
which is reflected from the emission spectra of the drug in presence of the Fe(lll) 
and Zn(II) quencher. They showed a consistent decrease in the intensity of lluores-
cence with increasing concentration of the metal ion until it was nearly completely 
quenched (Fig. 6) as a consequence of the complex formation between the metal 
ions and ciprofloxacin. 
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Fig. 6. The fluorescence emission spectra of drug quenched (.A) Fedll) and (Bl Zn(ll) 
Many workers''*-^ " have studied the interaction of drug with metal ions at temper-
ature exceeding 37 "C in order to show the Stem-Volmer plot although such experi-
ments above body temperature do not mimic the biological system. We, therefore, 
did all the experiments at room temperature. The fluorescence intensity increases 
rapidly with decrease in temperature. The lower stability at higher temperature also 
supports lowering in quenching. The fluorophore is quenched both by collision and 
complex formation with the metal ions. The complex formation is mainly due to 
ion dipole interaction. 
Fluorescence quenching refers to any process in which the fluorescence intensity 
of a given fluorophore decreases upon adding a quencher. Assuming that the fluore-
.scence intensity of a fluorophore-quencher complex is negligible as compared to 
an unquenched fluorophore, the intensity in the absence (F«) and presence (F) of 
the quencher is expressed by Stern-Volmer equation 
F. , /F=l+Ksv(Ql (3) 
where |Q) is the concentration of quencher, Ksv is the Stern-Volmer constant which 
is the equilibrium con,stant of the complex formed in the .static quenching process. 
If a system obeys the Stern-Volmer equation, a plot of F./F-l vs. |Q| will give 
straight line with a slope of Ksv and y-axis intercept. Fig. 8 represents the quenching 
of ciprofloxacin by Fe(IlI) and Zn(Il), respectively. The linearity of Stern-Volmer 
plot (Fig. 7) increases with increasing concentration of quencher. The values of 
Ksv and correlation coefficient are shown in Table-2. 
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Fig. 8. Double reciprocal plot of drug with Fe(III) and Zn(U) 
TABLE-2 
STERN-VOLMER CONSTANT (Ksv, BINDING CONSTANT (log k), 
BINDING SITE AND REGRESSION COEFFICIENT AT 25 and 35 °C 
Metal 
Fe(ni) 
Zn(n) 
Ksv/mol' 
25°C 35°C 
3.36x10^ 2.77x10^ 
2.97x10^ 2.48x10"' 
logK 
25°C 35°C 
9.42 9.58 
9.46 9.60 
n 
25 °C 
1.88 
1.89 
35 °C 
1.97 
2.01 
R= 
25 °C 
0.982 
0,981 
35 °C 
0.950 
0.965 
The metal ions with large nuclear charge and small size will experience greater 
ion-dipole interaction and hence the emission intensity in the case of Zn(II) should 
be less than that for Fe(IH) although FeHII) has greater nuclear charge and smaller 
ionic radius. 
The large value of stability constant of the complexes formed in solution reflects 
strong interaction between ciprofloxacin and the metal ions. 
Binding con.stant and binding sites: F^ or static quenching, the relationship 
between intensity and the concentration of quencher can be described by the binding 
constant formula"'": 
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log(F„-F)/F = log K + n log (Q) (4) 
where K is the binding constant (Table-3), n is the number of binding sites per 
ciprofloxacin. After the fluorescence quenching intensities on cipiofloxacin at 315 nm 
were measured, the double-logarithm algorithm was assessed by eqn. 4. Fig. 8 
shows double-logarithm curve and Table-2 gives the coiTcsponding calculated results. 
The linear correlation coefficient for all the curves are larger than 0.945. indicating 
that the interaction between meial ions and ciprofloxacin agrees well with the site-
binding model underlying eqn. 4. The results illustrate that there is a strong binding 
force between ciprofloxacin and metal ions and approximately two binding site 
would be formed in each case which is consistent with the previous studies that in 
acidic medium ciprofloxacin and metal ions form 2:1 complex. 
TABLE-3 
THERMODYNAMICS PARAMETERS AT 25 AND 35 °C 
Metal 
Fe(III) 
Zn(Il) 
AG (kj mol') 
25 °C 35 °C 
-53.77 -56.54 
-54.01 -56.62 
118.59 
98.94 
AS(kJmor' K') 
25 °C 35 °C 
180.85 183.96 
181.57 184.16 
Thermodynamic parameters and nature of binding forces: Considering the 
dependence of the binding constant on the temperature a thermodynamic process 
was considered to be responsible for this interaction. Therefore, the thermody-
namic parameters dependent on temperature were analyzed in order to further charact-
erize the forces acting between drug and metal ions. The thermodynamic parameters 
enthalpy changes (AH), entropy changes (AS) and free energy changes (AG) are the 
main evidences to determine the binding mode. If the temperature does not vary 
significantly, the enthalpy changes (AH) can be regarded as constant. The free energy 
change (AG) can be estimated from the following equation, based on the binding 
constant at different temperatures. 
AG = -2.303 RT log K (3) 
where R is the gas constant, T is the experimental temperature and K is the binding 
constant at the corresponding temperature. 
From the value of stability constant at different temperature the enthalpy changes 
can be calculated by u.sing equation: 
logK/K, = [1/T,-1/T2]AH/2.303R (4) 
The entropy changes can be calculated by using equation: 
AG = AH-TAS (5) 
Thermodynamics parameters for the interaction of metal ions and ciprofloxacin 
are shown in Table-3. The negative value of AG means that the interaction process 
is .spontaneous. The +ve AS value obtained for all investigated complex is chiuacter-
istic of chelation. It occurs because the water molecules that are normally arranged 
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in an orderly fashion around the ciprofloxacin and metal ions have acquired a random 
configuration as a result of chelation. This is referred as gain in configurational 
entropy". The +ve value of AH indicate that the processes are endothermic and 
binding between metal ions and ciprofloxacin is mainly AS-driven. with little contri-
bution from the enthalpy factor. 
Conclusion 
It is concluded that the drug stays as zwitter ions. Ionization of carboxylic 
group and protonation of piperazinyl group occurs. The two isosbestic points indicate 
the presence of three chemical species in solution. The result shows that the complex 
of ciprofloxacin with Fe(in) and Zn(II) are fairly stable. The thermodynamic para-
meters showed that the interaction between ciprofloxacin and metal ion was spontan-
eous and that the hydrophobic force was a major factor in the interaction. 
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